index,Regulator Name,Regulator Type,Regulator Subtype,Regulator HGNC Symbol,Regulator Database,Regulator ID,Regulator Compartment,Regulator Compartment ID,Regulated Name,Regulated Type,Regulated Subtype,Regulated HGNC Symbol,Regulated Database,Regulated ID,Regulated Compartment,Regulated Compartment ID,Sign,Connection Type,Mechanism,Site,Cell Line,Cell Type,Tissue Type,Organism,Score,Source,Statements,Paper IDs,Evidence Score,Match Score,Kind Score,Epistemic Value,Total Score
279,mapk,other,,,text,mapk,,,stat3,protein,,hgnc:11364,hgnc,11364,,,positive,i,activation,,,,,,0.65,nan,"nevertheless, these observations strengthen our claim that belinostat treatment attenuates mapk signaling, which in return triggers positive stat3 activation as a feedback mechanism.",pmc5537703,1,100,40,1,140
178,gabpa,protein,,hgnc:4071,hgnc,4071,,,tert,protein,,hgnc:11730,hgnc,11730,,,positive,i,activation,,,,,,0.86,nan,"amongst the several ets1 members that have been shown to bind at the sites created by the mutation at -124 position, gabpa has been shown to drive efficient tert transcription [xref_bibr].",pmc5288173,1,100,40,1,140
522,tgn-020,other,,,text,tgn-020,,,il6,protein,,hgnc:6018,hgnc,6018,,,negative,i,decreaseamount,,,,,,0.86,nan,"we thus found that tgn-020 upregulated the threshold of thermal and mechanical allodynia, downregulated the expression of interleukin-1β, interleukin-6, and tumor necrosis factor-α, attenuated the astrocytic activation and suppressed the activation of mitogen-activated protein kinase pathways in the spinal dorsal horn and dorsal root ganglion.",pmc6113736,1,100,40,1,140
521,tgn-020,other,,,text,tgn-020,,,il1b,protein,,hgnc:5992,hgnc,5992,,,negative,i,decreaseamount,,,,,,0.65,nan,"we thus found that tgn-020 upregulated the
threshold of thermal and mechanical allodynia, downregulated the expression of
interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha, attenuated the
astrocytic activation and suppressed the activation of mitogen-activated protein
kinase pathways in the spinal dorsal horn and dorsal root ganglion.",pmc6113736,1,100,40,1,140
503,tcf7l2,protein,,hgnc:11641,hgnc,11641,,,glucose,chemical,,,chebi,chebi:17234,,,negative,i,inhibition,,,,,,0.65,nan,"stable knockdown of foxo3, ncoa3, and tcf7l2 increased growth of dld-1 kras wt/- cells in low glucose without any growth advantage in normal glucose medium.",pmc5755028,1,100,40,1,140
79,dasatinib (anhydrous),chemical,,,chebi,chebi:49375,,,src,protein,,hgnc:11283,hgnc,11283,,,positive,i,activation,,,,,,0.65,nan,"due to the ability of dasatinib to target a number of kinases, in addition to src xref_bibr, xref_bibr, we wanted to next validate the role of src in mediating tumorigenesis and regulating the pi3k pathway, in the dasatinib-intrinsically resistant cell lines.",pmc5833015,1,100,40,1,140
81,dexamethasone,chemical,,,chebi,chebi:41879,,,bcl2,protein,,hgnc:990,hgnc,990,,,negative,i,inhibition,,,,,,0.65,nan,"for meki, synergism has been demonstrated for pi3k and akt inhibitors, dexamethasone, nutlin-3a, which induces the mdm2-p53 axis, and the bcl-2 and bcl-x (l) inhibitor, navitoclax (abt263).",pmc4067595,1,100,40,1,140
122,erk,other,,,text,erk,,,autophagy,biologicalprocess,,,go,go:0006914,,,negative,i,inhibition,,,,,,0.923,nan,the suppression of mek and erk pathway in nabut-senescent eras cells with high torc1 activity initially induces mtorc1 independent autophagy that destabilizes stringent anabolic and catabolic equilibrium of senescent cells resulting in apoptosis.,pmc5723691,1,100,40,1,140
123,erk,other,,,text,erk,,,autophagy,biologicalprocess,,,go,go:0006914,,,positive,i,activation,,,,,,0.65,nan,inhibition of mek and erk pathway in eras cells induced to senescence with nabut impairs autophagy and cellular survival.,pmc5723691,1,100,40,1,140
440,ras,other,,,text,ras,,,stat3,protein,,hgnc:11364,hgnc,11364,,,,i,phosphorylation,,,,,,0.86,nan,these data support the conclusion that ras-dependent stat3 s727 phosphorylation is mek dependent in tumors of both mouse and human origin.,pmc3843736,1,100,40,1,140
439,ras,other,,,text,ras,,,stat3,protein,,hgnc:11364,hgnc,11364,,,,d,phosphorylation,,,,,,0.65,nan,"these data suggest that activated ras is sufficient to maximally phosphorylate mitochondrial stat3, at least to an extent that saturates any function required for transformation.",pmc3843736,1,100,40,1,140
432,ras,other,,,text,ras,,,myc,protein,,hgnc:7553,hgnc,7553,,,negative,i,decreaseamount,,,,,,0.65,nan,"downregulation of ras and mapk1 resulted in ras-mapk1 inhibition, decreased mek and akt phosphorylation and decreased myc levels.",pmc5312311,1,100,40,1,140
158,ets1,protein,,hgnc:3488,hgnc,3488,,,tert,protein,,hgnc:11730,hgnc,11730,,,positive,i,activation,,,,,,0.65,nan,these data demonstrate that ets1 is selectively recruited to the mutant tert allele in melanoma cell lines and induce an allele specific activation of tert.,pmc5288173,1,100,40,1,140
159,ets1,protein,,hgnc:3488,hgnc,3488,,,tert,protein,,hgnc:11730,hgnc,11730,,,positive,i,increaseamount,,,,,,0.86,nan,"u0126 inhibited erk activation and reduced tert expression, which was not further decreased by ets1 or gabpa depletion.",pmc5288173,1,100,40,1,140
171,foxo3,protein,,hgnc:3821,hgnc,3821,,,glucose,chemical,,,chebi,chebi:17234,,,negative,i,inhibition,,,,,,0.65,nan,"stable knockdown of foxo3, ncoa3, and tcf7l2 increased growth of dld-1 kras wt/- cells in low glucose without any growth advantage in normal glucose medium.",pmc5755028,1,100,40,1,140
177,gabpa,protein,,hgnc:4071,hgnc,4071,,,tert,protein,,hgnc:11730,hgnc,11730,,,negative,i,inhibition,,,,,,0.65,nan,"gabpa could be in a complex preventing binding of the antibody by masking the epitope, or epigenetic modifications of the tert promoter in our cells could prevent binding of the transcription factor [xref_bibr].",pmc5288173,1,100,40,1,140
179,gabpa,protein,,hgnc:4071,hgnc,4071,,,tert,protein,,hgnc:11730,hgnc,11730,,,positive,i,increaseamount,,,,,,0.9419,nan,"as gabpa has been previously shown to drive efficient tert transcription in cell lines with the mutations [xref_bibr], we tested whether inhibition of gabpa by rna interference decreased tert expression.",pmc5288173,1,100,40,1,140
525,tiam1,protein,,hgnc:11805,hgnc,11805,,,rac1,protein,,hgnc:9801,hgnc,9801,,,positive,i,activation,,,,,,0.65,nan,"although the exact mechanism is unknown, nm23-h1 was shown to interact with factors involved in rac1 activation, such as the small gtpase arf6 or the nucleotide exchange factor tiam1 [xref_bibr, xref_bibr].",pmc4020307,1,100,40,1,140
185,gk,protein,,hgnc:4289,hgnc,4289,,,rps6,protein,,hgnc:10429,hgnc,10429,,,,i,dephosphorylation,,,,,,0.65,nan,"importantly, the c-src gk mutant abrogates the reduction in akt and rps6 phosphorylation observed with either single agent or the combination, indicating that the ability of dasatinib to reduce signaling through the pi3k pathway is mediated through its inhibitory effects on src.",pmc5833015,1,100,40,1,140
394,pi3k,other,,,text,pi3k,,,stat3,protein,,hgnc:11364,hgnc,11364,,,,i,phosphorylation,,,,,,0.65,nan,"these data also show that the raf-mek-erk pathway, and not the pi3k pathway triggered by ras oncoproteins leads to stat3 s727 phosphorylation.",pmc3843736,1,100,40,1,140
390,pi3k,other,,,text,pi3k,,,bcl2,protein,,hgnc:990,hgnc,990,,,negative,i,inhibition,,,,,,0.65,nan,"for meki, synergism has been demonstrated for pi3k and akt inhibitors, dexamethasone, nutlin-3a, which induces the mdm2-p53 axis, and the bcl-2 and bcl-x (l) inhibitor, navitoclax (abt263).",pmc4067595,1,100,40,1,140
217,integrins,biologicalprocess,,,go,go:0034666,,,hras,protein,,hgnc:5173,hgnc,5173,,,negative,i,inhibition,,,,,,0.65,nan,we demonstrated here that epithelial cells expressing the alpha4beta1 integrin and persistently engaged in vitro with the ecm glycoprotein emilin1 and gc1q promoted an integrin dependent downregulation of hras signaling.,pmc5432316,1,100,40,1,140
230,jnk,other,,,text,jnk,,,tnf,protein,,hgnc:11892,hgnc,11892,,,positive,i,activation,,,,,,0.86,nan,"finally, the negative regulation of the jnk mapk pathway by ptpn1 was found to reduce the tumor necrosis factor alpha (tnfalpha)-dependent cell death response.",pmc5636874,1,100,40,1,140
365,p70s6k-ca,other,,,text,p70s6k-ca,,,rps6,protein,,hgnc:10429,hgnc,10429,,,,i,dephosphorylation,,,,,,0.65,nan,"expression of p70s6k-ca was able to partially rescue the inhibition of rps6 phosphorylation in the presence of the combination therapy, as we observed a 2-fold to 5-fold attenuation in the reduction in rps6 phosphorylation when treating with the combination therapy, in comparison to the controls.",pmc5833015,1,100,40,1,140
248,let-7,other,,,text,let-7,,,hras,protein,,hgnc:5173,hgnc,5173,,,positive,i,activation,,,,,,0.65,nan,"to date, let-7 has been reported to target hras [xref_bibr] and kras [xref_bibr], mir-200c and mir-30c target kras, mir-148b targets nras, mir-7 targets raf1, mir-206 targets rasa1 and mir-21 targets spred1 in breast cancer cells [xref_bibr].",pmc5410235,1,100,40,1,140
347,nras,protein,,hgnc:7989,hgnc,7989,,,tert,protein,,hgnc:11730,hgnc,11730,,,positive,i,increaseamount,,,,,,0.65,nan,"the acquisition of tert promoter mutation in braf or nras mutated melanoma probably allows the re-expression of tert leading to the immortalization process on path to melanoma development, together with other alterations such as inactivation of cyclin dependent kinase inhibitor 2a (cdkn2a).",pmc5288173,1,100,40,1,140
344,nme1,protein,,hgnc:7849,hgnc,7849,,,rac1,protein,,hgnc:9801,hgnc,9801,,,negative,i,inhibition,,,,,,0.65,nan,elevated rac1 level upon nm23 knockdown suggests that nm23 inhibits rac1 activation.,pmc4020307,1,100,40,1,140
283,mapk1,protein,,hgnc:6871,hgnc,6871,,,myc,protein,,hgnc:7553,hgnc,7553,,,negative,i,decreaseamount,,,,,,0.65,nan,"downregulation of ras and mapk1 resulted in ras-mapk1 inhibition, decreased mek and akt phosphorylation and decreased myc levels.",pmc5312311,1,100,40,1,140
334,ncoa3,protein,,hgnc:7670,hgnc,7670,,,glucose,chemical,,,chebi,chebi:17234,,,negative,i,inhibition,,,,,,0.65,nan,"stable knockdown of foxo3, ncoa3, and tcf7l2 increased growth of dld-1 kras wt/- cells in low glucose without any growth advantage in normal glucose medium.",pmc5755028,1,100,40,1,140
298,mek,other,,,text,mek,,,stat3,protein,,hgnc:11364,hgnc,11364,,,negative,i,inhibition,,,,,,0.86,nan,"(2014) have previously demonstrated that mek inhibition induces activation of stat3 through a feedback mechanism, therefore supporting a strong mechanistic link between hdac inhibition and mapk signaling pathways (vultur etal., 2014).",pmc5537703,1,100,40,1,140
301,mek-erk,other,,,text,mek-erk,,,stat3,protein,,hgnc:11364,hgnc,11364,,,,i,phosphorylation,,,,,,0.65,nan,"moreover, we showed that inhibition of the mek-erk pathway with pd0325901 reduced stat3 s727 phosphorylation to undetectable levels.",pmc3843736,1,100,40,1,140
306,mir-181a,other,,,text,mir-181a,,,bcl2,protein,,hgnc:990,hgnc,990,,,negative,i,inhibition,,,,,,0.65,nan,bai et al. also demonstrated that mir-181a may reduce bcl2 and thus enhance chemosensitivity of aml cells [xref_bibr].,pmc5312311,1,100,40,1,140
50,braf,protein,,hgnc:1097,hgnc,1097,,,tert,protein,,hgnc:11730,hgnc,11730,,,positive,i,increaseamount,,,,,,0.65,nan,"the acquisition of tert promoter mutation in braf or nras mutated melanoma probably allows the re-expression of tert leading to the immortalization process on path to melanoma development, together with other alterations such as inactivation of cyclin dependent kinase inhibitor 2a (cdkn2a).",pmc5288173,1,100,40,1,140
157,ets1,protein,,hgnc:3488,hgnc,3488,,,tert,protein,,hgnc:11730,hgnc,11730,,,negative,i,decreaseamount,,,,,,0.65,nan,ets1 down-regulation partially inhibits tert expression in cell lines with the tert promoter mutations.,pmc5288173,1,100,40,1,140
542,u0126,chemical,,,chebi,chebi:90693,,,tert,protein,,hgnc:11730,hgnc,11730,,,positive,i,activation,,,,,,0.65,nan,"to evaluate the role of mapk activation in tert expression, four representative cell lines with (m74, wm266.4) or without (c8161, ukrv-mel21) tert promoter mutations were treated with the mek inhibitor u0126.",pmc5288173,1,100,40,1,140
4,afatinib,chemical,,,chebi,chebi:61390,,,egfr,protein,,hgnc:3236,hgnc,3236,,,negative,i,inhibition,,,,,,0.65,nan,"based on egfr and her2 dual inhibition by afatinib, we could clearly discriminate the organoid panel in two types of responders, namely the sensitive versus the resistant ones (xref_fig, green versus red lines respectively).",pmc5127645,1,100,40,1,140
23,arf6,protein,,hgnc:659,hgnc,659,,,rac1,protein,,hgnc:9801,hgnc,9801,,,positive,i,activation,,,,,,0.65,nan,"although the exact mechanism is unknown, nm23-h1 was shown to interact with factors involved in rac1 activation, such as the small gtpase arf6 or the nucleotide exchange factor tiam1 [xref_bibr, xref_bibr].",pmc4020307,1,100,40,1,140
13,ampk,other,,,text,ampk,,,autophagy,biologicalprocess,,,go,go:0006914,,,positive,i,activation,,,,,,0.923,nan,"to clarify whether the development of pd0325901 resistance is linked to ampk mediated autophagy, we used an atp-competitive inhibitor of amp-kinase activity compound c together in combination with pd0325901.",pmc5723691,1,100,40,1,140
543,u0126,chemical,,,chebi,chebi:90693,,,tert,protein,,hgnc:11730,hgnc,11730,,,positive,i,increaseamount,,,,,,0.65,nan,"u0126 inhibited erk activation and reduced tert expression, which was not further decreased by ets1 or gabpa depletion.",pmc5288173,1,100,40,1,140
557,vemurafenib,chemical,,,chebi,chebi:63637,,,ifng,protein,,hgnc:5438,hgnc,5438,,,positive,i,activation,,,,,,0.65,nan,"however, adoptively transferred t cells exhibited increased functionality as measured by ifn-gamma production and their ability to lyse tumor cells in mice treated with act and vemurafenib.",pmc3809567,1,100,40,1,140
9,akt inhibitors,other,,,text,akt inhibitors,,,bcl2,protein,,hgnc:990,hgnc,990,,,negative,i,inhibition,,,,,,0.65,nan,"for meki, synergism has been demonstrated for pi3k and akt inhibitors, dexamethasone, nutlin-3a, which induces the mdm2-p53 axis, and the bcl-2 and bcl-x (l) inhibitor, navitoclax (abt263).",pmc4067595,1,100,40,1,140
207,hras,protein,,hgnc:5173,hgnc,5173,,,stat3,protein,,hgnc:11364,hgnc,11364,,,,i,phosphorylation,,,,,,0.65,nan,"in this study we show that the h-ras oncoprotein engages the mek-erk pathway to drive phosphorylation of stat3 on s727, while phosphoinositide 3-kinase (pi3k) and mtor activity were superfluous.",pmc3843736,1,10,38,1,48
210,il1b,protein,,hgnc:5992,hgnc,5992,,,mapk,other,,,text,mapk,,,negative,i,inhibition,,,,,,"0.65,0.65","nan,nan","the brain injury and il-1beta stimulation reduced sirt1 and activated mapk pathway leading to the astrocyte activation.,we thus found that tgn-020 upregulated the threshold of thermal and mechanical allodynia, downregulated the expression of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha, attenuated the astrocytic activation and suppressed the activation of mitogen activated protein kinase pathways in the spinal dorsal horn and dorsal root ganglion.","pmc5372348,pmc6113736",2,1,40,1,42
99,dusp5,protein,,hgnc:3071,hgnc,3071,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,subtle changes in the spatiotemporal regulation and activity of erk induced by dusp5 and dusp6 inactivation may also explain the observed impact on invasion and migration in bcpap and 8505 cells.,pmc5599027,1,1,40,1,41
20,araf,protein,,hgnc:646,hgnc,646,,,mek,other,,,text,mek,,,,d,phosphorylation,,,,,,0.65,nan,"in contrast, immunoprecipitated raf1 and a-raf scarcely phosphorylated mek regardless of the differentiation stage (xref_fig and not depicted).",pmc2064279,1,1,40,1,41
21,araf,protein,,hgnc:646,hgnc,646,,,ras-erk,other,,,text,ras-erk,,,negative,i,inhibition,,,,,,0.923,nan,da-raf1 antagonizes the ras-erk pathway.,pmc2064279,1,1,40,1,41
22,araf,protein,,hgnc:646,hgnc,646,,,tnnt1,protein,,hgnc:11948,hgnc,11948,,,positive,i,activation,,,,,,0.65,nan,the transfection of daraf1 also elevated the ratio of myhc expressing cells (xref_fig) and tnt expressing cells (xref_fig) two- to several fold during differentiation.,pmc2064279,1,1,40,1,41
498,src,protein,,hgnc:11283,hgnc,11283,,,pi3k,other,,,text,pi3k,,,positive,i,activation,,,,,,0.65,nan,"therefore, this data supports a role for src mediated pi3k pathway activation, in thyroid cancer cell lines.",pmc5833015,1,1,40,1,41
497,src,protein,,hgnc:11283,hgnc,11283,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,negative,i,inhibition,,,,,,0.65,nan,"in support of this data, multiple laboratories have demonstrated that the combined inhibition of src and the mapk pathway results in synergistic inhibition of growth and increased apoptosis of thyroid cancer cells both in vitro and in vivo xref_bibr - xref_bibr.",pmc5833015,1,1,40,1,41
286,mdm2,protein,,hgnc:6973,hgnc,6973,,,tp53,protein,,hgnc:11998,hgnc,11998,,,negative,i,inhibition,,,,,,0.65,nan,"interestingly, hdac inhibitors have been previously implicated in the depletion of mutant p53 through the transcriptional induction of mdm2, an e3 ubiquitin ligase that negatively regulates p53, instead of directly affecting tp53 transcription (blagosklonny etal., 2005).",pmc5537703,1,1,40,1,41
115,egfr,protein,,hgnc:3236,hgnc,3236,,,pi3k,other,,,text,pi3k,,,positive,i,activation,,,,,,0.65,nan,"thus, suppression of mek1,2 in a subset of breast cancer cell lines results in the egfr mediated activation of pi3k and akt pathway [xref_bibr].",pmc5723691,1,1,40,1,41
29,bcl2,protein,,hgnc:990,hgnc,990,,,cell death,biologicalprocess,,,go,go:0008219,,,negative,i,inhibition,,,,,,0.65,nan,"as opposed to this, it has been reported that combined inhibition of anti-apoptotic bcl2 family members and effectors of the ras pathway can effectively induce cell death in kras mutant cancers.",pmc5127645,1,1,40,1,41
325,mtor,protein,,hgnc:3942,hgnc,3942,,,braf,protein,,hgnc:1097,hgnc,1097,,,negative,i,inhibition,,,,,,0.65,nan,"xref_bibr, xref_bibr another preclinical study demonstrated that the combination of selumetinib and a mammalian target of rapamycin (mtor) inhibitor (azd8055) which is downstream of pi3k and akt pathway, induces tumor regression in braf mutant uveal melanoma cell lines but not gnaq mutant cell lines.",pmc4179759,1,1,40,1,41
25,autophagy,biologicalprocess,,,go,go:0006914,,,cellular senescence,biologicalprocess,,,go,go:0090398,,,negative,i,inhibition,,,,,,0.86,nan,"a number of reports indicate that a proper activation of autophagy is required for the establishment of senescence [xref_bibr - xref_bibr], while others show that autophagy suppresses senescence [xref_bibr, xref_bibr].",pmc5723691,1,1,40,1,41
116,egfr,protein,,hgnc:3236,hgnc,3236,,,siah,other,,,text,siah,,,negative,i,inhibition,,,,,,0.65,nan,"3.2 a marked reduction of siah and egfr expression post-nst is correlated with tumor regression, as reflected in the nst efficacy and increased patient survival.",pmc5049993,1,1,40,1,41
114,egfr,protein,,hgnc:3236,hgnc,3236,,,panitumumab,other,,,text,panitumumab,,,positive,i,activation,,,,,,0.65,nan,"for example, kras mutations are associated with decreased disease control rate, shorter progression-free survival and reduced overall survival in patients with advanced or metastatic colorectal cancer treated with the egfr targeting antibodies cetuximab or panitumumab [xref_bibr - xref_bibr].",pmc2911390,1,1,40,1,41
113,egfr,protein,,hgnc:3236,hgnc,3236,,,kras,protein,,hgnc:6407,hgnc,6407,,,positive,i,activation,,,,,,0.65,nan,"as such, there has been no clear relationship between kras mutation status and clinical outcomes in patients treated with the egfr tyrosine kinase inhibitors gefitinib or erlotinib [xref_bibr].",pmc2911390,1,1,40,1,41
112,egfr,protein,,hgnc:3236,hgnc,3236,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,0.65,nan,"that rtks in fact can be very potent drivers of melanoma development is seen in xiphophorus hybrids, where overexpression of an egfr homolog stimulates proliferation and is sufficient to initiate and progress melanoma development.",pmc4846800,1,1,40,1,41
96,dusp5,protein,,hgnc:3071,hgnc,3071,,,braf,protein,,hgnc:1097,hgnc,1097,,,positive,i,activation,,,,,,0.86,nan,silencing of dusp5 or dusp6 phosphatases by sirna reduced the neoplastic properties of braf v600e -thyroid carcinoma cell lines.,pmc5599027,1,1,40,1,41
97,dusp5,protein,,hgnc:3071,hgnc,3071,,,cell growth,biologicalprocess,,,go,go:0016049,,,positive,i,activation,,,,,,0.86,nan,"we also originally demonstrated that loss of dusp5 and dusp6 in bcpap and 8505c cells impaired their anchorage independent cell growth, in agreement with our results of the migration and invasion assays which are in favor of a pro tumoral role of dusp5 and dusp6.",pmc5599027,1,1,40,1,41
326,mtor,protein,,hgnc:3942,hgnc,3942,,,gnaq,protein,,hgnc:4390,hgnc,4390,,,negative,i,inhibition,,,,,,0.65,nan,"xref_bibr, xref_bibr another preclinical study demonstrated that the combination of selumetinib and a mammalian target of rapamycin (mtor) inhibitor (azd8055) which is downstream of pi3k and akt pathway, induces tumor regression in braf mutant uveal melanoma cell lines but not gnaq mutant cell lines.",pmc4179759,1,1,40,1,41
98,dusp5,protein,,hgnc:3071,hgnc,3071,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,0.65,nan,"dusp5 and dusp6 induction was blocked by mek inhibition, resulting in a decrease in erk phosphorylation (xref_fig).",pmc5599027,1,1,40,1,41
211,il1b,protein,,hgnc:5992,hgnc,5992,,,"mitogen-activated protein
kinase",other,,,text,"mitogen-activated protein
kinase",,,positive,i,activation,,,,,,0.65,nan,"we thus found that tgn-020 upregulated the
threshold of thermal and mechanical allodynia, downregulated the expression of
interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha, attenuated the
astrocytic activation and suppressed the activation of mitogen-activated protein
kinase pathways in the spinal dorsal horn and dorsal root ganglion.",pmc6113736,1,1,40,1,41
530,tnf,protein,,hgnc:11892,hgnc,11892,,,jnk,other,,,text,jnk,,,,i,phosphorylation,,,,,,0.65,nan,"ptpn1 d181a failed to inhibit tnfalpha stimulated jnk phosphorylation, and led to an increased cell death in p65 deficient mef cells.",pmc5636874,1,1,40,1,41
512,tgfb1,protein,,hgnc:11766,hgnc,11766,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.65,nan,"consequently, one aspect of the physiological significance of the tgf-beta1-activated ras -- erk pathway and pi3k -- akt signaling might be preventing apoptosis that can be induced by tgf-beta1.",pmc4440819,1,1,40,1,41
528,tnf,protein,,hgnc:11892,hgnc,11892,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.65,nan,"since the sustained jnk activation is necessary for tnfalpha induced apoptosis, the cell death response was examined in p65 deficient mef cells, in which the nfkappab pathway was disrupted xref_bibr, xref_bibr.",pmc5636874,1,1,40,1,41
212,il1b,protein,,hgnc:5992,hgnc,5992,,,sirt1,protein,,hgnc:14929,hgnc,14929,,,negative,i,inhibition,,,,,,0.65,nan,the brain injury and il-1beta stimulation reduced sirt1 and activated mapk pathway leading to the astrocyte activation.,pmc5372348,1,1,40,1,41
529,tnf,protein,,hgnc:11892,hgnc,11892,,,cell death,biologicalprocess,,,go,go:0008219,,,positive,i,activation,,,,,,0.86,nan,"the results showed that ptpn1 decreased tnfalpha stimulated cell death responses, whereas ptpn1 d181a increased the cell death response presumably via sustained jnk phosphorylation.",pmc5636874,1,1,40,1,41
213,il6,protein,,hgnc:6018,hgnc,6018,,,mapk,other,,,text,mapk,,,negative,i,inhibition,,,,,,0.65,nan,"we thus found that tgn-020 upregulated the threshold of thermal and mechanical allodynia, downregulated the expression of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha, attenuated the astrocytic activation and suppressed the activation of mitogen activated protein kinase pathways in the spinal dorsal horn and dorsal root ganglion.",pmc6113736,1,1,40,1,41
214,il6,protein,,hgnc:6018,hgnc,6018,,,mapk,other,,,text,mapk,,,positive,i,activation,,,,,,0.65,nan,"we thus found that tgn-020 upregulated the threshold of thermal and mechanical allodynia, downregulated the expression of interleukin-1β, interleukin-6, and tumor necrosis factor-α, attenuated the astrocytic activation and suppressed the activation of mitogen-activated protein kinase pathways in the spinal dorsal horn and dorsal root ganglion.",pmc6113736,1,1,40,1,41
215,il6,protein,,hgnc:6018,hgnc,6018,,,"mitogen-activated protein
kinase",other,,,text,"mitogen-activated protein
kinase",,,positive,i,activation,,,,,,0.65,nan,"we thus found that tgn-020 upregulated the
threshold of thermal and mechanical allodynia, downregulated the expression of
interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha, attenuated the
astrocytic activation and suppressed the activation of mitogen-activated protein
kinase pathways in the spinal dorsal horn and dorsal root ganglion.",pmc6113736,1,1,40,1,41
19,araf,protein,,hgnc:646,hgnc,646,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.86,nan,"furthermore, overexpressed da-raf1 abrogated erk activation, whereas the knockdown of da-raf facilitated erk activation.",pmc2064279,1,1,40,1,41
18,araf,protein,,hgnc:646,hgnc,646,,,cell differentiation,biologicalprocess,,,go,go:0030154,,,positive,i,activation,,,,,,0.923,nan,these results suggest the possibility that da-raf1 positively regulates skeletal muscle cell differentiation.,pmc2064279,1,1,40,1,41
531,tnf,protein,,hgnc:11892,hgnc,11892,,,jnk,other,,,text,jnk,,,positive,i,activation,,,,,,0.65,nan,"jip1 has been previously shown to mediate tnfalpha stimulation of the jnk pathway, such that tnfalpha treatment may be a useful means to stimulate jnk pathway for the screening that exploits jip1-phosphatase tethers xref_bibr, xref_bibr.",pmc5636874,1,1,40,1,41
517,tgfb1,protein,,hgnc:11766,hgnc,11766,,,esr2,protein,,hgnc:3468,hgnc,3468,,,negative,i,decreaseamount,,,,,,0.65,nan,"hif-1alpha and erbeta have been reported to mutually reduce the expression and function of the other [xref_bibr - xref_bibr], and tgfbeta1 signaling has also been reported to attenuate erbeta expression and its migration-suppressive ability [xref_bibr, xref_bibr].",pmc5410235,1,1,40,1,41
516,tgfb1,protein,,hgnc:11766,hgnc,11766,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.923,nan,"thus, regulatory mechanisms of the weak and transient activation of the ras -- erk pathway induced by tgf-beta1 need to be elucidated.",pmc4440819,1,1,40,1,41
515,tgfb1,protein,,hgnc:11766,hgnc,11766,,,epithelial to mesenchymal transition,biologicalprocess,,,go,go:0001837,,,positive,i,activation,,,,,,0.923,nan,"taken together, these results indicate that da-raf is required for the induction of emt by tgf-beta1 in rle cells.",pmc4440819,1,1,40,1,41
187,glucose,chemical,,,chebi,chebi:17234,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.65,nan,"in these brain tumors mir-181a was shown to target the anti-apoptotic genes bcl2 and mcl1, and downregulated mir-181a reduced glucose deprivation induced apoptosis and caused mitochondrial dysfunction in astrocytes [xref_bibr, xref_bibr, xref_bibr].",pmc5312311,1,1,40,1,41
514,tgfb1,protein,,hgnc:11766,hgnc,11766,,,epithelial to mesenchymal transition,biologicalprocess,,,go,go:0001837,,,negative,i,inhibition,,,,,,0.65,nan,"these results imply that the low levels of transient activation of mek and erk, which are brought about by tgf- beta 1 treatment, do not inhibit emt, but that the fgf2 induced high levels of sustained activation of mek and erk suppress tgf- beta 1 induced emt in rle cells.",pmc4440819,1,1,40,1,41
513,tgfb1,protein,,hgnc:11766,hgnc,11766,,,cdh1,protein,,hgnc:1748,hgnc,1748,,,negative,i,decreaseamount,,,,,,0.65,nan,"tgf-beta1 treatment reduced the e-cadherin protein level, whereas the level was hardly affected in daraf sirna introduced cells (xref_fig).",pmc4440819,1,1,40,1,41
209,il1b,protein,,hgnc:5992,hgnc,5992,,,gfap,protein,,hgnc:4235,hgnc,4235,,,positive,i,increaseamount,,,,,,0.65,nan,"in the present study, the il-1beta stimulation triggered an elevated level of gfap and induced the astrocyte hypertrophy; this phenomenon was confirmed by the lesion site in a traumatic brain injury.",pmc5372348,1,1,40,1,41
426,ras,other,,,text,ras,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,"0.65,0.923,0.65,0.65,0.65,0.65","nan,nan,nan,nan,nan,nan","further investigation of individual contribution of the ras isoforms indicated kras as major ras activator of the erk signaling in these cells.,the ras induced erk pathway (raf -- mek -- erk) is typically activated by growth factors through their receptor tyrosine kinases (rtks), which mobilize adaptor proteins, such as shc and grb2, and guanine nucleotide exchange factors (gefs) like sos.,oncogenic ras causes constitutive activation of the erk pathway, resulting in cellular transformation and tumorigenesis.,in most cell types the erk pathway which is activated by ras is one of the key pathways required to trigger cell proliferation.,our data delineate a complex interaction between bet proteins and ras signaling in which bet inhibition can either activate or inhibit erk, depending on the context.,recently, ptpn11 (shp2), a non receptor type ptp, was reported to play an oncogene like role in laryngeal cancer, hepatocellular carcinoma and glioblastoma, and the mechanism appeared to involve dephosphorylating ras to activate the ras and erk pathway xref_bibr - xref_bibr.","pmc4254013,pmc4440819,pmc2064279,pmc5432316,pmc5908790,pmc6006154",6,0.1,39,1,39.6
128,erk,other,,,text,erk,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,"0.65,0.65,0.86","nan,nan,nan","for instance, the growth factor induced activation of ras leads to erk pathway mediated cell proliferation and morphogenesis during animal development.,on the other hand, activation of the mapk-pathway by the synergistic action of factors like scf, fgf, or hgf stimulates strong sustained erk activation, which triggers melanocyte proliferation.,this research highlighted that erk, jnk, and p38 mapk activation was regulated by tlr4 pathway, and that inhibition of tlr4, myd88, erk, jnk, and p38 attenuated proliferation and induced apoptosis esophageal cancer cells in vitro.","pmc2064279,pmc4846800,pmc5190119",3,0.1,39,1,39.3
46,braf,protein,,hgnc:1097,hgnc,1097,,,mek,other,,,text,mek,,,positive,i,activation,,,,,,"0.8775000000000001,0.65,0.8775000000000001","nan,nan,nan","the g596r substitution (found in one case) impairs the kinase activity of braf, which can not activate mek directly but is still capable of activating mek-erk signalling by forming heterodimers with craf (which is activated in a ras independent manner), and also increases the activation of mek-erk signalling [xref_bibr].,these results are compatible with the notion that b-raf is the main activator of mek in most cell types.,the biochemical analysis of these “kinase-impaired” mutations revealed that although they reduce braf's enzymatic activity, braf still activates mek through dimerization with craf in a ras dependent manner (wan et al., xref ; garnett et al., xref ).","pmc4695180,pmc2064279,pmc4846800",3,0.1,39,1,39.3
269,mapk,other,,,text,mapk,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,"0.65,0.65,0.65","nan,nan,nan","preclinical data have demonstrated that mek inhibition by selumetinib is one of the effective strategies for targeting dysregulated mapk pathway that leads to unregulated cell proliferation and development and progression of melanoma.,inhibition of tlr4 and mapk pathways suppresses proliferation and induces apoptosis of esophageal cancer cells.,in hematopoietic malignancies, including aml, activating oncogenic ras mutations contribute to malignant phenotypes by phosphorylating and activating downstream effectors such as the mitogen activated protein kinase kinase (mapkk, also known as mek), mitogen activated protein kinase (mapk), and the pi3k-akt downstream effectors, thereby promoting aberrant cell proliferation and survival [xref_bibr].","pmc4179759,pmc5190119,pmc5312311",3,0.1,39,1,39.3
294,mek,other,,,text,mek,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,"0.65,0.65,0.65","nan,nan,nan","in contrast, fgf2 stimulation or overexpression of constitutively active ras, raf, or mek enhances the activity of the tgf-beta1-induced ras -- erk pathway.,the analysis of melanomas from patients relapsed on braf inhibitor treatment revealed the vast complexity of the mapk signaling network and over the last years a plethora of mechanisms have been identified that allow cells to bypass braf inhibition by activating other signaling nodes eventually re-establishing mek activity and hence reactivation of erk [for a detailed review see lito et al., xref_bibr], which is thought to occur in> 70% of patients.,this suggests that erk activation observed in all cell lines tested was not mediated by mek.","pmc4440819,pmc4846800,pmc6006154",3,0.1,39,1,39.3
136,erk,other,,,text,erk,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,"0.65,0.65","nan,nan","our results demonstrated that ulixertinib (bvd-523), a potent and highly selective inhibitor of erk1/2, was able to inhibit erk phosphorylation in vitro in all cll cases with mutations in genes of the ras-braf-mapk-erk pathway.,the inhibition of mek prevented erk phosphorylation resulting in erk not being translocated to the nucleus (middle images have nuclei with very low-stained signals for erk).","pmc6395334,pmc6006154",2,0.1,39,1,39.2
240,kras,protein,,hgnc:6407,hgnc,6407,,,nras,protein,,hgnc:7989,hgnc,7989,,,negative,i,inhibition,,,,,,"0.65,0.65","nan,nan","others showed the appearance or disappearance of nras and kras variants with low vafs (the occurrence of kras g12a and g12r in mm-340; the occurrence of kras q61l in mm-200, which also retained kras q61h at a quite constant vaf; the loss of kras g12s in mm-004; the loss of kras g13d in mm-151, which also stably carried kras q61h; the loss of nras q61k in mm-327, which also harbored the kras q61h mutation in about 40% of the sequencing reads at both timepoints).,others showed the appearance or disappearance of nras and kras variants with low vafs (the occurrence of kras g12a and g12r in mm-340; the occurrence of kras q61l in mm-200, which also retained kras q61h at a quite constant vaf; the loss of kras g12s in mm-004; the loss of kras g13d in mm-151, which also stably carried kras q61h; the loss of nras q61k in mm-327, which also harbored the kras q61h mutation in about 40% of the sequencing reads at both timepoints).","pmc4695180,pmc4695180",2,0.1,39,1,39.2
239,kras,protein,,hgnc:6407,hgnc,6407,,,mm-327,other,,,text,mm-327,,,negative,i,inhibition,,,,,,"0.65,0.65","nan,nan","others showed the appearance or disappearance of nras and kras variants with low vafs (the occurrence of kras g12a and g12r in mm-340; the occurrence of kras q61l in mm-200, which also retained kras q61h at a quite constant vaf; the loss of kras g12s in mm-004; the loss of kras g13d in mm-151, which also stably carried kras q61h; the loss of nras q61k in mm-327, which also harbored the kras q61h mutation in about 40% of the sequencing reads at both timepoints).,others showed the appearance or disappearance of nras and kras variants with low vafs (the occurrence of kras g12a and g12r in mm-340; the occurrence of kras q61l in mm-200, which also retained kras q61h at a quite constant vaf; the loss of kras g12s in mm-004; the loss of kras g13d in mm-151, which also stably carried kras q61h; the loss of nras q61k in mm-327, which also harbored the kras q61h mutation in about 40% of the sequencing reads at both timepoints).","pmc4695180,pmc4695180",2,0.1,39,1,39.2
238,kras,protein,,hgnc:6407,hgnc,6407,,,mm-151,other,,,text,mm-151,,,negative,i,inhibition,,,,,,"0.65,0.65","nan,nan","others showed the appearance or disappearance of nras and kras variants with low vafs (the occurrence of kras g12a and g12r in mm-340; the occurrence of kras q61l in mm-200, which also retained kras q61h at a quite constant vaf; the loss of kras g12s in mm-004; the loss of kras g13d in mm-151, which also stably carried kras q61h; the loss of nras q61k in mm-327, which also harbored the kras q61h mutation in about 40% of the sequencing reads at both timepoints).,others showed the appearance or disappearance of nras and kras variants with low vafs (the occurrence of kras g12a and g12r in mm-340; the occurrence of kras q61l in mm-200, which also retained kras q61h at a quite constant vaf; the loss of kras g12s in mm-004; the loss of kras g13d in mm-151, which also stably carried kras q61h; the loss of nras q61k in mm-327, which also harbored the kras q61h mutation in about 40% of the sequencing reads at both timepoints).","pmc4695180,pmc4695180",2,0.1,39,1,39.2
236,kras,protein,,hgnc:6407,hgnc,6407,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,"0.65,0.65","nan,nan","previously, a dependence on hras and nras in kras driven cell proliferation has been described xref_bibr consistent with the proposed interdependency.,the reduced proliferation induced by tf-np-mir-181a treatment was reversed by lentiviral expression of kras, nras and mapk1 in oci-aml3 cells (xref_supplementary; xref_supplementary) attenuating the anti-leukemic activity of tf-np-mir-181a and thereby supporting the relevance of these targets to leukemogenesis.","pmc5467702,pmc5312311",2,0.1,39,1,39.2
435,ras,other,,,text,ras,,,raf,other,,,text,raf,,,positive,i,activation,,,,,,"0.86,0.65","nan,nan","all four isoforms of ras are able to activate all three members of the raf gene family (a raf, b raf, raf-1).,ras activates raf, leading to the extracellular regulated kinase (erk)-mitogen-activated protein kinase pathway, which is involved in a variety of cellular, physiological, and pathological responses.","pmc4067595,pmc2064279",2,0.1,39,1,39.2
266,mapk,other,,,text,mapk,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,negative,i,inhibition,,,,,,"0.86,0.65","nan,nan","in support of this data, multiple laboratories have demonstrated that the combined inhibition of src and the mapk pathway results in synergistic inhibition of growth and increased apoptosis of thyroid cancer cells both in vitro and in vivo xref_bibr - xref_bibr.,inhibition of tlr4 and mapk pathways suppresses proliferation and induces apoptosis of esophageal cancer cells.","pmc5833015,pmc5190119",2,0.1,39,1,39.2
267,mapk,other,,,text,mapk,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,"0.65,0.65","nan,nan","in the present study, we tried to elaborate the potential mechanism of mitochondria dependent apoptosis induced by mapk pathways.,our data in this study showed that inactivation of mapk inhibited viability and induced apoptosis of esophageal cancer cells by ppargamma agonist or sirna targeting erk, jnk, and p38, which are consistent with these results.","pmc5729429,pmc5190119",2,0.1,39,1,39.2
268,mapk,other,,,text,mapk,,,braf,protein,,hgnc:1097,hgnc,1097,,,positive,i,activation,,,,,,"0.86,0.65","nan,nan","taken together, these data suggest that mapk pathway activation in braf v600 mutant melanoma cells has a direct suppressive effect on the capacity of dc to activate t cells.,higher mapk pathway activation in braf v600e mutated thyroid cell lines.","pmc3809567,pmc5599027",2,0.1,39,1,39.2
428,ras,other,,,text,ras,,,kras,protein,,hgnc:6407,hgnc,6407,,,positive,i,activation,,,,,,"0.65,0.65","nan,nan","crebbp mutations also frequently co-occur with ras pathway activating mutations, particularly kras, xref_bibr, xref_bibr - xref_bibr suggestive of a possible link between crebbp attenuation and oncogenic signaling.,although bet inhibitors transcriptionally down-regulate a number of oncogenic pathways 3, these data suggest that bet inhibition is not sufficient to counteract the pro growth and survival effects of activated ras signaling in the kras mutant setting.","pmc5395114,pmc5908790",2,0.1,39,1,39.2
409,raf,other,,,text,raf,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,"0.65,0.65","nan,nan","in contrast, fgf2 stimulation or overexpression of constitutively active ras, raf, or mek enhances the activity of the tgf-beta1-induced ras -- erk pathway.,activation of the raf mediated erk pathway by oncogenic ras induces transformation in mouse fibroblasts.","pmc4440819,pmc2064279",2,0.1,39,1,39.2
311,mir-382-5p,other,,,text,mir-382-5p,,,cell survival,other,,,text,cell survival,,,positive,i,activation,,,,,,"0.86,0.923","nan,nan","thereby, mir-382-5p promoted breast cancer cell viability, clonogenicity, survival, migration, invasion and in vivo tumorigenesis and metastasis.,mir-382-5p promotes breast cancer cell viability, clonogenicity, survival, migration and invasion.","pmc5410235,pmc5410235",2,0.1,39,1,39.2
292,mek,other,,,text,mek,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,"0.65,0.65","nan,nan","activation of the mapk signaling pathway leads to a kinase cascade culminating downstream in the phosphorylation of erk by mek.,the inhibition of mek prevented erk phosphorylation resulting in erk not being translocated to the nucleus (middle images have nuclei with very low stained signals for erk).","pmc5599027,pmc6006154",2,0.1,39,1,39.2
272,mapk,other,,,text,mapk,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,"0.65,0.65","nan,nan","xref_fig a, shrna knockdown of map4k4 did not inhibit mek activation (represented as phosphorylated mek), thus excluding the possibility that mapk induces erk activation through mek.,pparγ agonist suppressed erk mapk signal activation to inhibit activity of cellular no and reactive oxygen species formation, counteracting lps-induced inflammatory response in pulp cells [ xref ].","pmc5467491,pmc5190119",2,0.1,39,1,39.2
539,u0126,chemical,,,chebi,chebi:90693,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,"0.65,0.86","nan,nan","the expression level of alphasma in tgf-beta1-stimulated rle cells was hardly affected by treatment with u0126, which inhibits the erk pathway (xref_fig).,the results showed that u0126 significantly inhibited the erk activation but exerted no effect on the jnk or p38mapk activation in comparison to the dmso injection (p < 0.05 for erk; p> 0.05 for jnk and p38mapk; fig.","pmc4440819,pmc5372348",2,0.1,39,1,39.2
297,mek,other,,,text,mek,,,ras,other,,,text,ras,,,positive,i,activation,,,,,,"0.65,0.65","nan,nan","the ras pathway signature is upregulated in breast cancer cell lines that have acquired resistance to akt inhibition, and is downregulated by inhibition of mek.,western blot data show that unlike treatment with pd0325901 or nabut alone, inhibition of mek and erk in senescent cells causes a decrease in the ras content.","pmc2911390,pmc5723691",2,0.1,39,1,39.2
314,mir-382-5p,other,,,text,mir-382-5p,,,neoplasm metastasis,other,,,text,neoplasm metastasis,,,positive,i,activation,,,,,,"0.86,0.65","nan,nan","mir-382-5p promotes in vivo breast cancer tumorigenesis and metastasis.,thereby, mir-382-5p promoted breast cancer cell viability, clonogenicity, survival, migration, invasion and in vivo tumorigenesis and metastasis.","pmc5410235,pmc5410235",2,0.1,39,1,39.2
495,small interfering rna,other,,,text,small interfering rna,,,expression,other,,,text,expression,,,negative,i,inhibition,,,,,,"0.86,0.65","nan,nan","the inhibition of p38 mapk expression by sirna silencing resulted in a decrease in mapkapk-2 activation after sa application, but it had no significant effect on cell viability or the level of phosphorylated erk pathway members.,in these experiments, the inhibition of ptprs expression by sirna did not bring about an increase in mek phosphorylation.","pmc4783893,pmc6006154",2,0.1,39,1,39.2
45,braf,protein,,hgnc:1097,hgnc,1097,,,mapk,other,,,text,mapk,,,positive,i,activation,,,,,,"0.65,0.65","nan,nan","we recently explored a potential link between constitutive mapk pathway upregulation driven by a braf v600 mutation and dc function using a human melanoma-dc co-culture system.,in this paper, higher levels of p-mek in human braf v600e thyroid carcinoma cell lines in comparison with the others is in line with the conventional knowledge that the mapk pathway is activated more robustly by the braf v600e oncogene [xref_bibr].","pmc3809567,pmc5599027",2,0.1,39,1,39.2
340,nf1,protein,,hgnc:7765,hgnc,7765,,,ras,other,,,text,ras,,,negative,i,inhibition,,,,,,"0.65,0.65","nan,nan","the nf1 gene encodes neurofibromin (nf1), a gap that inhibits ras signaling by stimulating hydrolysis of active ras-gtp into inactive ras-gdp.,these include not only the ~ 50% of braf mutations, but also> 25% nras mutations and ~ 14% of melanomas with mutations in the ras suppressor nf1 (cancergenomeatlasnetwork 2015).","pmc4067595,pmc4846800",2,0.1,39,1,39.2
383,pd 0325901,chemical,,,chebi,chebi:88249,,,mek,other,,,text,mek,,,negative,i,inhibition,,,,,,0.86,nan,"therefore, we asked how mek and erk inhibition by pd0325901 affects the viability of cells induced to senescence with nabut and whether pd0325901 is able to induce ampk dependent autophagy in the senescent cells.",pmc5723691,1,0.1,39,1,39.1
388,pi3k,other,,,text,pi3k,,,angiogenesis,biologicalprocess,,,go,go:0001525,,,positive,i,activation,,,,,,0.65,nan,"mutation at codons 12, 13 or 61 locks ras in a gtp bound active state, which initiates diverse signaling cascades including raf-mek-erk, pi3k and ral pathways that drive proliferation, survival and angiogenesis [xref_bibr].",pmc3843736,1,0.1,39,1,39.1
387,perk12,other,,,text,perk12,,,hrasgtp,other,,,text,hrasgtp,,,positive,i,activation,,,,,,0.65,nan,epithelial cells expressing endogenous alpha4 integrin and persistently plated on gc1q inhibited perk1/2 increasing hrasgtp and especially the hrasgtp ubiquitinated form (hrasgtp-ub).,pmc5432316,1,0.1,39,1,39.1
386,peripheral nerve injuries,other,,,text,peripheral nerve injuries,,,neuralgia,other,,,text,neuralgia,,,positive,i,activation,,,,,,0.65,nan,"the findings provide evidence for understanding the mechanisms
underlying the analgesic effects of tgn-020 in an cci-induced np model and support a
novel strategy for treating peripheral nerve injury–induced np.",pmc6113736,1,0.1,39,1,39.1
385,pebp1,protein,,hgnc:8630,hgnc,8630,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.65,nan,both spry and rkip bind to raf to inhibit the erk pathway by preventing the binding of mek.,pmc2064279,1,0.1,39,1,39.1
327,mtorc1,biologicalprocess,,,go,go:0031931,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,0.65,nan,"however, in control ras transformed cells elevated activity of mtorc1 provides viability and supports high proliferation rate.",pmc5723691,1,0.1,39,1,39.1
384,pd 0325901,chemical,,,chebi,chebi:88249,,,ras,other,,,text,ras,,,negative,i,inhibition,,,,,,0.65,nan,"combination of i-bet151 and pd0325901 produced synergistic effects (ci < 0.78; see methods) most commonly in, but not limited to, ras pathway mutant models.",pmc5908790,1,0.1,39,1,39.1
346,nras,protein,,hgnc:7989,hgnc,7989,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,0.65,nan,"the reduced proliferation induced by tf-np-mir-181a treatment was reversed by lentiviral expression of kras, nras and mapk1 in oci-aml3 cells (xref_supplementary; xref_supplementary) attenuating the anti-leukemic activity of tf-np-mir-181a and thereby supporting the relevance of these targets to leukemogenesis.",pmc5312311,1,0.1,39,1,39.1
382,pd 0325901,chemical,,,chebi,chebi:88249,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.86,nan,"to clarify whether the cell response to mek and erk inhibition by pd0325901 is specific for the eras engineered cell line or inhibition of mek and erk signaling would successfully eliminate also other ras expressing senescent tumor cells, we used ki-ras mutated a549 human lung adenocarcinoma cells.",pmc5723691,1,0.1,39,1,39.1
389,pi3k,other,,,text,pi3k,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,negative,i,inhibition,,,,,,0.65,nan,"nonetheless, combined inhibition of both the mapk and the pi3k pathways, with trametinib and dasatinib, with or without at7867, respectively, correlates with reduced rps6 phosphorylation and enhanced inhibition of growth and increased apoptosis.",pmc5833015,1,0.1,39,1,39.1
328,mtorc1,biologicalprocess,,,go,go:0031931,,,cellular senescence,biologicalprocess,,,go,go:0090398,,,positive,i,activation,,,,,,0.86,nan,it has been shown that inhibition of mtorc1 by rapamycin and torin1 in imr90 er : ras senescent human cells reduces the expression of senescence marker sa-beta-gal and development of sasp without rescuing cells from the proliferation arrest [xref_bibr].,pmc5723691,1,0.1,39,1,39.1
381,pd 0325901,chemical,,,chebi,chebi:88249,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,0.65,nan,"inhibition of the mek-erk pathway by using the mek inhibitor pd0325901 impaired s727 phosphorylation, along with erk phosphorylation, as expected (xref_fig, lane 4).",pmc3843736,1,0.1,39,1,39.1
329,mycbp2,protein,,hgnc:23386,hgnc,23386,,,ras,other,,,text,ras,,,negative,i,inhibition,,,,,,0.65,nan,our pam analysis could further reduce the modified ras pathway signature gene set from 16 to 7 genes in the affy_ff classifier.,pmc5069826,1,0.1,39,1,39.1
380,pd 0325901,chemical,,,chebi,chebi:88249,,,erk,other,,,text,erk,,,,i,dephosphorylation,,,,,,0.65,nan,"this pd0325901 concentration was not sufficient to completely abolish erk phosphorylation, although it did reduce phosphorylation of wild type stat3-s727 to undetectable levels.",pmc3843736,1,0.1,39,1,39.1
379,pbx3,protein,,hgnc:8634,hgnc,8634,,,raf1,protein,,hgnc:9829,hgnc,9829,,,positive,i,activation,,,,,,0.65,nan,both mir-320 overexpression and pbx3 knockdown inhibited raf-1 and mapk activation.,pmc5609034,1,0.1,39,1,39.1
330,myog,protein,,hgnc:7612,hgnc,7612,,,cell differentiation,biologicalprocess,,,go,go:0030154,,,negative,i,inhibition,,,,,,0.65,nan,"this suppression results in the aborted expression of myogenin, which induces muscle differentiation.",pmc2064279,1,0.1,39,1,39.1
378,pbx3,protein,,hgnc:8634,hgnc,8634,,,mapk,other,,,text,mapk,,,positive,i,activation,,,,,,0.65,nan,both mir-320 overexpression and pbx3 knockdown inhibited raf-1 and mapk activation.,pmc5609034,1,0.1,39,1,39.1
377,pbx3,protein,,hgnc:8634,hgnc,8634,,,cell growth,biologicalprocess,,,go,go:0016049,,,positive,i,activation,,,,,,0.65,nan,"pbx3 (pre-b cell leukemia homeobox 3), a putative target gene of mir-320, has been reported to be upregulated in various tumors and promote tumor cell growth through regulating makp and erk pathway.",pmc5609034,1,0.1,39,1,39.1
549,vegf,other,,,text,vegf,,,necrotic cell death,biologicalprocess,,,go,go:0070265,,,positive,i,activation,,,,,,0.65,nan,"several mechanisms that may account for the improved immune response have been described such as increased mda expression on melanoma cells and decreased intra-tumoral vegf production, others remain speculative, such as increased cross presentation to dcs resulting from braf and mek inhibition mediated necrosis and apoptosis of melanoma cells.",pmc3809567,1,0.1,39,1,39.1
556,vemurafenib,chemical,,,chebi,chebi:63637,,,firefly luciferase,other,,,text,firefly luciferase,,,positive,i,activation,,,,,,0.65,nan,"in this study, no difference in frequencies of adoptively transferred t cells was observed in tumors, lymph nodes, or spleen as assessed ex vivo by flow cytometry and immunofluorescence imaging and in vivo by tracking of the firefly luciferase transgene labeled t cells using bioluminescence imaging when mice were treated with vemurafenib in addition to act.",pmc3809567,1,0.1,39,1,39.1
323,"mss11
 by",other,,,text,"mss11
 by",,,xv-1 loci,other,,,text,xv-1 loci,,,positive,i,activation,,,,,,0.65,nan,"the chromosome xiv locus corresponds to end3 3s, while allele replacements in a backcross segregant that carried the six-way interaction confirmed that flo8 3s, mss11 by, and ira2delta2933 underlie the chromosome v, xiii, and xv-1 loci, respectively (xref_fig and xref_supplementary; methods).",pmc4618523,1,0.1,39,1,39.1
393,pi3k,other,,,text,pi3k,,,nras,protein,,hgnc:7989,hgnc,7989,,,positive,i,activation,,,,,,0.65,nan,"furthermore, pi3-kinase signaling is also activated downstream of mutant nras suggesting possible mek and pi3-kinase inhibitor combinations.",pmc4846800,1,0.1,39,1,39.1
400,ppp2,other,,,text,ppp2,,,fingolimod hydrochloride,chemical,,,chebi,chebi:63112,,,positive,i,activation,,,,,,0.86,nan,"the pp2a activator fty720 was purchased from cayman chemical (ann arbor, mi, usa).",pmc5467491,1,0.1,39,1,39.1
399,ppp2,other,,,text,ppp2,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.65,nan,erk activation can be rescued by pp2a inhibitor oa in map4k4-knockdown cells and suppressed by pp2a activator fty720 in map4k4 overexpressing cells.,pmc5467491,1,0.1,39,1,39.1
398,pparg,protein,,hgnc:9236,hgnc,9236,,,"transcription, dna-templated",biologicalprocess,,,go,go:0006351,,,positive,i,activation,,,,,,0.65,nan,"peroxisome proliferator activated receptor gamma (ppargamma) is one of ligand activated transcription factors within the nuclear steroid hormone receptor superfamily and forms a sub-family along with the other two subtypes, pparalpha and pparbeta and delta [xref_bibr].",pmc5190119,1,0.1,39,1,39.1
397,pparg,protein,,hgnc:9236,hgnc,9236,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,negative,i,inhibition,,,,,,0.949980317,nan,"in conclusion, our data suggested that activation of pparg suppressed proliferation and induced apoptosis of esophageal cancer cells by inhibiting tlr4 dependent mapk pathway.",pmc5190119,1,0.1,39,1,39.1
396,pparg,protein,,hgnc:9236,hgnc,9236,,,cell growth,biologicalprocess,,,go,go:0016049,,,negative,i,inhibition,,,,,,0.65,nan,"the role of ppargamma in the progression of esophageal cancer remains controversial : activation of ppargamma inhibits cell growth and induces apoptosis in vitro; however, ppargamma agonists promote tumor growth in xenografted mice.",pmc5190119,1,0.1,39,1,39.1
315,mir-382-5p,other,,,text,mir-382-5p,,,rerg,protein,,hgnc:15980,hgnc,15980,,,negative,i,inhibition,,,,,,0.65,nan,"taken together, these results implicated that mir-382-5p suppresses rerg by directly targeting its 3 ' utr, and thereby reduces ras and erk pathway activation.",pmc5410235,1,0.1,39,1,39.1
395,pparg,protein,,hgnc:9236,hgnc,9236,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.94993439,nan,"in conclusion, our data suggested that activation of pparg suppressed proliferation and induced apoptosis of esophageal cancer cells by inhibiting tlr4 dependent mapk pathway.",pmc5190119,1,0.1,39,1,39.1
548,vegf,other,,,text,vegf,,,cell adhesion,biologicalprocess,,,go,go:0007155,,,positive,i,activation,,,,,,0.65,nan,"it was previously shown that vegf and vegfr -2 inhibition can upregulate endothelial adhesion molecules in tumor vessels, which can in turn increase the infiltration of leukocytes in tumors.",pmc3809567,1,0.1,39,1,39.1
392,pi3k,other,,,text,pi3k,,,mdm2-p53 axis,other,,,text,mdm2-p53 axis,,,negative,i,inhibition,,,,,,0.65,nan,"for meki, synergism has been demonstrated for pi3k and akt inhibitors, dexamethasone, nutlin-3a, which induces the mdm2-p53 axis, and the bcl-2 and bcl-x (l) inhibitor, navitoclax (abt263).",pmc4067595,1,0.1,39,1,39.1
322,"mss11
 by",other,,,text,"mss11
 by",,,xiii,other,,,text,xiii,,,positive,i,activation,,,,,,0.65,nan,"the chromosome xiv locus corresponds to end3 3s, while allele replacements in a backcross segregant that carried the six-way interaction confirmed that flo8 3s, mss11 by, and ira2delta2933 underlie the chromosome v, xiii, and xv-1 loci, respectively (xref_fig and xref_supplementary; methods).",pmc4618523,1,0.1,39,1,39.1
391,pi3k,other,,,text,pi3k,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,0.65,nan,"mutation at codons 12, 13 or 61 locks ras in a gtp bound active state, which initiates diverse signaling cascades including raf-mek-erk, pi3k and ral pathways that drive proliferation, survival and angiogenesis [xref_bibr].",pmc3843736,1,0.1,39,1,39.1
316,mir-382-5p,other,,,text,mir-382-5p,,,rerg,protein,,hgnc:15980,hgnc,15980,,,positive,i,activation,,,,,,0.86,nan,"furthermore, we found that mir-382-5p directly targets and represses rerg to attenuate the inhibitory effects of rerg on the oncogenic ras and erk pathway.",pmc5410235,1,0.1,39,1,39.1
317,mir-382-5p mimics,other,,,text,mir-382-5p mimics,,,rerg,protein,,hgnc:15980,hgnc,15980,,,negative,i,decreaseamount,,,,,,0.65,nan,"western blot analysis confirmed that mir-382-5p mimics markedly and specifically decreased rerg expression, but pcdna3-rerg-transfected mcf-7 cells overexpressed rerg protein.",pmc5410235,1,0.1,39,1,39.1
318,mir181a,other,,,text,mir181a,,,mapk1,protein,,hgnc:6871,hgnc,6871,,,negative,i,decreaseamount,,,,,,0.65,nan,"mir181a overexpression by a lenti-181a vector reduced kras, nras, and mapk1 protein levels 5.2, 2.1, and 6.5-fold, respectively, compared to scramble expressing controls in mv4-11 cells.",pmc5312311,1,0.1,39,1,39.1
319,mir335,other,,,text,mir335,,,mapk1,protein,,hgnc:6871,hgnc,6871,,,positive,i,increaseamount,,,,,,0.65,nan,"one possible mechanism is the deregulated expression of a microrna, mir335 that targets and regulates levels of erk2.",pmc4067595,1,0.1,39,1,39.1
320,mir7-1,protein,,hgnc:31638,hgnc,31638,,,raf1,protein,,hgnc:9829,hgnc,9829,,,positive,i,activation,,,,,,0.65,nan,"to date, let-7 has been reported to target hras [xref_bibr] and kras [xref_bibr], mir-200c and mir-30c target kras, mir-148b targets nras, mir-7 targets raf1, mir-206 targets rasa1 and mir-21 targets spred1 in breast cancer cells [xref_bibr].",pmc5410235,1,0.1,39,1,39.1
321,mnsod,other,,,text,mnsod,,,reactive oxygen species,chemical,,,chebi,chebi:26523,,,negative,i,inhibition,,,,,,0.65,nan,"it is known that the jnk pathway is transiently activated when cells are stimulated with tnfalpha, because the nfkappab pathway induces expression of mnsod and thereby prevents not only the accumulation of ros, but also the oxidation and inactivation of ptps by ros xref_bibr, xref_bibr.",pmc5636874,1,0.1,39,1,39.1
331,nanoparticles,other,,,text,nanoparticles,,,tf,protein,,hgnc:11740,hgnc,11740,,,positive,i,activation,,,,,,0.65,nan,"the delivery of mir-181a mimics to target aml cells using transferrin targeting lipopolyplex nanoparticles (np) increased mature mir-181a; downregulated kras, nras and mapk1; and resulted in decreased phosphorylation of the downstream ras effectors.",pmc5312311,1,0.1,39,1,39.1
550,vegf,other,,,text,vegf,,,neoplasm invasiveness,other,,,text,neoplasm invasiveness,,,positive,i,activation,,,,,,0.65,nan,"it was previously shown that vegf and vegfr -2 inhibition can upregulate endothelial adhesion molecules in tumor vessels, which can in turn increase the infiltration of leukocytes in tumors.",pmc3809567,1,0.1,39,1,39.1
375,parkinson disease,other,,,text,parkinson disease,,,jun,protein,,hgnc:6204,hgnc,6204,,,negative,i,inhibition,,,,,,0.65,nan,also we suggest that erythroid induction of haematopoietic progenitor cells is primarily attributable to pd mediated inhibition of jun activation.,pmc5824365,1,0.1,39,1,39.1
376,parkinson disease,other,,,text,parkinson disease,,,mncs,other,,,text,mncs,,,negative,i,inhibition,,,,,,0.65,nan,"based on our results, pd could significantly inhibit exvivo proliferation and self-renewal of both mncs and cd34 + cells.",pmc5824365,1,0.1,39,1,39.1
359,p38,other,,,text,p38,,,mapkapk2,protein,,hgnc:6887,hgnc,6887,,,positive,i,activation,,,,,,0.65,nan,"anisomycin induced p38 mapk activation resulted in a strong activation (phosphorylation) of mapkapk-2 (xref_fig a), 12 h after treatment.",pmc4783893,1,0.1,39,1,39.1
338,ncoa3,protein,,hgnc:7670,hgnc,7670,,,ras,other,,,text,ras,,,negative,i,inhibition,,,,,,0.65,nan,"together, knockdown of ncoa3, foxo3, and tcf7l2 modulated ras pathway associated proteins primarily in the kras activating mutant background.",pmc5755028,1,0.1,39,1,39.1
358,p38,other,,,text,p38,,,jnk,other,,,text,jnk,,,negative,i,inhibition,,,,,,0.65,nan,"gao et al. (2013) identified that the inhibition of jnk, but not erk and p38, suppressed gfap upregulation in an astrocyte scratched injury model in vitro, implying that jnk was involved in regulating astrocyte activation under physiological conditions.",pmc5372348,1,0.1,39,1,39.1
357,p38,other,,,text,p38,,,extracellular signal-regulated kinases 1 and 2,other,,,text,extracellular signal-regulated kinases 1 and 2,,,negative,i,inhibition,,,,,,0.65,nan,"several studies [xref_bibr, xref_bibr] have shown that in some types of cells, p38 mapk can inhibit the c-raf --> mek1/2 --> erk1/2 (extracellular signal regulated kinases 1 and 2) pathway, i.e., the erk signaling pathway.",pmc4783893,1,0.1,39,1,39.1
356,p38,other,,,text,p38,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.923,nan,"several studies [xref_bibr, xref_bibr] have shown that in some types of cells, p38 mapk can inhibit the c-raf --> mek1/2 --> erk1/2 (extracellular signal regulated kinases 1 and 2) pathway, i.e., the erk signaling pathway.",pmc4783893,1,0.1,39,1,39.1
355,p38,other,,,text,p38,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,0.86,nan,"figure xref_fig and xref_fig showed that silence of tlr4, myd88, erk, jnk, and p38 inhibited proliferation of ec109 cells.",pmc5190119,1,0.1,39,1,39.1
354,p38,other,,,text,p38,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,negative,i,inhibition,,,,,,0.65,nan,"figure xref and xref showed that silence of tlr4, myd88, erk, jnk, and p38 inhibited proliferation of ec109 cells.",pmc5190119,1,0.1,39,1,39.1
339,nf1,protein,,hgnc:7765,hgnc,7765,,,mvd,protein,,hgnc:7529,hgnc,7529,,,positive,i,activation,,,,,,0.86,nan,"bi-allelic inactivation of nf1 induces an mpd, which can be progressed to aml using retro-viral mutagenesis to induce secondary genetic aberrations.",pmc4067595,1,0.1,39,1,39.1
402,ptc,other,,,text,ptc,,,dusp6,protein,,hgnc:3072,hgnc,3072,,,positive,i,activation,,,,,,0.65,nan,dusp5 and dusp6 are specifically induced by the mek-erk pathway in the three ptc oncogenes inducible thyroid cell lines.,pmc5599027,1,0.1,39,1,39.1
341,ngf,protein,,hgnc:7808,hgnc,7808,,,cell differentiation,biologicalprocess,,,go,go:0030154,,,positive,i,activation,,,,,,0.65,nan,this pathway is essential for ngf induced neuronal differentiation in pc12 cells.,pmc2064279,1,0.1,39,1,39.1
342,nme1,protein,,hgnc:7849,hgnc,7849,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.65,nan,"in this review i summarize how nm23-h1 inhibits the ras and erk cascade in human cell lines, and examine how the nm23 homolog ndk-1 modifies the outcome of ras signaling in the model organism caenorhabditis elegans [xref_bibr].",pmc4020307,1,0.1,39,1,39.1
353,p38,other,,,text,p38,,,cell death,biologicalprocess,,,go,go:0008219,,,positive,i,activation,,,,,,0.65,nan,"furthermore, p38 mapk activation resulted in induction of cell death (xref_fig c) within 48 h after anisomycin application, again similar to that seen in sa treated cells.",pmc4783893,1,0.1,39,1,39.1
352,p38,other,,,text,p38,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.86,nan,"therefore, we tested the role of p38 mapk signaling pathway activation in apoptosis induction by sa, representing saturated fas, in nes2y cells.",pmc4783893,1,0.1,39,1,39.1
351,p38,other,,,text,p38,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,negative,i,inhibition,,,,,,0.86,nan,"as expected, knockdown of tlr4, myd88, erk, jnk, and p38 induced apoptosis of ec109 cells.",pmc5190119,1,0.1,39,1,39.1
350,okadaic acid,chemical,,,chebi,chebi:44658,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,erk activation can be rescued by pp2a inhibitor oa in map4k4-knockdown cells and suppressed by pp2a activator fty720 in map4k4 overexpressing cells.,pmc5467491,1,0.1,39,1,39.1
349,octadecanoic acid,chemical,,,chebi,chebi:28842,,,p38,other,,,text,p38,,,positive,i,activation,,,,,,0.65,nan,"in the present study, we demonstrated that p38 mapk is activated during apoptosis induction by stearic acid (sa) in the human pancreatic beta-cells nes2y.",pmc4783893,1,0.1,39,1,39.1
348,octadecanoic acid,chemical,,,chebi,chebi:28842,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.65,nan,saturated stearic acid (sa) induces apoptosis in the human pancreatic beta-cells nes2y.,pmc4783893,1,0.1,39,1,39.1
552,vegfr,biologicalprocess,,,go,go:0005172,,,neoplasm invasiveness,other,,,text,neoplasm invasiveness,,,positive,i,activation,,,,,,0.65,nan,"it was previously shown that vegf and vegfr -2 inhibition can upregulate endothelial adhesion molecules in tumor vessels, which can in turn increase the infiltration of leukocytes in tumors.",pmc3809567,1,0.1,39,1,39.1
343,nme1,protein,,hgnc:7849,hgnc,7849,,,neoplasm metastasis,other,,,text,neoplasm metastasis,,,negative,i,inhibition,,,,,,0.65,nan,the metastasis suppressor nm23 as a modulator of ras and erk signaling.,pmc4020307,1,0.1,39,1,39.1
553,vemurafenib,chemical,,,chebi,chebi:63637,,,braf,protein,,hgnc:1097,hgnc,1097,,,negative,i,inhibition,,,,,,0.65,nan,"finally, we found that vemurafenib inhibition of braf activation in mutated u266 cells affected the expression of genes known to be associated with mm.",pmc4695180,1,0.1,39,1,39.1
337,ncoa3,protein,,hgnc:7670,hgnc,7670,,,ras,other,,,text,ras,,,negative,i,decreaseamount,,,,,,0.65,nan,"among these, stable knockdown of foxo3, ncoa3, and tcf7l2 restored growth in low glucose but reduced mek and mapk phosphorylation, reduced anchorage independent growth, and modulated expressions of glut1 and ras pathway related proteins.",pmc5755028,1,0.1,39,1,39.1
360,p38,other,,,text,p38,,,mcf2l2,protein,,hgnc:30319,hgnc,30319,,,positive,i,activation,,,,,,0.65,nan,"further,
tgn-020 treatment could affect p38 mapk signaling pathway activation in drg
(p < 0.05; figure 4) but not in the spinal cord
(p > 0.05; figure 5).",pmc6113736,1,0.1,39,1,39.1
345,nme1,protein,,hgnc:7849,hgnc,7849,,,ras,other,,,text,ras,,,negative,i,inhibition,,,,,,0.86,nan,"overexpression of nm23-h1 in mda-mb-435 breast carcinoma cells resulted in decreased activated mapk (pmapk) levels without affecting the level of total mapk, suggesting that nm23-h1 inhibits ras and mapk signaling through ksr phosphorylation and inactivation [xref_bibr].",pmc4020307,1,0.1,39,1,39.1
361,p38,other,,,text,p38,,,mek,other,,,text,mek,,,negative,i,inhibition,,,,,,0.65,nan,"several studies [xref_bibr, xref_bibr] have shown that in some types of cells, p38 mapk can inhibit the c-raf --> mek1/2 --> erk1/2 (extracellular signal regulated kinases 1 and 2) pathway, i.e., the erk signaling pathway.",pmc4783893,1,0.1,39,1,39.1
374,parkinson disease,other,,,text,parkinson disease,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,"also, inhibition of erk signalling by pd leads to spontaneous erythroid differentiation of ucb-mncs, which is in concomitant with overexpression of erythroid lineage transcription factors, the presence of more cd235 + cells and increasing number of bfu-e colony in the population of pd expanded mncs.",pmc5824365,1,0.1,39,1,39.1
373,parkinson disease,other,,,text,parkinson disease,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.65,nan,"further, according to our results, erk inhibition by pd and consequently jun hampering promotes the path of erythroid differentiation of mncs.",pmc5824365,1,0.1,39,1,39.1
372,parkinson disease,other,,,text,parkinson disease,,,cell survival,other,,,text,cell survival,,,negative,i,inhibition,,,,,,0.65,nan,"as shown in figure xref_fig a, pd reduced dose-dependently cell viability.",pmc5824365,1,0.1,39,1,39.1
332,navitoclax,other,,,text,navitoclax,,,cell death,biologicalprocess,,,go,go:0008219,,,positive,i,activation,,,,,,0.65,nan,"indeed, cell death could be induced by low concentrations of navitoclax when combined with high concentrations of afatinib and selumetinib.",pmc5127645,1,0.1,39,1,39.1
371,parkinson disease,other,,,text,parkinson disease,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,negative,i,inhibition,,,,,,0.65,nan,"based on our results, pd could significantly inhibit exvivo proliferation and self-renewal of both mncs and cd34 + cells.",pmc5824365,1,0.1,39,1,39.1
333,ncoa3,protein,,hgnc:7670,hgnc,7670,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,0.65,nan,"hence, stable knockdown of foxo3, ncoa3, and tcf7l2 significantly reduced anchorage independent growth and mek and erk phosphorylation.",pmc5755028,1,0.1,39,1,39.1
555,vemurafenib,chemical,,,chebi,chebi:63637,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,0.86,nan,"45 our results showed that vemurafenib and dabrafenib were not able to decrease levels of erk phosphorylation significantly in mutated cases, although a slight effect was observed after dabrafenib treatment which could be an off-target effect.",pmc6395334,1,0.1,39,1,39.1
370,parkinson disease,other,,,text,parkinson disease,,,cell differentiation,biologicalprocess,,,go,go:0030154,,,positive,i,activation,,,,,,0.65,nan,an interesting question raised for us is how pd can promote erythroid differentiation of ucb-mncs.,pmc5824365,1,0.1,39,1,39.1
369,parkinson disease,other,,,text,parkinson disease,,,cd34,protein,,hgnc:1662,hgnc,1662,,,negative,i,inhibition,,,,,,0.86,nan,"moreover, invivo analysis demonstrates that pd reduces engraftment capacity of exvivo expanded cd34 + cells.",pmc5824365,1,0.1,39,1,39.1
554,vemurafenib,chemical,,,chebi,chebi:63637,,,erk,other,,,text,erk,,,,i,dephosphorylation,,,,,,0.65,nan,"vemurafenib, at a dose of 2.5 mum, was not able to inhibit basal erk phosphorylation or after anti-igm stimulation in mutated cases, while a slight effect was observed after treatment with 2.5 mum of dabrafenib.",pmc6395334,1,0.1,39,1,39.1
368,page4,protein,,hgnc:4108,hgnc,4108,,,phenazine-1-carboxylate,chemical,,,chebi,chebi:62248,,,positive,i,activation,,,,,,0.65,nan,page4 overexpression promoted pca cells growth in vivo.,pmc6339303,1,0.1,39,1,39.1
367,page4,protein,,hgnc:4108,hgnc,4108,,,dna damage,other,,,text,dna damage,,,negative,i,inhibition,,,,,,0.65,nan,page4 overexpression protected pca cells from oxidative stress inducing cell death by reducing dna damage.,pmc6339303,1,0.1,39,1,39.1
366,page4,protein,,hgnc:4108,hgnc,4108,,,cell death,biologicalprocess,,,go,go:0008219,,,positive,i,activation,,,,,,0.65,nan,page4 overexpression protected pca cells from oxidative stress inducing cell death by reducing dna damage.,pmc6339303,1,0.1,39,1,39.1
551,vegfr,biologicalprocess,,,go,go:0005172,,,cell adhesion,biologicalprocess,,,go,go:0007155,,,positive,i,activation,,,,,,0.65,nan,"it was previously shown that vegf and vegfr -2 inhibition can upregulate endothelial adhesion molecules in tumor vessels, which can in turn increase the infiltration of leukocytes in tumors.",pmc3809567,1,0.1,39,1,39.1
364,p38,other,,,text,p38,,,raf1,protein,,hgnc:9829,hgnc,9829,,,negative,i,inhibition,,,,,,0.65,nan,"several studies [ xref , xref ] have shown that in some types of cells, p38 mapk can inhibit the c-raf → mek1/2 → erk1/2 (extracellular signal-regulated kinases 1 and 2) pathway, i.e. , the erk signaling pathway.",pmc4783893,1,0.1,39,1,39.1
335,ncoa3,protein,,hgnc:7670,hgnc,7670,,,mapk,other,,,text,mapk,,,,i,phosphorylation,,,,,,0.65,nan,"among these, stable knockdown of foxo3, ncoa3, and tcf7l2 restored growth in low glucose but reduced mek and mapk phosphorylation, reduced anchorage independent growth, and modulated expressions of glut1 and ras pathway related proteins.",pmc5755028,1,0.1,39,1,39.1
363,p38,other,,,text,p38,,,pp38,other,,,text,pp38,,,positive,i,increaseamount,,,,,,0.65,nan,"in this study, we applied the inhibitors of erk, jnk, and p38 to inhibit the expression of p-erk, p-jnk, or p-p38, which could, in turn, suppress the gfap upregulation and improve the cell hypertrophy.",pmc5372348,1,0.1,39,1,39.1
336,ncoa3,protein,,hgnc:7670,hgnc,7670,,,mek,other,,,text,mek,,,,i,phosphorylation,,,,,,0.86,nan,"among these, stable knockdown of foxo3, ncoa3, and tcf7l2 restored growth in low glucose but reduced mek and mapk phosphorylation, reduced anchorage independent growth, and modulated expressions of glut1 and ras pathway related proteins.",pmc5755028,1,0.1,39,1,39.1
362,p38,other,,,text,p38,,,p38,other,,,text,p38,,,positive,i,increaseamount,,,,,,0.65,nan,"inhibition of p38 mapk expression by sirna silencing and inhibition of p38 mapk activity by the specific inhibitor sb202190 after sa application, as well as p38 mapk overexpression using plasmid transfection, had no significant effect on cell viability (see xref_fig c, xref_fig c and xref_fig c).",pmc4783893,1,0.1,39,1,39.1
401,protein (35 mg protein,other,,,text,protein (35 mg protein,,,alb,protein,,hgnc:399,hgnc,399,,,negative,i,inhibition,,,,,,0.65,nan,"briefly, equal amounts of protein (35 mg protein in 20 ml
for tissue samples) were separated using sodium dodecyl sulfate-polyacrylamide
gel, transferred on to polyvinylidene difluoride membranes (millipore, usa), and
blocked using 5% bovine serum albumin (bsa).",pmc6113736,1,0.1,39,1,39.1
536,u0126,chemical,,,chebi,chebi:90693,,,becn1,protein,,hgnc:1034,hgnc,1034,,,positive,i,activation,,,,,,0.65,nan,"the microarray analysis identified pycard and cd24a to be upregulated by u0126 only, becn1 (beclin1) by both u0126 and ifn-alpha, as well as gbp2b (alias gbp-1) and irf7 by ifn-alpha only.",pmc4535867,1,0.1,39,1,39.1
403,ptk2,protein,,hgnc:9611,hgnc,9611,,,ras,other,,,text,ras,,,positive,i,activation,,,,,,0.65,nan,phosphorylation of fak (tyr925) generates a binding site for sh2 bearing molecules and triggers a ras dependent activation of the map kinase pathway [xref_bibr].,pmc5432316,1,0.1,39,1,39.1
478,selumetinib,chemical,,,chebi,chebi:90227,,,mek,other,,,text,mek,,,negative,i,inhibition,,,,,,0.65,nan,preclinical data have demonstrated that mek inhibition by selumetinib is one of the effective strategies for targeting dysregulated mapk pathway that leads to unregulated cell proliferation and development and progression of melanoma.,pmc4179759,1,0.1,39,1,39.1
490,sirt1,protein,,hgnc:14929,hgnc,14929,,,jnk,other,,,text,jnk,,,negative,i,inhibition,,,,,,0.65,nan,sirt1 overexpression upregulated erk activation and downregulated jnk and p38mapk activation induced by il-1beta-stimulation in vitro and brain injury in vivo.,pmc5372348,1,0.1,39,1,39.1
489,sirt1,protein,,hgnc:14929,hgnc,14929,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,sirt1 overexpression upregulated erk activation and downregulated jnk and p38mapk activation induced by il-1beta-stimulation in vitro and brain injury in vivo.,pmc5372348,1,0.1,39,1,39.1
488,sirolimus,chemical,,,chebi,chebi:9168,,,mtorc1,biologicalprocess,,,go,go:0031931,,,negative,i,inhibition,,,,,,0.65,nan,it has been shown that inhibition of mtorc1 by rapamycin and torin1 in imr90 er : ras senescent human cells reduces the expression of senescence marker sa-beta-gal and development of sasp without rescuing cells from the proliferation arrest [xref_bibr].,pmc5723691,1,0.1,39,1,39.1
487,signal transduction,biologicalprocess,,,go,go:0007165,,,cell differentiation,biologicalprocess,,,go,go:0030154,,,negative,i,inhibition,,,,,,0.65,nan,inhibition of mek and erk signalling pathway promotes erythroid differentiation and reduces hscs engraftment in exvivo expanded haematopoietic stem cells.,pmc5824365,1,0.1,39,1,39.1
486,sfl1,other,,,text,sfl1,,,ras,other,,,text,ras,,,negative,i,inhibition,,,,,,0.65,nan,this suggests that iradelta2933 disrupts sfl1 mediated transcriptional repression of ras target genes.,pmc4618523,1,0.1,39,1,39.1
485,sfl1,other,,,text,sfl1,,,flo11,other,,,text,flo11,,,positive,i,activation,,,,,,0.65,nan,"given that ira2delta2933 alleviated repression of flo11 in 3s, we hypothesized that it might do so by indirectly inhibiting sfl1, which is thought to negatively regulate flo11 and other targets of the ras pathway when ras signaling is low by recruiting the ssn6-tup1 corepressor complex [xref_bibr], which in turn recruits the histone deacetylase hda1 [xref_bibr, xref_bibr].",pmc4618523,1,0.1,39,1,39.1
484,ser-ala,chemical,,,chebi,chebi:74801,,,parp1,protein,,hgnc:270,hgnc,270,,,positive,i,activation,,,,,,0.65,nan,"sa application resulted in significant induction of cell death within 48 h after sa application (xref_fig a), and increased caspase-7, -8, -9 and parp (a substrate of activated executioner caspases) cleavage 18 h after sa application (xref_fig b).",pmc4783893,1,0.1,39,1,39.1
483,ser-ala,chemical,,,chebi,chebi:74801,,,p38,other,,,text,p38,,,positive,i,activation,,,,,,0.951,nan,"in this paper, we showed that p38 mapk kinase was activated by sa (see above).",pmc4783893,1,0.1,39,1,39.1
482,ser-ala,chemical,,,chebi,chebi:74801,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.65,nan,"in this study, we tested the involvement of the p38 mapk signaling pathway in stearic acid (sa)-induced apoptosis in the human pancreatic β-cells nes2y. furthermore, this study showed that, together with p38 mapk pathway activation, apoptosis-inducing sa also inhibits the erk pathway in nes2y cells.",pmc4783893,1,0.1,39,1,39.1
481,ser-ala,chemical,,,chebi,chebi:74801,,,cell death,biologicalprocess,,,go,go:0008219,,,positive,i,activation,,,,,,0.86,nan,"our previous studies showed that sa, at a concentration of 1 mm, induced cell death in most nes2y cells within 48 h of application.",pmc4783893,1,0.1,39,1,39.1
480,ser-ala,chemical,,,chebi,chebi:74801,,,casp7,protein,,hgnc:1508,hgnc,1508,,,positive,i,activation,,,,,,0.65,nan,"sa application resulted in significant induction of cell death within 48 h after sa application (xref_fig a), and increased caspase-7, -8, -9 and parp (a substrate of activated executioner caspases) cleavage 18 h after sa application (xref_fig b).",pmc4783893,1,0.1,39,1,39.1
479,ser-ala,chemical,,,chebi,chebi:74801,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.94757,nan,saturated stearic acid (sa) induces apoptosis in the human pancreatic beta-cells nes2y.,pmc4783893,1,0.1,39,1,39.1
477,selumetinib,chemical,,,chebi,chebi:90227,,,mapk,other,,,text,mapk,,,negative,i,inhibition,,,,,,0.65,nan,"xref_bibr - xref_bibr therefore, mapk pathway inhibition by selumetinib was evaluated in other malignancies, including colorectal, pancreatic, non-small-cell lung, and hepatocellular cancer, as well as melanoma.",pmc4179759,1,0.1,39,1,39.1
404,ptpn1,protein,,hgnc:9642,hgnc,9642,,,insr,protein,,hgnc:6091,hgnc,6091,,,,d,dephosphorylation,,,,,,0.8775000000000001,nan,"previous studies have shown that ptpn1 directly dephosphorylates insulin receptor (ir) and insulin receptor substrates (irs), which results in downregulation of insulin signaling xref_bibr, xref_bibr.",pmc5636874,1,0.1,39,1,39.1
476,selumetinib,chemical,,,chebi,chebi:90227,,,gnaq,protein,,hgnc:4390,hgnc,4390,,,positive,i,activation,,,,,,0.65,nan,"xref_bibr, xref_bibr another preclinical study demonstrated that the combination of selumetinib and a mammalian target of rapamycin (mtor) inhibitor (azd8055) which is downstream of pi3k and akt pathway, induces tumor regression in braf mutant uveal melanoma cell lines but not gnaq mutant cell lines.",pmc4179759,1,0.1,39,1,39.1
475,selumetinib,chemical,,,chebi,chebi:90227,,,erk,other,,,text,erk,,,,i,dephosphorylation,,,,,,0.65,nan,"xref_bibr, xref_bibr in tumor biopsy samples, selumetinib treatment induced strong inhibition of erk phosphorylation, on average, by 79% by immunohistochemistry.",pmc4179759,1,0.1,39,1,39.1
474,selumetinib,chemical,,,chebi,chebi:90227,,,braf,protein,,hgnc:1097,hgnc,1097,,,positive,i,activation,,,,,,0.65,nan,"xref_bibr, xref_bibr another preclinical study demonstrated that the combination of selumetinib and a mammalian target of rapamycin (mtor) inhibitor (azd8055) which is downstream of pi3k and akt pathway, induces tumor regression in braf mutant uveal melanoma cell lines but not gnaq mutant cell lines.",pmc4179759,1,0.1,39,1,39.1
473,sb202190,other,,,text,sb202190,,,raf1,protein,,hgnc:9829,hgnc,9829,,,positive,i,activation,,,,,,0.65,nan,"however, it should be mentioned that this inhibitor effect could be the result of a direct effect of the inhibitor on the erk pathway, since activation of c-raf by sb202190 has been documented [xref_bibr].",pmc4783893,1,0.1,39,1,39.1
472,sb 203580,chemical,,,chebi,chebi:90705,,,p38,other,,,text,p38,,,negative,i,inhibition,,,,,,0.86,nan,"similarly, sp600125 or sb203580 could inhibit the jnk activation or p38mapk activation, respectively, but did not affect the other two pathways.",pmc5372348,1,0.1,39,1,39.1
471,sb 203580,chemical,,,chebi,chebi:90705,,,jnk,other,,,text,jnk,,,negative,i,inhibition,,,,,,0.65,nan,"similarly, sp600125 or sb203580 could inhibit the jnk activation or p38mapk activation, respectively, but did not affect the other two pathways.",pmc5372348,1,0.1,39,1,39.1
470,rtk,other,,,text,rtk,,,mek,other,,,text,mek,,,positive,i,activation,,,,,,0.65,nan,"recently, increased p-erk1/2 levels were reported in ovarian cancer models rendered resistant to bet inhibition, which was suggested to result from transcriptional up-regulation of receptor tyrosine kinases (rtks) that activate mek and erk signaling 7.",pmc5908790,1,0.1,39,1,39.1
469,rtk,other,,,text,rtk,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,"recently, increased p-erk1/2 levels were reported in ovarian cancer models rendered resistant to bet inhibition, which was suggested to result from transcriptional up-regulation of receptor tyrosine kinases (rtks) that activate mek and erk signaling 7.",pmc5908790,1,0.1,39,1,39.1
468,resveratrol,chemical,,,chebi,chebi:27881,,,gfap,protein,,hgnc:4235,hgnc,4235,,,positive,i,increaseamount,,,,,,0.65,nan,"moreover, the administration of resveratrol, a pharmacological sirt1 agonist, attenuated astrocyte activation by decreasing the gfap expression and improving the cell morphology in vivo.",pmc5372348,1,0.1,39,1,39.1
467,rerg,protein,,hgnc:15980,hgnc,15980,,,ras,other,,,text,ras,,,negative,i,inhibition,,,,,,0.923,nan,"we found that rerg not only reduced ras activation but also slightly reduced its stability, though not to statistically significant levels.",pmc5410235,1,0.1,39,1,39.1
466,rerg,protein,,hgnc:15980,hgnc,15980,,,mir-382-5p,other,,,text,mir-382-5p,,,negative,i,inhibition,,,,,,0.65,nan,"to examine whether rerg compensative expression attenuated the oncogenic effects of mir-382-5p on breast cancer cell viability and progression, we co-transfected pcdna3-rerg or empty vector with mir-382-5p mimics or mnc into mcf-7 cells.",pmc5410235,1,0.1,39,1,39.1
465,rerg,protein,,hgnc:15980,hgnc,15980,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.86,nan,"however, we also found that ras protein expression slightly decreased upon rerg overexpression, which complicates the potential mechanism by which rerg deactivates the ras and erk pathway, including through a direct ras and rerg interaction, substrate competition, or ras protein destabilization.",pmc5410235,1,0.1,39,1,39.1
491,sirt1,protein,,hgnc:14929,hgnc,14929,,,mapk,other,,,text,mapk,,,negative,i,inhibition,,,,,,0.65,nan,the overexpression of sirt1 by agonist or transfection attenuated astrocyte activation regulated the mapk pathway activation.,pmc5372348,1,0.1,39,1,39.1
492,sirt1,protein,,hgnc:14929,hgnc,14929,,,p38,other,,,text,p38,,,negative,i,inhibition,,,,,,0.65,nan,sirt1 overexpression upregulated erk activation and downregulated jnk and p38mapk activation induced by il-1beta-stimulation in vitro and brain injury in vivo.,pmc5372348,1,0.1,39,1,39.1
493,smad,other,,,text,smad,,,tgfb,other,,,text,tgfb,,,positive,i,activation,,,,,,0.65,nan,"combination or crosstalk of these non smad signaling pathways or between smad and non smad signaling produces diverse biological responses of tgf-beta, such as cell proliferation, differentiation, growth arrest, apoptosis, and emt.",pmc4440819,1,0.1,39,1,39.1
494,small interfering rna,other,,,text,small interfering rna,,,dusp6,protein,,hgnc:3072,hgnc,3072,,,negative,i,inhibition,,,,,,0.65,nan,"dusp5 and/or dusp6 sirna inactivation did not affect proliferation in two braf v600e mutated cell lines, which may be explained by a compensatory increase in other phosphatases.",pmc5599027,1,0.1,39,1,39.1
534,trametinib,chemical,,,chebi,chebi:75998,,,mek,other,,,text,mek,,,positive,i,activation,,,,,,0.65,nan,we further show that bet inhibition reverses adaptive re-activation of mek and erk signaling triggered by trametinib treatment in a mek dependent cell line (rko).,pmc5908790,1,0.1,39,1,39.1
533,trametinib,chemical,,,chebi,chebi:75998,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,we further show that bet inhibition reverses adaptive re-activation of mek and erk signaling triggered by trametinib treatment in a mek dependent cell line (rko).,pmc5908790,1,0.1,39,1,39.1
532,trametinib,chemical,,,chebi,chebi:75998,,,erk,other,,,text,erk,,,,i,dephosphorylation,,,,,,0.65,nan,"the results showed that ectopic expression of map4k4 in a549 cells partially prevented mek inhibitor trametinib mediated inhibition of erk phosphorylation, supporting that map4k4 activation could bypass the effect of mek inhibitor.",pmc5467491,1,0.1,39,1,39.1
527,tlr4,protein,,hgnc:11850,hgnc,11850,,,mapk,other,,,text,mapk,,,positive,i,activation,,,,,,0.65,nan,"moreover, it has been reported that mapk activation was mediated by tlr4 and myd88 pathway [xref_bibr].",pmc5190119,1,0.1,39,1,39.1
526,tlr4,protein,,hgnc:11850,hgnc,11850,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,0.923,nan,"figure xref_fig and xref_fig showed that silence of tlr4, myd88, erk, jnk, and p38 inhibited proliferation of ec109 cells.",pmc5190119,1,0.1,39,1,39.1
537,u0126,chemical,,,chebi,chebi:90693,,,cell growth,biologicalprocess,,,go,go:0016049,,,negative,i,inhibition,,,,,,0.65,nan,"previous work showed that the combination of azd8055 and mek inhibitor u0126 enhanced the cell growth inhibition of nb cells invitro and invivo 26, indicating the importance of this pathway.",pmc6396142,1,0.1,39,1,39.1
538,u0126,chemical,,,chebi,chebi:90693,,,erk,other,,,text,erk,,,,i,dephosphorylation,,,,,,0.65,nan,western blots confirmed that u0126 inhibited erk phosphorylation.,pmc5288173,1,0.1,39,1,39.1
524,tgn-020,other,,,text,tgn-020,,,interleukin-1β,other,,,text,interleukin-1β,,,negative,i,decreaseamount,,,,,,0.65,nan,"we thus found that tgn-020 upregulated the threshold of thermal and mechanical allodynia, downregulated the expression of interleukin-1β, interleukin-6, and tumor necrosis factor-α, attenuated the astrocytic activation and suppressed the activation of mitogen-activated protein kinase pathways in the spinal dorsal horn and dorsal root ganglion.",pmc6113736,1,0.1,39,1,39.1
523,tgn-020,other,,,text,tgn-020,,,inflammatory response,biologicalprocess,,,go,go:0006954,,,negative,i,inhibition,,,,,,0.65,nan,"the present study showed that aqp4 inhibitor tgn-020 could exert a remarkable
analgesic effect against cci-induced np by inhibiting the production of inflammation
and astrocytic activation, thereby attenuating erk activation in neurons, satellite
cells in the peripheral nervous system, and astrocytes in the central nervous system
(cns) after injury.",pmc6113736,1,0.1,39,1,39.1
540,u0126,chemical,,,chebi,chebi:90693,,,gbp1,protein,,hgnc:4182,hgnc,4182,,,positive,i,activation,,,,,,0.65,nan,"the microarray analysis identified pycard and cd24a to be upregulated by u0126 only, becn1 (beclin1) by both u0126 and ifn-alpha, as well as gbp2b (alias gbp-1) and irf7 by ifn-alpha only.",pmc4535867,1,0.1,39,1,39.1
520,tgn-020,other,,,text,tgn-020,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.86,nan,"astrocytic erk activation was attenuated by the administration of tgn-020 in
both spinal cord and dorsal root ganglion.",pmc6113736,1,0.1,39,1,39.1
519,tgn-020,other,,,text,tgn-020,,,erk,other,,,text,erk,,,,i,dephosphorylation,,,,,,0.86,nan,"tgn-020 prevented
erk and jnk phosphorylation both in the spinal cord and drg.",pmc6113736,1,0.1,39,1,39.1
518,tgn-020,other,,,text,tgn-020,,,central nervous system,other,,,text,central nervous system,,,positive,i,activation,,,,,,0.65,nan,"the present study showed that aqp4 inhibitor tgn-020 could exert a remarkable
analgesic effect against cci-induced np by inhibiting the production of inflammation
and astrocytic activation, thereby attenuating erk activation in neurons, satellite
cells in the peripheral nervous system, and astrocytes in the central nervous system
(cns) after injury.",pmc6113736,1,0.1,39,1,39.1
511,tgfb,other,,,text,tgfb,,,smad,other,,,text,smad,,,positive,i,activation,,,,,,0.9419,nan,"tgf-beta induces both canonical smad signaling and non canonical signaling, including the ras induced erk pathway (raf-mek-erk).",pmc4440819,1,0.1,39,1,39.1
510,tgfb,other,,,text,tgfb,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,tgf-beta activates both smad signaling and the ras -- erk pathway.,pmc4440819,1,0.1,39,1,39.1
509,tf-np-sc,other,,,text,tf-np-sc,,,tf-np-mir-181a,other,,,text,tf-np-mir-181a,,,positive,i,activation,,,,,,0.65,nan,"there was a 4.8, 4.3 and 7.8-fold reduction of myc protein in kg1a, oci-aml3 and mv4-11 treated with tf-np-mir-181a compared to those treated with tf-np-sc control.",pmc5312311,1,0.1,39,1,39.1
508,tf-np-mir-181a,other,,,text,tf-np-mir-181a,,,mek,other,,,text,mek,,,negative,i,inhibition,,,,,,0.65,nan,"compared to tf-np-sc, tf-np-mir-181a decreased p-mek protein by 6.8, 2.2 and 4.5-fold and p-akt protein by 2.0, 2.5 and 5.7-fold in kg1a, oci-aml3 and mv4-11 cells, respectively.",pmc5312311,1,0.1,39,1,39.1
507,tf-np-mir-181a,other,,,text,tf-np-mir-181a,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.86,nan,"treatment with tf-np-mir-181a induced apoptosis in both mv4-11 (28.69 +/- 5.88% vs. 15.92 +/- 0.7% annexinv+, p = 0.02) and oci-aml3 cells (20.15 +/- 2.58% vs. 8.54 +/- 1.42% annexinv+, p < 0.0001) compared to tf-np-sc treatment at 96 hours.",pmc5312311,1,0.1,39,1,39.1
505,tcf7l2,protein,,hgnc:11641,hgnc,11641,,,mek,other,,,text,mek,,,,i,phosphorylation,,,,,,0.86,nan,"hence, stable knockdown of foxo3, ncoa3, and tcf7l2 significantly reduced anchorage independent growth and mek and erk phosphorylation.",pmc5755028,1,0.1,39,1,39.1
504,tcf7l2,protein,,hgnc:11641,hgnc,11641,,,kras,protein,,hgnc:6407,hgnc,6407,,,negative,i,inhibition,,,,,,0.65,nan,"stable knockdown of foxo3, ncoa3, and tcf7l2 increased growth of dld-1 kras wt/- cells in low glucose without any growth advantage in normal glucose medium.",pmc5755028,1,0.1,39,1,39.1
541,u0126,chemical,,,chebi,chebi:90693,,,irf7,protein,,hgnc:6122,hgnc,6122,,,positive,i,activation,,,,,,0.65,nan,"the microarray analysis identified pycard and cd24a to be upregulated by u0126 only, becn1 (beclin1) by both u0126 and ifn-alpha, as well as gbp2b (alias gbp-1) and irf7 by ifn-alpha only.",pmc4535867,1,0.1,39,1,39.1
502,tcf7l2,protein,,hgnc:11641,hgnc,11641,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,"stable knockdown of foxo3 or tcf7l2 reduced pmek and perk in dld-1 cells with kras g13d mutation and rko cells with braf v600e mutation, to an extent similar to knockdown of kras or braf.",pmc5755028,1,0.1,39,1,39.1
501,tcf7l2,protein,,hgnc:11641,hgnc,11641,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,0.65,nan,"hence, stable knockdown of foxo3, ncoa3, and tcf7l2 significantly reduced anchorage independent growth and mek and erk phosphorylation.",pmc5755028,1,0.1,39,1,39.1
500,sult4a1,protein,,hgnc:14903,hgnc,14903,,,ras,other,,,text,ras,,,negative,i,inhibition,,,,,,0.65,nan,"we hypothesized that effective nst, which has been shown to slow tumor growth and reduce tumor volume, would inactivate or decrease the ras pathway signal that drives mammary tumor progression and metastasis.",pmc5049993,1,0.1,39,1,39.1
496,sos,other,,,text,sos,,,ras,other,,,text,ras,,,positive,i,activation,,,,,,0.65,nan,rtks often signal to the ras and erk cascade via grb-2 (growth factor receptor bound protein 2) and the guanine nucleotide exchange factor (gef) sos (son of sevenless) to activate the small gtpase ras.,pmc4020307,1,0.1,39,1,39.1
464,rerg,protein,,hgnc:15980,hgnc,15980,,,cell survival,other,,,text,cell survival,,,negative,i,inhibition,,,,,,0.923,nan,"conversely, rerg overexpression in hs578t cells reduced cell viability and colony forming ability in rerg stably transfected clones compared to vector (vec) control groups.",pmc5410235,1,0.1,39,1,39.1
463,reactive oxygen species,chemical,,,chebi,chebi:26523,,,pts,protein,,hgnc:9689,hgnc,9689,,,negative,i,inhibition,,,,,,0.65,nan,"it is known that the jnk pathway is transiently activated when cells are stimulated with tnfalpha, because the nfkappab pathway induces expression of mnsod and thereby prevents not only the accumulation of ros, but also the oxidation and inactivation of ptps by ros xref_bibr, xref_bibr.",pmc5636874,1,0.1,39,1,39.1
462,rdm1,protein,,hgnc:19950,hgnc,19950,,,ras-raf-mitogen-activated protein kinase kinase,other,,,text,ras-raf-mitogen-activated protein kinase kinase,,,positive,i,activation,,,,,,0.65,nan,"interestingly, knockdown of rdm1 inactivated the ras-raf-mitogen-activated protein kinase kinase (mek)-extracellular signal regulated kinase (erk) signaling pathway.",pmc6396142,1,0.1,39,1,39.1
431,ras,other,,,text,ras,,,mek-erk,other,,,text,mek-erk,,,positive,i,activation,,,,,,0.65,nan,"ras engages numerous signaling pathways to elicit its tumorigenic activities, primarily the mek-erk, phosphoinositol-3-kinase (pi3k), and ral pathways [xref_bibr].",pmc3843736,1,0.1,39,1,39.1
429,ras,other,,,text,ras,,,mapk,other,,,text,mapk,,,positive,i,activation,,,,,,0.8775000000000001,nan,phosphorylation of stat3 on s727 in ras transformed mefs and its inhibition by treatment with mek inhibitors provided strong evidence for a role for ras activated mapk in stat3 s727 phosphorylation.,pmc3843736,1,0.1,39,1,39.1
427,ras,other,,,text,ras,,,gdp,chemical,,,chebi,chebi:17552,,,positive,i,activation,,,,,,0.65,nan,"xref_bibr, xref_bibr less frequently, mutations occur (eg, at alanine 146) that lower the affinity of ras proteins for gdp, allowing exchange of gdp for gtp without upstream signaling through gefs.",pmc5467702,1,0.1,39,1,39.1
425,ras,other,,,text,ras,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,0.65,nan,it is noteworthy that free cytosolic ca 2+ is a positive regulator of ras gtpase activating proteins (gaps) such as capri and rasal that are responsible for converting hrasgtp to hrasgdp [ xref – xref ]; it reduces the levels of hrasgtp and thus of ras-dependent erk phosphorylation [ xref ].,pmc5432316,1,0.1,39,1,39.1
424,ras,other,,,text,ras,,,cellular senescence,biologicalprocess,,,go,go:0090398,,,positive,i,activation,,,,,,0.65,nan,"also, a549 cells induced to senescence by nabut and treated with pd0325901 demonstrate ras co-localization with lc3 in the cytoplasm, implying that this phenomenon may be common for various ras expressing cells.",pmc5723691,1,0.1,39,1,39.1
423,ras,other,,,text,ras,,,cell death,biologicalprocess,,,go,go:0008219,,,positive,i,activation,,,,,,0.65,nan,"as opposed to this, it has been reported that combined inhibition of anti-apoptotic bcl2 family members and effectors of the ras pathway can effectively induce cell death in kras mutant cancers.",pmc5127645,1,0.1,39,1,39.1
422,ras,other,,,text,ras,,,cascade,other,,,text,cascade,,,positive,d,activation,,,,,,0.65,nan,"since it was shown that golgi-associated ras was able to activate the mapk signaling cascade in a timely and quantitatively different manner, it was proposed that compartmentalized ras signaling would increase the complexity of possibilities for downstream signaling xref .",pmc3498325,1,0.1,39,1,39.1
421,ras,other,,,text,ras,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,negative,i,inhibition,,,,,,0.65,nan,"consequently, one aspect of the physiological significance of the tgf-beta1-activated ras -- erk pathway and pi3k -- akt signaling might be preventing apoptosis that can be induced by tgf-beta1.",pmc4440819,1,0.1,39,1,39.1
420,ras,other,,,text,ras,,,akt,other,,,text,akt,,,,i,phosphorylation,,,,,,0.65,nan,"downregulation of ras and mapk1 resulted in ras-mapk1 inhibition, decreased mek and akt phosphorylation and decreased myc levels.",pmc5312311,1,0.1,39,1,39.1
419,ralgds,protein,,hgnc:9842,hgnc,9842,,,rala,protein,,hgnc:9839,hgnc,9839,,,positive,i,activation,,,,,,0.65,nan,"deregulated pi3k signaling (e.g., loss of the negative regulator pten) is one of the most commonly mutated tumor suppressors seen in cancer, particularly malignancies of the central nervous system and endometrium [xref_bibr]; constitutive raf signaling (e.g., raf600e mutation) drives approximately 60% of melanoma [xref_bibr]; elevated ral expression is seen in colon, bladder and prostate cancers [xref_bibr]; and ralgds activation of ral has been implicated in ras driven skin cancer [xref_bibr].",pmc3843736,1,0.1,39,1,39.1
535,trib2,protein,,hgnc:30809,hgnc,30809,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,0.65,nan,etv4/5 [ xref ] can replace ras/mapk pathway activation and trib2 can enhance erk phosphorylation [ xref ].,pmc5069826,1,0.1,39,1,39.1
417,rala,protein,,hgnc:9839,hgnc,9839,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,0.65,nan,"mutation at codons 12, 13 or 61 locks ras in a gtp bound active state, which initiates diverse signaling cascades including raf-mek-erk, pi3k and ral pathways that drive proliferation, survival and angiogenesis [xref_bibr].",pmc3843736,1,0.1,39,1,39.1
416,raf1,protein,,hgnc:9829,hgnc,9829,,,mir7-1,protein,,hgnc:31638,hgnc,31638,,,positive,i,activation,,,,,,0.65,nan,"to date, let-7 has been reported to target hras [xref_bibr] and kras [xref_bibr], mir-200c and mir-30c target kras, mir-148b targets nras, mir-7 targets raf1, mir-206 targets rasa1 and mir-21 targets spred1 in breast cancer cells [xref_bibr].",pmc5410235,1,0.1,39,1,39.1
545,ulixertinib,other,,,text,ulixertinib,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,0.65,nan,"our results demonstrated that ulixertinib (bvd-523), a potent and highly selective inhibitor of erk1/2, was able to inhibit erk phosphorylation in vitro in all cll cases with mutations in genes of the ras-braf-mapk-erk pathway.",pmc6395334,1,0.1,39,1,39.1
546,ulixertinib,other,,,text,ulixertinib,,,erk,other,,,text,erk,,,negative,i,decreaseamount,,,,,,0.65,nan,"in contrast, ulixertinib, a pan-erk inhibitor, decreased phospho-erk levels.",pmc6395334,1,0.1,39,1,39.1
415,raf1,protein,,hgnc:9829,hgnc,9829,,,mek,other,,,text,mek,,,positive,i,activation,,,,,,0.65,nan,"some of these mechanisms involve activating nras mutations or loss of the ras suppressor nf1, braf amplification or alternative splicing leading to braf truncations and overexpression or mutation of the mek activators craf, cot/tpl2/map3k8 or mlks.",pmc4846800,1,0.1,39,1,39.1
414,raf1,protein,,hgnc:9829,hgnc,9829,,,mek,other,,,text,mek,,,,d,phosphorylation,,,,,,0.65,nan,"in contrast, immunoprecipitated raf1 and a-raf scarcely phosphorylated mek regardless of the differentiation stage (xref_fig and not depicted).",pmc2064279,1,0.1,39,1,39.1
413,raf1,protein,,hgnc:9829,hgnc,9829,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,0.65,nan,"while no considerable reduction in erk1/2 activation was achieved by araf depletion, braf and craf silencing each reduced the level of erk1/2 phosphorylation.",pmc4254013,1,0.1,39,1,39.1
412,raf-mek-erk,other,,,text,raf-mek-erk,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,0.65,nan,"mutation at codons 12, 13 or 61 locks ras in a gtp bound active state, which initiates diverse signaling cascades including raf-mek-erk, pi3k and ral pathways that drive proliferation, survival and angiogenesis [xref_bibr].",pmc3843736,1,0.1,39,1,39.1
411,raf,other,,,text,raf,,,mek,other,,,text,mek,,,positive,i,activation,,,,,,0.8775000000000001,nan,"raf subsequently activates mek1/2, which display restricted substrate specificity for erk1/2.",pmc4067595,1,0.1,39,1,39.1
547,vegf,other,,,text,vegf,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.65,nan,"several mechanisms that may account for the improved immune response have been described such as increased mda expression on melanoma cells and decreased intra-tumoral vegf production, others remain speculative, such as increased cross presentation to dcs resulting from braf and mek inhibition mediated necrosis and apoptosis of melanoma cells.",pmc3809567,1,0.1,39,1,39.1
410,raf,other,,,text,raf,,,mek,other,,,text,mek,,,,d,phosphorylation,,,,,,0.8775000000000001,nan,"raf serine/threonine kinase phosphorylates mek to activate mek, and activated mek then phosphorylates erk, leading to its activation (shaul and seger, 2007; wellbrock etal., 2004).",pmc5467491,1,0.1,39,1,39.1
408,ptprs,protein,,hgnc:9681,hgnc,9681,,,phosphatase,other,,,text,phosphatase,,,negative,i,inhibition,,,,,,0.65,nan,"native mutations in ptprs, present in ~ 10% of crc, may reduce its phosphatase activity while increasing erk activation and downstream transcriptional signaling.",pmc6006154,1,0.1,39,1,39.1
407,ptprs,protein,,hgnc:9681,hgnc,9681,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.9419,nan,"clearly, not only did the reduction of ptprs expression modulate the erk activity in cells with a mutant kras driven erk pathway, but an increase in erk activation was also seen in the cells with wild-type kras.",pmc6006154,1,0.1,39,1,39.1
406,ptprj,protein,,hgnc:9673,hgnc,9673,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.65,nan,"for example, receptor-type ptps ptpre (ptpepsilon) and ptprj (dep-1) were shown to inhibit erk activation in vitro using nih3t3, hek293 and/or hela model cell lines xref_bibr, xref_bibr.",pmc6006154,1,0.1,39,1,39.1
405,ptpn1,protein,,hgnc:9642,hgnc,9642,,,jak2,protein,,hgnc:6192,hgnc,6192,,,,d,dephosphorylation,,,,,,0.8775000000000001,nan,"ptpn1 also dephosphorylates activated stat3 and jak2, and regulates leptin signaling xref_bibr - xref_bibr.",pmc5636874,1,0.1,39,1,39.1
430,ras,other,,,text,ras,,,mek,other,,,text,mek,,,,i,phosphorylation,,,,,,0.65,nan,"downregulation of ras and mapk1 resulted in ras-mapk1 inhibition, decreased mek and akt phosphorylation and decreased myc levels.",pmc5312311,1,0.1,39,1,39.1
313,mir-382-5p,other,,,text,mir-382-5p,,,neoplasm invasiveness,other,,,text,neoplasm invasiveness,,,positive,i,activation,,,,,,0.65,nan,"therefore, mir-382-5p also reduced cancer cell apoptosis and promoted cell migration and invasion.",pmc5410235,1,0.1,39,1,39.1
461,rdm1,protein,,hgnc:19950,hgnc,19950,,,ras-raf-mek-erk,other,,,text,ras-raf-mek-erk,,,positive,i,activation,,,,,,0.65,nan,rdm1 promotes cell proliferation by regulating ras-raf-mek-erk signaling pathway.,pmc6396142,1,0.1,39,1,39.1
433,ras,other,,,text,ras,,,neoplasm metastasis,other,,,text,neoplasm metastasis,,,positive,i,activation,,,,,,0.65,nan,"we hypothesized that effective nst, which has been shown to slow tumor growth and reduce tumor volume, would inactivate or decrease the ras pathway signal that drives mammary tumor progression and metastasis.",pmc5049993,1,0.1,39,1,39.1
460,rdm1,protein,,hgnc:19950,hgnc,19950,,,ras,other,,,text,ras,,,positive,i,increaseamount,,,,,,0.65,nan,"our results showed that knockdown of rdm1 significantly decreased the level of ras, p-braf, p-mek and p-erk in sh-sy5y and sk-n-as sirdm1 cells.",pmc6396142,1,0.1,39,1,39.1
459,rdm1,protein,,hgnc:19950,hgnc,19950,,,mek,other,,,text,mek,,,positive,i,increaseamount,,,,,,0.65,nan,"our results showed that knockdown of rdm1 significantly decreased the level of ras, p-braf, p-mek and p-erk in sh-sy5y and sk-n-as sirdm1 cells.",pmc6396142,1,0.1,39,1,39.1
458,rdm1,protein,,hgnc:19950,hgnc,19950,,,mek,other,,,text,mek,,,positive,i,activation,,,,,,0.65,nan,"interestingly, knockdown of rdm1 inactivated the ras-raf-mitogen-activated protein kinase kinase (mek)-extracellular signal regulated kinase (erk) signaling pathway.",pmc6396142,1,0.1,39,1,39.1
457,rdm1,protein,,hgnc:19950,hgnc,19950,,,growth,other,,,text,growth,,,negative,i,inhibition,,,,,,0.65,nan,silencing rdm1 inhibits in vivo growth of nb cells.,pmc6396142,1,0.1,39,1,39.1
456,rdm1,protein,,hgnc:19950,hgnc,19950,,,erk,other,,,text,erk,,,positive,i,increaseamount,,,,,,0.65,nan,"our results showed that knockdown of rdm1 significantly decreased the level of ras, p-braf, p-mek and p-erk in sh-sy5y and sk-n-as sirdm1 cells.",pmc6396142,1,0.1,39,1,39.1
455,rdm1,protein,,hgnc:19950,hgnc,19950,,,cellular proliferation,other,,,text,cellular proliferation,,,negative,i,inhibition,,,,,,0.65,nan,knocking down rdm1 inhibits cellular proliferation.,pmc6396142,1,0.1,39,1,39.1
454,rdm1,protein,,hgnc:19950,hgnc,19950,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,0.923,nan,"firstly, we found knockdown of rdm1 could reduce nb cell proliferation, augment cell apoptosis and induce cell cycle arrest.",pmc6396142,1,0.1,39,1,39.1
453,rdm1,protein,,hgnc:19950,hgnc,19950,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,negative,i,inhibition,,,,,,0.65,nan,"in addition, rdm1 -/- cells exhibited increased sensitivity to cisplatin, a common chemotherapy drug, and disruption of rdm1 suppressed nb cell proliferation.",pmc6396142,1,0.1,39,1,39.1
452,rdm1,protein,,hgnc:19950,hgnc,19950,,,cell cycle,biologicalprocess,,,go,go:0007049,,,positive,i,activation,,,,,,0.65,nan,lack of rdm1 augments cell apoptosis and induces cell cycle arrest.,pmc6396142,1,0.1,39,1,39.1
451,rdm1,protein,,hgnc:19950,hgnc,19950,,,cell cycle,biologicalprocess,,,go,go:0007049,,,negative,i,inhibition,,,,,,0.86,nan,"we also report that loss of rdm1 augmented cell apoptosis and induced cell cycle arrest, and that stable knockdown of rdm1 significantly inhibited nb tumor growth in a xenograft mouse model.",pmc6396142,1,0.1,39,1,39.1
450,rdm1,protein,,hgnc:19950,hgnc,19950,,,braf,protein,,hgnc:1097,hgnc,1097,,,positive,i,increaseamount,,,,,,0.65,nan,"our results showed that knockdown of rdm1 significantly decreased the level of ras, p-braf, p-mek and p-erk in sh-sy5y and sk-n-as sirdm1 cells.",pmc6396142,1,0.1,39,1,39.1
449,rdm1,protein,,hgnc:19950,hgnc,19950,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.65,nan,lack of rdm1 augments cell apoptosis and induces cell cycle arrest.,pmc6396142,1,0.1,39,1,39.1
448,rdm1,protein,,hgnc:19950,hgnc,19950,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,negative,i,inhibition,,,,,,0.86,nan,"firstly, we found knockdown of rdm1 could reduce nb cell proliferation, augment cell apoptosis and induce cell cycle arrest.",pmc6396142,1,0.1,39,1,39.1
447,rasip1,protein,,hgnc:24716,hgnc,24716,,,mapk-luciferase reporter,other,,,text,mapk-luciferase reporter,,,positive,i,activation,,,,,,0.65,nan,"as shown in xref_fig, transient transfection of a rasip1 expression vector increased mapk-luciferase reporter activity dose-dependently, particularly in the presence of bfgf.",pmc3498325,1,0.1,39,1,39.1
446,ras/raf/mek/erk,other,,,text,ras/raf/mek/erk,,,interferon,other,,,text,interferon,,,negative,i,inhibition,,,,,,0.65,nan,"furthermore, inhibition of the ras/raf/mek/erk pathway at the level of ras, mek, or erk was sufficient to restore ifn signaling.",pmc4535867,1,0.1,39,1,39.1
445,ras-guanidine exchange factors,other,,,text,ras-guanidine exchange factors,,,ras,other,,,text,ras,,,positive,i,activation,,,,,,0.65,nan,"upon activation of a growth factor receptor, ras-guanidine exchange factors (e.g. shp2 encoded by ptpn11) activate ras by enabling binding of gtp, which activates the raf and pi3 kinases and ralgds.",pmc5886052,1,0.1,39,1,39.1
444,ras-guanidine exchange factors,other,,,text,ras-guanidine exchange factors,,,gtp,chemical,,,chebi,chebi:15996,,,positive,i,activation,,,,,,0.65,nan,"upon activation of a growth factor receptor, ras-guanidine exchange factors (e.g. shp2 encoded by ptpn11) activate ras by enabling binding of gtp, which activates the raf and pi3 kinases and ralgds.",pmc5886052,1,0.1,39,1,39.1
443,ras-erk1/2,other,,,text,ras-erk1/2,,,lid onset,other,,,text,lid onset,,,positive,i,activation,,,,,,0.65,nan,compelling genetic and pharmacological evidence indicates that ras-erk1/2 inhibition prevents lid onset and may even revert already established dyskinetic symptoms.,pmc6194127,1,0.1,39,1,39.1
442,ras-erk,other,,,text,ras-erk,,,"transcription, dna-templated",biologicalprocess,,,go,go:0006351,,,positive,i,activation,,,,,,0.65,nan,the ras-erk pathway negatively regulates skeletal muscle cell differentiation by suppressing the expression or functions of the muscle specific transcription factors myod and mef2.,pmc2064279,1,0.1,39,1,39.1
441,ras-erk,other,,,text,ras-erk,,,cell differentiation,biologicalprocess,,,go,go:0030154,,,negative,i,inhibition,,,,,,0.65,nan,the ras-erk pathway negatively regulates skeletal muscle cell differentiation by suppressing the expression or functions of the muscle specific transcription factors myod and mef2.,pmc2064279,1,0.1,39,1,39.1
544,u0126,chemical,,,chebi,chebi:90693,,,ukrv-mel21,other,,,text,ukrv-mel21,,,positive,i,activation,,,,,,0.65,nan,"to evaluate the role of mapk activation in tert expression, four representative cell lines with (m74, wm266.4) or without (c8161, ukrv-mel21) tert promoter mutations were treated with the mek inhibitor u0126.",pmc5288173,1,0.1,39,1,39.1
438,ras,other,,,text,ras,,,rerg,protein,,hgnc:15980,hgnc,15980,,,positive,i,activation,,,,,,0.65,nan,"we found that rerg not only reduced ras activation but also slightly reduced its stability, though not to statistically significant levels.",pmc5410235,1,0.1,39,1,39.1
437,ras,other,,,text,ras,,,ras,other,,,text,ras,,,positive,i,activation,,,,,,0.65,nan,"recently, ptpn11 (shp2), a non receptor type ptp, was reported to play an oncogene like role in laryngeal cancer, hepatocellular carcinoma and glioblastoma, and the mechanism appeared to involve dephosphorylating ras to activate the ras and erk pathway xref_bibr - xref_bibr.",pmc6006154,1,0.1,39,1,39.1
436,ras,other,,,text,ras,,,raf-mek-erk,other,,,text,raf-mek-erk,,,positive,i,activation,,,,,,0.65,nan,"therefore, to define whether ras activation of the raf-mek-erk pathway and the consequent s727 phospohorylation of the mitochondrial pool of stat3 was important for transformation, we performed colony assays as a measure of anchorage independent cell growth.",pmc3843736,1,0.1,39,1,39.1
434,ras,other,,,text,ras,,,phosphoinositol-3-kinase,other,,,text,phosphoinositol-3-kinase,,,positive,i,activation,,,,,,0.65,nan,"ras engages numerous signaling pathways to elicit its tumorigenic activities, primarily the mek-erk, phosphoinositol-3-kinase (pi3k), and ral pathways [xref_bibr].",pmc3843736,1,0.1,39,1,39.1
418,ralgds,protein,,hgnc:9842,hgnc,9842,,,ral,other,,,text,ral,,,positive,i,activation,,,,,,0.65,nan,"deregulated pi3k signaling (e.g., loss of the negative regulator pten) is one of the most commonly mutated tumor suppressors seen in cancer, particularly malignancies of the central nervous system and endometrium [ xref ]; constitutive raf signaling (e.g., raf600e mutation) drives approximately 60% of melanoma [ xref ]; elevated ral expression is seen in colon, bladder and prostate cancers [ xref ]; and ralgds activation of ral has been implicated in ras-driven skin cancer [ xref ].",pmc3843736,1,0.1,39,1,39.1
0,"3',5'-cyclic amp",chemical,,,chebi,chebi:17489,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,"up-regulation of intracellular camp levels, which induces the differentiation process, triggers a very transient (< = 60 min) and weak activation of erk.",pmc4846800,1,0.1,39,1,39.1
312,mir-382-5p,other,,,text,mir-382-5p,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.65,nan,"taken together, these results implicated that mir-382-5p suppresses rerg by directly targeting its 3 ' utr, and thereby reduces ras and erk pathway activation.",pmc5410235,1,0.1,39,1,39.1
77,dabrafenib,chemical,,,chebi,chebi:75045,,,erk,other,,,text,erk,,,,i,dephosphorylation,,,,,,0.65,nan,"45 our results showed that vemurafenib and dabrafenib were not able to decrease levels of erk phosphorylation significantly in mutated cases, although a slight effect was observed after dabrafenib treatment which could be an off-target effect.",pmc6395334,1,0.1,39,1,39.1
111,ec 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor,chemical,,,chebi,chebi:88286,,,mapk,other,,,text,mapk,,,positive,i,activation,,,,,,0.65,nan,"although mapk pathway inhibitors such as braf inhibitors and mek inhibitors have demonstrated significant improvement of the clinical response rate, pfs, and os in comparison with chemotherapy in patients with advanced melanoma harboring braf mutations, most responders develop a resistance to the therapy within a year.",pmc4179759,1,0.1,39,1,39.1
110,ec 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor,chemical,,,chebi,chebi:88286,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,"to further test that map4k4 bypasses mek to activate erk, we tested whether overexpression of map4k4 prevents mek inhibitor mediated inhibition of erk.",pmc5467491,1,0.1,39,1,39.1
109,ec 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor,chemical,,,chebi,chebi:88286,,,erk,other,,,text,erk,,,,i,dephosphorylation,,,,,,0.65,nan,"the results showed that ectopic expression of map4k4 in a549 cells partially prevented mek inhibitor trametinib mediated inhibition of erk phosphorylation, supporting that map4k4 activation could bypass the effect of mek inhibitor.",pmc5467491,1,0.1,39,1,39.1
108,ec 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor,chemical,,,chebi,chebi:88286,,,cell growth,biologicalprocess,,,go,go:0016049,,,positive,i,activation,,,,,,0.65,nan,"previous work showed that the combination of azd8055 and mek inhibitor u0126 enhanced the cell growth inhibition of nb cells invitro and invivo 26, indicating the importance of this pathway.",pmc6396142,1,0.1,39,1,39.1
107,ec 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor,chemical,,,chebi,chebi:88286,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,negative,i,inhibition,,,,,,0.65,nan,"over-expression of the anti-apoptotic blc2a1 protein blocks braf and mek inhibitor induced apoptosis, and intriguingly, bcl2a1 expression is regulated by mitf.",pmc4846800,1,0.1,39,1,39.1
106,e3_ub_ligase,other,,,text,e3_ub_ligase,,,tp53,protein,,hgnc:11998,hgnc,11998,,,positive,i,activation,,,,,,0.65,nan,"interestingly, hdac inhibitors have been previously implicated in the depletion of mutant p53 through the transcriptional induction of mdm2, an e3 ubiquitin ligase that negatively regulates p53, instead of directly affecting tp53 transcription (blagosklonny etal., 2005).",pmc5537703,1,0.1,39,1,39.1
105,dusp6,protein,,hgnc:3072,hgnc,3072,,,neoplasm invasiveness,other,,,text,neoplasm invasiveness,,,positive,i,activation,,,,,,0.86,nan,"finally, dusp5 and dusp6 silencing reduced the cell migration and invasion capacities of two braf v600e thyroid cancer cell lines, thus suggesting a pro tumorigenic role of these phosphatases in ptc.",pmc5599027,1,0.1,39,1,39.1
104,dusp6,protein,,hgnc:3072,hgnc,3072,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,subtle changes in the spatiotemporal regulation and activity of erk induced by dusp5 and dusp6 inactivation may also explain the observed impact on invasion and migration in bcpap and 8505 cells.,pmc5599027,1,0.1,39,1,39.1
103,dusp6,protein,,hgnc:3072,hgnc,3072,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,0.65,nan,"dusp5 and dusp6 induction was blocked by mek inhibition, resulting in a decrease in erk phosphorylation (xref_fig).",pmc5599027,1,0.1,39,1,39.1
102,dusp6,protein,,hgnc:3072,hgnc,3072,,,cell migration,biologicalprocess,,,go,go:0016477,,,positive,i,activation,,,,,,0.65,nan,"finally, dusp5 and dusp6 silencing reduced the cell migration and invasion capacities of two braf v600e thyroid cancer cell lines, thus suggesting a pro tumorigenic role of these phosphatases in ptc.",pmc5599027,1,0.1,39,1,39.1
101,dusp6,protein,,hgnc:3072,hgnc,3072,,,cell growth,biologicalprocess,,,go,go:0016049,,,positive,i,activation,,,,,,0.86,nan,in bcpap and 8505c cells loss of dusp5 and dusp6 impaired the anchorage independent cell growth in soft agar 21 days after dusp5 or dusp6 inactivation albeit with no statistical significance for dusp6 sirna in bcpap cells (xref_fig).,pmc5599027,1,0.1,39,1,39.1
100,dusp6,protein,,hgnc:3072,hgnc,3072,,,braf,protein,,hgnc:1097,hgnc,1097,,,positive,i,activation,,,,,,0.86,nan,"finally, dusp5 and dusp6 silencing reduced the cell migration and invasion capacities of two braf v600e thyroid cancer cell lines, thus suggesting a pro tumorigenic role of these phosphatases in ptc.",pmc5599027,1,0.1,39,1,39.1
95,dusp,other,,,text,dusp,,,erk,other,,,text,erk,,,,d,dephosphorylation,,,,,,0.8775000000000001,nan,"other members of the dusp family that dephosphorylate erk are induced by mapk signaling (the nuclear dusp1, dusp2 and dusp4; the cytosolic dusp7 and dusp9) [xref_bibr] and are, thus, good candidate genes to study in order to understand the compensatory increase in this context.",pmc5599027,1,0.1,39,1,39.1
94,doxycycline,chemical,,,chebi,chebi:50845,,,p70s6k-ca,other,,,text,p70s6k-ca,,,positive,i,increaseamount,,,,,,0.65,nan,the addition of doxycycline induced the expression of p70s6k-ca.,pmc5833015,1,0.1,39,1,39.1
93,dnm,other,,,text,dnm,,,endocytosis,biologicalprocess,,,go,go:0006897,,,positive,i,activation,,,,,,0.65,nan,arf6 by recruiting nm23-h1 was reported to facilitate dynamin mediated endocytosis during adherens junctions disassembly and nm23-h1 was suggested to provide a source of gtp for arf6 [xref_bibr].,pmc4020307,1,0.1,39,1,39.1
92,dnm,other,,,text,dnm,,,endocytosis,biologicalprocess,,,go,go:0006897,,,negative,i,inhibition,,,,,,0.65,nan,"awd functions as a negative regulator of cell migration in tracheal and border cells by downregulating receptor levels on the cell surface through dynamin mediated endocytosis [xref_bibr, xref_bibr], thus it suppresses cell motility through receptor internalization.",pmc4020307,1,0.1,39,1,39.1
91,dner,protein,,hgnc:24456,hgnc,24456,,,mek,other,,,text,mek,,,positive,i,activation,,,,,,0.65,nan,we further show that bet inhibition reverses adaptive re-activation of mek and erk signaling triggered by trametinib treatment in a mek dependent cell line (rko).,pmc5908790,1,0.1,39,1,39.1
90,dner,protein,,hgnc:24456,hgnc,24456,,,mek,other,,,text,mek,,,negative,i,inhibition,,,,,,0.65,nan,sustained inhibition of mek and erk signaling by the bet and mek combination.,pmc5908790,1,0.1,39,1,39.1
89,dner,protein,,hgnc:24456,hgnc,24456,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,we further show that bet inhibition reverses adaptive re-activation of mek and erk signaling triggered by trametinib treatment in a mek dependent cell line (rko).,pmc5908790,1,0.1,39,1,39.1
88,dner,protein,,hgnc:24456,hgnc,24456,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.86,nan,"our data delineate a complex interaction between bet proteins and ras signaling in which bet inhibition can either activate or inhibit erk, depending on the context.",pmc5908790,1,0.1,39,1,39.1
87,dnase1,protein,,hgnc:2956,hgnc,2956,,,qiagen,other,,,text,qiagen,,,positive,i,activation,,,,,,0.65,nan,total rna was isolated with the qiaamp rna blood mini kit (qiagen) and treated with dnase i (roche).,pmc5755028,1,0.1,39,1,39.1
86,dnase1,protein,,hgnc:2956,hgnc,2956,,,kit,other,,,text,kit,,,positive,i,activation,,,,,,0.65,nan,total rna was isolated with the qiaamp rna blood mini kit (qiagen) and treated with dnase i (roche).,pmc5755028,1,0.1,39,1,39.1
85,dimethyl sulfoxide,chemical,,,chebi,chebi:28262,,,u0126,chemical,,,chebi,chebi:90693,,,positive,i,activation,,,,,,0.65,nan,rna was isolated from rasv12 cells treated with 20mum u0126 or 500units/ml ifn-alpha or treated with vehicle (dmso) for 6h.,pmc4535867,1,0.1,39,1,39.1
84,dimethyl sulfoxide,chemical,,,chebi,chebi:28262,,,ras,other,,,text,ras,,,positive,i,activation,,,,,,0.65,nan,rna was isolated from rasv12 cells treated with 20mum u0126 or 500units/ml ifn-alpha or treated with vehicle (dmso) for 6h.,pmc4535867,1,0.1,39,1,39.1
83,dimethyl sulfoxide,chemical,,,chebi,chebi:28262,,,ifna,other,,,text,ifna,,,positive,i,activation,,,,,,0.65,nan,rna was isolated from rasv12 cells treated with 20mum u0126 or 500units/ml ifn-alpha or treated with vehicle (dmso) for 6h.,pmc4535867,1,0.1,39,1,39.1
82,dexamethasone,chemical,,,chebi,chebi:41879,,,mdm2-p53 axis,other,,,text,mdm2-p53 axis,,,negative,i,inhibition,,,,,,0.65,nan,"for meki, synergism has been demonstrated for pi3k and akt inhibitors, dexamethasone, nutlin-3a, which induces the mdm2-p53 axis, and the bcl-2 and bcl-x (l) inhibitor, navitoclax (abt263).",pmc4067595,1,0.1,39,1,39.1
80,dendritic cells,other,,,text,dendritic cells,,,mapk,other,,,text,mapk,,,positive,i,activation,,,,,,0.65,nan,we recently explored a potential link between constitutive mapk pathway upregulation driven by a braf v600 mutation and dc function using a human melanoma-dc co-culture system.,pmc3809567,1,0.1,39,1,39.1
117,egfr-mek-erk,other,,,text,egfr-mek-erk,,,cell cycle,biologicalprocess,,,go,go:0007049,,,negative,i,inhibition,,,,,,0.65,nan,dual inhibition of the egfr-mek-erk pathway induces a g1 cell cycle arrest.,pmc5127645,1,0.1,39,1,39.1
118,egfr-mek-erk,other,,,text,egfr-mek-erk,,,cell death,biologicalprocess,,,go,go:0008219,,,negative,i,inhibition,,,,,,0.65,nan,"moreover, dual inhibition of the egfr-mek-erk pathway in ras mutant organoids induced a transient cell-cycle arrest rather than cell death.",pmc5127645,1,0.1,39,1,39.1
119,egfr-ras-erk,other,,,text,egfr-ras-erk,,,kras,protein,,hgnc:6407,hgnc,6407,,,positive,i,activation,,,,,,0.65,nan,"in summary, these data indicate that inhibition of the egfr-ras-erk pathway, independent of inhibitor combination, predominantly inhibits cell-cycle progression in kras mutant crc organoids.",pmc5127645,1,0.1,39,1,39.1
138,erk,other,,,text,erk,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.65,nan,"in agreement with isp inhibition, reduced ptprs expression in these cell lines brought about increased erk 1/2 phosphorylation.",pmc6006154,1,0.1,39,1,39.1
150,erk,other,,,text,erk,,,ras,other,,,text,ras,,,positive,i,activation,,,,,,0.65,nan,"western blot data show that unlike treatment with pd0325901 or nabut alone, inhibition of mek and erk in senescent cells causes a decrease in the ras content.",pmc5723691,1,0.1,39,1,39.1
149,erk,other,,,text,erk,,,p90rsk,other,,,text,p90rsk,,,,d,phosphorylation,,,,,,0.65,nan,"the increase in erk phosphorylation was associated with an increase in erk stimulated gene expression (dusp6, cmyc) and erk specific phosphorylation of p90rsk, elk1 and msk1 xref_bibr - xref_bibr.",pmc6006154,1,0.1,39,1,39.1
148,erk,other,,,text,erk,,,nras,protein,,hgnc:7989,hgnc,7989,,,negative,i,inhibition,,,,,,0.65,nan,"phosphorylation of erk1/2, downstream molecules of mek, was effectively inhibited with selumetinib in melanoma, colorectal cancer, pancreatic cancer, non-small-cell lung cancer, and hepatocellular cancer cell lines harboring braf, nras, or kras mutations.",pmc4179759,1,0.1,39,1,39.1
147,erk,other,,,text,erk,,,mtorc1,biologicalprocess,,,go,go:0031931,,,positive,i,activation,,,,,,0.65,nan,"our data demonstrate that the suppression of mek and erk pathway in senescent cells does not abolish mtorc1 activity, specific for nabut treated cells.",pmc5723691,1,0.1,39,1,39.1
146,erk,other,,,text,erk,,,kras,protein,,hgnc:6407,hgnc,6407,,,positive,i,activation,,,,,,0.65,nan,we also observed ptprs ko mediated feedback inhibition of ras-gtp expression in association with erk activation in wt kras but not mutant kras cell lines.,pmc6006154,1,0.1,39,1,39.1
145,erk,other,,,text,erk,,,kras,protein,,hgnc:6407,hgnc,6407,,,negative,i,inhibition,,,,,,0.65,nan,"phosphorylation of erk1/2, downstream molecules of mek, was effectively inhibited with selumetinib in melanoma, colorectal cancer, pancreatic cancer, non-small-cell lung cancer, and hepatocellular cancer cell lines harboring braf, nras, or kras mutations.",pmc4179759,1,0.1,39,1,39.1
144,erk,other,,,text,erk,,,kras,protein,,hgnc:6407,hgnc,6407,,,,d,phosphorylation,,,,,,0.65,nan,"in support of this notion, our biochemical analyses using a specific peptide inhibitor, sirna and crispr knockout demonstrated that inhibition or loss of ptprs resulted in elevated erk phosphorylation in both mutant kras and wild-type kras crc cell lines (fig.  xref ).",pmc6006154,1,0.1,39,1,39.1
143,erk,other,,,text,erk,,,jnk,other,,,text,jnk,,,negative,i,inhibition,,,,,,0.65,nan,"gao et al. (2013) identified that the inhibition of jnk, but not erk and p38, suppressed gfap upregulation in an astrocyte scratched injury model in vitro, implying that jnk was involved in regulating astrocyte activation under physiological conditions.",pmc5372348,1,0.1,39,1,39.1
142,erk,other,,,text,erk,,,hypersensitivity,biologicalprocess,,,go,go:0002524,,,positive,i,activation,,,,,,0.65,nan,"the double staining was
used to detect the expression of p-erk and gfap in the spinal cord and drg so as
to investigate whether the analgesic effect of inhibiting aqp4 expression was
due to a correlation between erk activation in astrocytes and hypersensitivity
after cci.",pmc6113736,1,0.1,39,1,39.1
141,erk,other,,,text,erk,,,gfap,protein,,hgnc:4235,hgnc,4235,,,positive,i,increaseamount,,,,,,0.65,nan,"moreover, western blot demonstrated that the inhibition of erk, jnk, or p38mapk pathway significantly suppressed the gfap protein level at 4day after il-1beta stimulation in primary astrocytes (p < 0.01 for all; fig.",pmc5372348,1,0.1,39,1,39.1
140,erk,other,,,text,erk,,,gfap,protein,,hgnc:4235,hgnc,4235,,,positive,i,activation,,,,,,0.65,nan,"in summary, this study found that sirt1 is an important topic for astrocyte activation induced by il-1beta stimulation in vitro and traumatic brain injury in vivo; inhibition of erk, jnk, or p38mapk activation suppressed gfap upregulation and improved the cell hypertrophy to attenuate the astrocyte activation; sirt1 interacted with erk pathway activation via a synergic way, but an antergic way with jnk and p38mapk pathway activation to mediate the expression of gfap and astrocyte morphology that is the astrocyte activation.",pmc5372348,1,0.1,39,1,39.1
139,erk,other,,,text,erk,,,ets,other,,,text,ets,,,,i,phosphorylation,,,,,,0.9804,nan,"several ets proteins can be phosphorylated by erk, and this modification activates their transcriptional activation [ xref ].",pmc5288173,1,0.1,39,1,39.1
137,erk,other,,,text,erk,,,erk,other,,,text,erk,,,negative,i,decreaseamount,,,,,,0.65,nan,"in this study, we applied the inhibitors of erk, jnk, and p38 to inhibit the expression of p-erk, p-jnk, or p-p38, which could, in turn, suppress the gfap upregulation and improve the cell hypertrophy.",pmc5372348,1,0.1,39,1,39.1
120,emilin1,protein,,hgnc:19880,hgnc,19880,,,cell growth,biologicalprocess,,,go,go:0016049,,,negative,i,inhibition,,,,,,0.65,nan,the extracellular matrix protein emilin1 silences the ras-erk pathway via alpha4beta1 integrin and decreases tumor cell growth.,pmc5432316,1,0.1,39,1,39.1
135,erk,other,,,text,erk,,,elk1,protein,,hgnc:3321,hgnc,3321,,,,d,phosphorylation,,,,,,0.86,nan,"in addition, we also examined the erk specific phosphorylation of elk1, msk1 and p90-rsk xref_bibr, xref_bibr.",pmc6006154,1,0.1,39,1,39.1
134,erk,other,,,text,erk,,,ec 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor,chemical,,,chebi,chebi:88286,,,positive,i,activation,,,,,,0.65,nan,"the results showed that ectopic expression of map4k4 in a549 cells partially prevented mek inhibitor trametinib mediated inhibition of erk phosphorylation, supporting that map4k4 activation could bypass the effect of mek inhibitor.",pmc5467491,1,0.1,39,1,39.1
133,erk,other,,,text,erk,,,ec 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor,chemical,,,chebi,chebi:88286,,,negative,i,inhibition,,,,,,0.65,nan,"the results showed that ectopic expression of map4k4 in a549 cells partially prevented mek inhibitor trametinib mediated inhibition of erk phosphorylation, supporting that map4k4 activation could bypass the effect of mek inhibitor.",pmc5467491,1,0.1,39,1,39.1
132,erk,other,,,text,erk,,,dusp6,protein,,hgnc:3072,hgnc,3072,,,positive,i,increaseamount,,,,,,0.65,nan,"accordingly, increasing levels of p-erk will induce dusp5 and dusp6 expression, which in turn will be rapidly degraded.",pmc5599027,1,0.1,39,1,39.1
131,erk,other,,,text,erk,,,dusp6,protein,,hgnc:3072,hgnc,3072,,,,d,phosphorylation,,,,,,0.8775000000000001,nan,"moreover, erk can phosphorylate dusp6 on two different serines and subsequently enhances its proteasomal degradation [xref_bibr].",pmc5599027,1,0.1,39,1,39.1
130,erk,other,,,text,erk,,,cxcr4,protein,,hgnc:2561,hgnc,2561,,,positive,i,increaseamount,,,,,,0.65,nan,"so, based on our results, inhibition of mek and erk pathway can down-regulate the cxcr4 expression in ucb cd34 + cells during exvivo expansion, which may also contribute to the reduced engraftment ability of pd expanded cells.",pmc5824365,1,0.1,39,1,39.1
129,erk,other,,,text,erk,,,cell survival,other,,,text,cell survival,,,negative,i,inhibition,,,,,,0.65,nan,we showed that the suppression of mek and erk pathway in control eras cells results in the damage of the internal structure of mitochondria and activation of ampk dependent cytoprotective autophagy that degrades the damaged mitochondria and thereby restores cell viability.,pmc5723691,1,0.1,39,1,39.1
127,erk,other,,,text,erk,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,negative,i,inhibition,,,,,,0.65,nan,"figure xref and xref showed that silence of tlr4, myd88, erk, jnk, and p38 inhibited proliferation of ec109 cells.",pmc5190119,1,0.1,39,1,39.1
126,erk,other,,,text,erk,,,cell differentiation,biologicalprocess,,,go,go:0030154,,,negative,i,inhibition,,,,,,0.94757,nan,"likewise, constitutive activation of the erk pathway prevents the cells exiting from the self-renewal and entering a differentiation process 34.",pmc5824365,1,0.1,39,1,39.1
125,erk,other,,,text,erk,,,braf,protein,,hgnc:1097,hgnc,1097,,,negative,i,inhibition,,,,,,0.65,nan,"phosphorylation of erk1/2, downstream molecules of mek, was effectively inhibited with selumetinib in melanoma, colorectal cancer, pancreatic cancer, non-small-cell lung cancer, and hepatocellular cancer cell lines harboring braf, nras, or kras mutations.",pmc4179759,1,0.1,39,1,39.1
124,erk,other,,,text,erk,,,braf,protein,,hgnc:1097,hgnc,1097,,,,i,phosphorylation,,,,,,0.65,nan,"accordingly, a different spectrum of efficacy against non-v600 braf mutants has been described for vemurafenib and dabrafenib.  xref  in contrast, activation of erk was detected in unmutated cll cases, potentially due to erk activation by the b-cell receptor signaling complex as it has been described that braf inhibitor-related erk phosphorylation can be partially abrogated by blocking b-cell receptor signaling with syk inhibitors.  xref  ",pmc6395334,1,0.1,39,1,39.1
121,erk,other,,,text,erk,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,negative,i,inhibition,,,,,,0.65,nan,"this research highlighted that erk, jnk, and p38 mapk activation was regulated by tlr4 pathway, and that inhibition of tlr4, myd88, erk, jnk, and p38 attenuated proliferation and induced apoptosis esophageal cancer cells in vitro.",pmc5190119,1,0.1,39,1,39.1
78,dabrafenib,chemical,,,chebi,chebi:75045,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,0.65,nan,"the braf inhibitors vemurafenib and dabrafenib were not able to inhibit phosphorylation of erk, the downstream effector of the pathway, in primary cells.",pmc6395334,1,0.1,39,1,39.1
76,cysteine proteinase 1,other,,,text,cysteine proteinase 1,,,glial cell activation,biologicalprocess,,,go,go:0061900,,,positive,i,activation,,,,,,0.65,nan,"the upregulation of proinflammatory cytokines such as the il-1β,
il-6, and tnf-α was responsible for cci-induced glial cell activation.",pmc6113736,1,0.1,39,1,39.1
152,erk,other,,,text,erk,,,"transcription, dna-templated",biologicalprocess,,,go,go:0006351,,,positive,i,activation,,,,,,0.65,nan,"nevertheless, because mitf is crucial for cell survival, its expression in proliferative cells is ensured through the erk induced transcription factor brn2.",pmc4846800,1,0.1,39,1,39.1
75,cyp19a1,protein,,hgnc:2594,hgnc,2594,,,testosterone,chemical,,,chebi,chebi:17347,,,positive,i,activation,,,,,,0.65,nan,"in addition, the literature also suggested that the main source of estrogen in men is the process that showed aromatase catalyzed testosterone into estradiol.",pmc5958651,1,0.1,39,1,39.1
41,braf,protein,,hgnc:1097,hgnc,1097,,,cellular senescence,biologicalprocess,,,go,go:0090398,,,positive,i,activation,,,,,,0.65,nan,braf v600e can stimulate senescence in human melanocytes in vitro.,pmc4846800,1,0.1,39,1,39.1
40,braf,protein,,hgnc:1097,hgnc,1097,,,cd4,protein,,hgnc:1678,hgnc,1678,,,positive,i,activation,,,,,,0.65,nan,similar increases in tumor infiltration by cd8 cells (but not cd4 cells) and decrease upon tumor progression in melanoma patients treated with braf or dual braf and mek inhibition was reported by frederick et al..,pmc3809567,1,0.1,39,1,39.1
39,braf,protein,,hgnc:1097,hgnc,1097,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,negative,i,inhibition,,,,,,0.65,nan,braf inhibition does however eventually induce apoptosis and necrosis as evident by the fact that tumors shrink markedly in the majority of patients.,pmc3809567,1,0.1,39,1,39.1
38,bet inhibitors,other,,,text,bet inhibitors,,,dner,protein,,hgnc:24456,hgnc,24456,,,positive,i,activation,,,,,,0.65,nan,"selective bet inhibitors, such as i-bet151 and the clinical molecule gsk525762 (i-bet762; i-bet) xref_bibr, xref_bibr, abrogate binding of bet proteins to acetylated chromatin thereby inhibiting bet dependent transcription xref_bibr, xref_bibr.",pmc5908790,1,0.1,39,1,39.1
37,belinostat,chemical,,,chebi,chebi:61076,,,sos,other,,,text,sos,,,negative,i,inhibition,,,,,,0.923,nan,we further validated this using both chemical and genetic means whereby the depletion of sos by belinostat was prevented through the addition of the proteasomal inhibitor bortezomib or sirna knockdown of fbxo3 and fbxw10.,pmc5537703,1,0.1,39,1,39.1
36,belinostat,chemical,,,chebi,chebi:61076,,,mapk,other,,,text,mapk,,,negative,i,inhibition,,,,,,0.923,nan,3.3 belinostat blocks sos and mapk activation in cisplatin resistant cells.,pmc5537703,1,0.1,39,1,39.1
35,belinostat,chemical,,,chebi,chebi:61076,,,histone_h4,protein,,hgnc:29607,hgnc,29607,,,,i,deacetylation,,,,,,0.65,nan,"while hdac inhibitors have been reported to resensitize erlotinib resistant cells by transcriptionally reducing egfr expression (chen etal., 2013; liffers etal., 2016), sos mrna levels were found to be unchanged following the addition of belinostat even though belinostat dose dependently induced acetylation of histones h3 and h4.",pmc5537703,1,0.1,39,1,39.1
34,belinostat,chemical,,,chebi,chebi:61076,,,histone,chemical,,,chebi,chebi:15358,,,,i,acetylation,,,,,,0.86,nan,we first investigated the possibility of transcriptional perturbations through histone acetylation induced by belinostat to explain sos downregulation.,pmc5537703,1,0.1,39,1,39.1
33,belinostat,chemical,,,chebi,chebi:61076,,,cisplatin,chemical,,,chebi,chebi:27899,,,positive,i,activation,,,,,,0.65,nan,we propose that belinostat synergizes cisplatin in platinum resistant scc cells through upregulation of genes that regulate ubiquitin mediated proteasomal degradation leading to disruptions of key survival signaling molecules.,pmc5537703,1,0.1,39,1,39.1
32,belinostat,chemical,,,chebi,chebi:61076,,,cell death,biologicalprocess,,,go,go:0008219,,,positive,i,activation,,,,,,0.65,nan,"collectively, these data suggest that treatment with belinostat induces cell death in lung scc cells, possibly through the suppression of mapk signaling and bim regulation.",pmc5537703,1,0.1,39,1,39.1
31,belinostat,chemical,,,chebi,chebi:61076,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.86,nan,"increasing doses of belinostat induced apoptosis in scc cells, which is consistent with previous observations analyzing the effects of other hdac inhibitors (moore etal., 2004; zhang etal., 2004).",pmc5537703,1,0.1,39,1,39.1
30,bcl2l11,protein,,hgnc:994,hgnc,994,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.65,nan,"accordingly, silencing of bim partially reduced apoptosis in belinostat treated calu-1 and h520 cells, as shown by the decrease in annexin-v-positive cells.",pmc5537703,1,0.1,39,1,39.1
26,azd-8055,chemical,,,chebi,chebi:91329,,,cell growth,biologicalprocess,,,go,go:0016049,,,negative,i,inhibition,,,,,,0.65,nan,"previous work showed that the combination of azd8055 and mek inhibitor u0126 enhanced the cell growth inhibition of nb cells invitro and invivo 26, indicating the importance of this pathway.",pmc6396142,1,0.1,39,1,39.1
24,aromatase inhibitors,other,,,text,aromatase inhibitors,,,testosterone,chemical,,,chebi,chebi:17347,,,positive,i,activation,,,,,,0.65,nan,aromatase inhibitors could inhibit the conversion of testosterone into estradiol; thereby reduced the concentration of serum estradiol.,pmc5958651,1,0.1,39,1,39.1
17,apoptotic process,biologicalprocess,,,go,go:0006915,,,cell death,biologicalprocess,,,go,go:0008219,,,positive,i,activation,,,,,,0.65,nan,"meanwhile, activation of pjnk2 and p-p38 mapk signaling confirmed cell death induced by a mitochondrial dependent apoptosis pathway.",pmc5729429,1,0.1,39,1,39.1
16,"anthra[1,9-cd]pyrazol-6(2h)-one",chemical,,,chebi,chebi:90695,,,p38,other,,,text,p38,,,negative,i,inhibition,,,,,,0.65,nan,"similarly, sp600125 or sb203580 could inhibit the jnk activation or p38mapk activation, respectively, but did not affect the other two pathways.",pmc5372348,1,0.1,39,1,39.1
15,"anthra[1,9-cd]pyrazol-6(2h)-one",chemical,,,chebi,chebi:90695,,,jnk,other,,,text,jnk,,,negative,i,inhibition,,,,,,0.65,nan,"similarly, sp600125 or sb203580 could inhibit the jnk activation or p38mapk activation, respectively, but did not affect the other two pathways.",pmc5372348,1,0.1,39,1,39.1
14,ampk,other,,,text,ampk,,,cellular senescence,biologicalprocess,,,go,go:0090398,,,negative,i,inhibition,,,,,,0.65,nan,despite the high activity of mtorc1 and cell cycle arrest the pd0325901 treated eras cells do not undergo senescence due to the activation of ampk dependent autophagy that blocks the senescence program.,pmc5723691,1,0.1,39,1,39.1
12,alpha4beta1 mab,other,,,text,alpha4beta1 mab,,,cell adhesion,biologicalprocess,,,go,go:0007155,,,negative,i,inhibition,,,,,,0.65,nan,"thus, the alpha4beta1 mab greatly reduced cell adhesion to gc1q and the alpha2beta1 mab fully inhibited cell adhesion to collagen type i.",pmc5432316,1,0.1,39,1,39.1
11,alpha2beta1 mab,other,,,text,alpha2beta1 mab,,,cell adhesion,biologicalprocess,,,go,go:0007155,,,negative,i,inhibition,,,,,,0.65,nan,"thus, the alpha4beta1 mab greatly reduced cell adhesion to gc1q and the alpha2beta1 mab fully inhibited cell adhesion to collagen type i.",pmc5432316,1,0.1,39,1,39.1
10,akt inhibitors,other,,,text,akt inhibitors,,,mdm2-p53 axis,other,,,text,mdm2-p53 axis,,,negative,i,inhibition,,,,,,0.65,nan,"for meki, synergism has been demonstrated for pi3k and akt inhibitors, dexamethasone, nutlin-3a, which induces the mdm2-p53 axis, and the bcl-2 and bcl-x (l) inhibitor, navitoclax (abt263).",pmc4067595,1,0.1,39,1,39.1
8,akt,other,,,text,akt,,,tf-np-sc,other,,,text,tf-np-sc,,,negative,i,inhibition,,,,,,0.65,nan,"compared to tf-np-sc, tf-np-mir-181a decreased p-mek protein by 6.8, 2.2 and 4.5-fold and p-akt protein by 2.0, 2.5 and 5.7-fold in kg1a, oci-aml3 and mv4-11 cells, respectively.",pmc5312311,1,0.1,39,1,39.1
7,akt,other,,,text,akt,,,selumetinib,chemical,,,chebi,chebi:90227,,,positive,i,activation,,,,,,0.65,nan,"xref_bibr in non-small-cell lung cancer cell lines, selumetinib resistance was mediated by a high level of akt activity, and the resistance was reversed by akt inhibition.",pmc4179759,1,0.1,39,1,39.1
6,agt,protein,,hgnc:333,hgnc,333,,,inflammatory response,biologicalprocess,,,go,go:0006954,,,positive,i,activation,,,,,,0.65,nan,"previous studies demonstrated that ppargamma agonist rgz suppressed the expression of tlr4 mrna and protein in alveolar macrophages [xref_bibr] and that ppargamma agonist pioglitazone attenuated angiotensinii induced inflammatory response in cardiac fibroblast cells through inhibition of the tlr4 signaling pathway [xref_bibr], which are consistent with our study.",pmc5190119,1,0.1,39,1,39.1
5,afatinib,chemical,,,chebi,chebi:61390,,,erbb2,protein,,hgnc:3430,hgnc,3430,,,negative,i,inhibition,,,,,,0.65,nan,"based on egfr and her2 dual inhibition by afatinib, we could clearly discriminate the organoid panel in two types of responders, namely the sensitive versus the resistant ones (xref_fig, green versus red lines respectively).",pmc5127645,1,0.1,39,1,39.1
3,afatinib,chemical,,,chebi,chebi:61390,,,cell death,biologicalprocess,,,go,go:0008219,,,positive,i,activation,,,,,,0.65,nan,"afatinib (egfr and her2i), either alone or in combination with selumetinib (meki), induced significant degrees of cell death, in line with our 72 hr monitoring of drug response.",pmc5127645,1,0.1,39,1,39.1
2,"7-(3,5-dimethyl-4-isoxazolyl)-8-methoxy-1-[(1r)-1-(2-pyridinyl)ethyl]-3h-imidazo[4,5-c]quinolin-2-one",chemical,,,chebi,chebi:95083,,,ras,other,,,text,ras,,,negative,i,inhibition,,,,,,0.65,nan,"combination of i-bet151 and pd0325901 produced synergistic effects (ci < 0.78; see methods) most commonly in, but not limited to, ras pathway mutant models.",pmc5908790,1,0.1,39,1,39.1
42,braf,protein,,hgnc:1097,hgnc,1097,,,erk,other,,,text,erk,,,,i,dephosphorylation,,,,,,0.65,nan,"while no considerable reduction in erk1/2 activation was achieved by araf depletion, braf and craf silencing each reduced the level of erk1/2 phosphorylation.",pmc4254013,1,0.1,39,1,39.1
43,braf,protein,,hgnc:1097,hgnc,1097,,,malonaldehyde,chemical,,,chebi,chebi:566274,,,negative,i,decreaseamount,,,,,,0.65,nan,it has been suggested that oncogenic braf suppresses mda expression through microphthalmia associated transcription factor.,pmc3809567,1,0.1,39,1,39.1
44,braf,protein,,hgnc:1097,hgnc,1097,,,malonaldehyde,chemical,,,chebi,chebi:566274,,,negative,i,inhibition,,,,,,0.65,nan,this observation was specific to braf mutant tumors and independent of braf inhibition mediated upregulation of mda.,pmc3809567,1,0.1,39,1,39.1
62,cellular senescence,biologicalprocess,,,go,go:0090398,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,negative,i,inhibition,,,,,,0.65,nan,"playing a cytoprotective role in cancer cells, autophagy acts as an antagonist to such a powerful tumor-suppressor mechanism as cellular senescence, wherein cells permanently arrest their proliferation even in the presence of strong mitogenic signals [xref_bibr - xref_bibr].",pmc5723691,1,0.1,39,1,39.1
74,cyp19a1,protein,,hgnc:2594,hgnc,2594,,,conversion,other,,,text,conversion,,,negative,i,inhibition,,,,,,0.65,nan,aromatase inhibitors could inhibit the conversion of testosterone into estradiol; thereby reduced the concentration of serum estradiol.,pmc5958651,1,0.1,39,1,39.1
73,csf2,protein,,hgnc:2434,hgnc,2434,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,"the activation of erk signalling by gm-csf is also considered to be important for differentiation and maturation of macrophage and megakaryocytes 16, 17, 39, 40, 41, 42, 43.",pmc5824365,1,0.1,39,1,39.1
72,crebbp,protein,,hgnc:2348,hgnc,2348,,,ras/raf/mek/erk,other,,,text,ras/raf/mek/erk,,,negative,i,inhibition,,,,,,0.86,nan,"importantly, we show that crebbp directly acetylates kras and that crebbp knockdown enhances signaling of the ras/raf/mek/erk pathway in ras pathway mutated acute lymphoblastic leukemia cells, which are still sensitive to mek inhibitors.",pmc5395114,1,0.1,39,1,39.1
71,crebbp,protein,,hgnc:2348,hgnc,2348,,,ras,other,,,text,ras,,,negative,i,inhibition,,,,,,0.86,nan,"western blotting showed an increase in p-erk levels in preb 697 shcbp cells compared to shneg cells and in l829r and l914 primagraft all samples after sicbp knockdown, suggesting that crebbp reduction enhances ras pathway activation (xref_fig).",pmc5395114,1,0.1,39,1,39.1
70,crebbp,protein,,hgnc:2348,hgnc,2348,,,nr3c1,protein,,hgnc:7978,hgnc,7978,,,positive,i,increaseamount,,,,,,0.65,nan,stable crebbp knockdown impairs expression of gr target genes but does not alter response to gc.,pmc5395114,1,0.1,39,1,39.1
69,crebbp,protein,,hgnc:2348,hgnc,2348,,,nr3c1,protein,,hgnc:7978,hgnc,7978,,,negative,i,decreaseamount,,,,,,0.65,nan,"in mhh-call-2 cells, transient crebbp knockdown was associated with reduced ach3k18 expression, but neither impairment in induced camp dependent nor gr target gene expression (cxcr4, mknk2, dusp10 and rgs16; p> 0.2 and gilz, fkbp5, nr3c1 and itga9; p> 0.7, respectively).",pmc5395114,1,0.1,39,1,39.1
68,crebbp,protein,,hgnc:2348,hgnc,2348,,,kras,protein,,hgnc:6407,hgnc,6407,,,,d,acetylation,,,,,,0.9955263,nan,"we show, however, that kras is directly acetylated by crebbp and that knockdown of crebbp is associated with enhanced signaling of the ras/raf/mek/erk pathway in ras pathway mutant all cells.",pmc5395114,1,0.1,39,1,39.1
67,crebbp,protein,,hgnc:2348,hgnc,2348,,,crebbp,protein,,hgnc:2348,hgnc,2348,,,,i,deacetylation,,,,,,0.65,nan,"xref_bibr, xref_bibr in mouse embryonic fibroblast cell models, crebbp mutations were shown to cause reduced acetylation of crebbp target residues, as well as reduced expression of camp dependent and glucocorticoid (gc) responsive genes.",pmc5395114,1,0.1,39,1,39.1
66,crebbp,protein,,hgnc:2348,hgnc,2348,,,"3',5'-cyclic amp",chemical,,,chebi,chebi:17489,,,negative,i,decreaseamount,,,,,,0.65,nan,"xref_bibr, xref_bibr in mouse embryonic fibroblast cell models, crebbp mutations were shown to cause reduced acetylation of crebbp target residues, as well as reduced expression of camp dependent and glucocorticoid (gc) responsive genes.",pmc5395114,1,0.1,39,1,39.1
65,cpt,other,,,text,cpt,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.65,nan,"several studies suggest that mitogen activated protein kinase (mapk) and akt signaling pathways respond to extra-cellular stimuli and are involved in apoptosis induced by cpt derivatives [xref_bibr, xref_bibr].",pmc5729429,1,0.1,39,1,39.1
64,cisplatin,chemical,,,chebi,chebi:27899,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,0.86,nan,"in cisplatin-resistant cells that demonstrated aberrant mapk activation, combined treatment with belinostat significantly inhibited cisplatin-induced erk phosphorylation and exhibited strong synergistic cytotoxicity.",pmc5537703,1,0.1,39,1,39.1
63,cish,protein,,hgnc:1984,hgnc,1984,,,,protein,,hgnc:,hgnc,,,,,i,autophosphorylation,,,,,,0.65,nan,the activator kinase requires no kinase activity but requires n-terminal (nta: n-terminal acidic motif) phosphorylation to allosterically stimulate cis -autophosphorylation and transactivation of the partner receiver kinase.,pmc4020307,1,0.1,39,1,39.1
61,cell differentiation,biologicalprocess,,,go,go:0030154,,,cell cycle,biologicalprocess,,,go,go:0007049,,,negative,i,inhibition,,,,,,0.65,nan,"skeletal muscle cell differentiation necessitates irreversible cell cycle arrest in g 0 phase, the expression of a battery of muscle specific genes, and cell fusion to form multinucleated myotubes.",pmc2064279,1,0.1,39,1,39.1
47,braf,protein,,hgnc:1097,hgnc,1097,,,multiple myeloma,other,,,text,multiple myeloma,,,positive,i,activation,,,,,,0.65,nan,"in order to elucidate the transcriptional programmes related to braf activation in mm, we used vemurafenib (a braf inhibitor that has recently proved to be a promising anti-myeloma drug in clinical settings) [xref_bibr] to inhibit braf activity in u266 cells which carry the k601n mutation and showing constitutive activation of mek and erk signalling (xref_supplementary).",pmc4695180,1,0.1,39,1,39.1
60,cdk4,protein,,hgnc:1773,hgnc,1773,,,pi3k,other,,,text,pi3k,,,positive,i,activation,,,,,,0.65,nan,"xref_bibr, xref_bibr one of the possible explanations for the failed anticancer activity is that nras mutations activate multiple pathways including cdk4 driven cell-cycle progression and pi3k and akt signaling in addition to mapk pathway.",pmc4179759,1,0.1,39,1,39.1
59,cdk4,protein,,hgnc:1773,hgnc,1773,,,akt,other,,,text,akt,,,positive,i,activation,,,,,,0.65,nan,"xref_bibr, xref_bibr one of the possible explanations for the failed anticancer activity is that nras mutations activate multiple pathways including cdk4 driven cell-cycle progression and pi3k and akt signaling in addition to mapk pathway.",pmc4179759,1,0.1,39,1,39.1
58,cci,other,,,text,cci,,,neuralgia,other,,,text,neuralgia,,,positive,i,activation,,,,,,0.65,nan,"the phosphorylation of mapk pathways contributes
to the abundance of aqp4 and is known to be involved in the development of
cci-induced np.",pmc6113736,1,0.1,39,1,39.1
57,cci,other,,,text,cci,,,gfap,protein,,hgnc:4235,hgnc,4235,,,positive,i,increaseamount,,,,,,0.65,nan,"immunofluorescent staining showed that cci-induced the elevated gfap expression
compared with sham control 4 days after injury.",pmc6113736,1,0.1,39,1,39.1
56,cci,other,,,text,cci,,,gfap,protein,,hgnc:4235,hgnc,4235,,,positive,i,activation,,,,,,0.86,nan,"these results suggested a
previously unrecognized mechanism whereby cci induced glial activation and np via
the erk activation pathway, which might be a potential therapeutic target for
inflammation-related np.",pmc6113736,1,0.1,39,1,39.1
55,cci,other,,,text,cci,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,"however, cci induced an
increase in p-erk in satellite cells and nonmyelinating schwann cells.",pmc6113736,1,0.1,39,1,39.1
54,bvd-523,other,,,text,bvd-523,,,erk,other,,,text,erk,,,,i,dephosphorylation,,,,,,0.65,nan,"our results demonstrated that ulixertinib (bvd-523), a potent and highly selective inhibitor of erk1/2, was able to inhibit erk phosphorylation in vitro in all cll cases with mutations in genes of the ras-braf-mapk-erk pathway.",pmc6395334,1,0.1,39,1,39.1
53,braf inhibitors,other,,,text,braf inhibitors,,,mapk,other,,,text,mapk,,,positive,i,activation,,,,,,0.65,nan,"although mapk pathway inhibitors such as braf inhibitors and mek inhibitors have demonstrated significant improvement of the clinical response rate, pfs, and os in comparison with chemotherapy in patients with advanced melanoma harboring braf mutations, most responders develop a resistance to the therapy within a year.",pmc4179759,1,0.1,39,1,39.1
52,braf inhibitors,other,,,text,braf inhibitors,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,0.86,nan,"braf inhibitors vemurafenib and dabrafenib were not able to inhibit erk phosphorylation, the downstream effector of the pathway, in primary cells.",pmc6395334,1,0.1,39,1,39.1
51,braf inhibitors,other,,,text,braf inhibitors,,,braf,protein,,hgnc:1097,hgnc,1097,,,positive,i,activation,,,,,,0.65,nan,"we next evaluated the effect of braf inhibitors (vemurafenib, a specific inhibitor of the braf v600e mutation, and dabrafenib, specific for braf v600e and v600k variants) in cells from 17 cll cases, nine containing mutations in genes of the ras-braf-mapk-erk pathway (kitlg, ptpn11, kras, braf, mapk1, map2k1 and map2k2) and eight u-ighv cll cases with no alterations in this pathway.",pmc6395334,1,0.1,39,1,39.1
49,braf,protein,,hgnc:1097,hgnc,1097,,,necrotic cell death,biologicalprocess,,,go,go:0070265,,,negative,i,inhibition,,,,,,0.65,nan,braf inhibition does however eventually induce apoptosis and necrosis as evident by the fact that tumors shrink markedly in the majority of patients.,pmc3809567,1,0.1,39,1,39.1
48,braf,protein,,hgnc:1097,hgnc,1097,,,mutation,other,,,text,mutation,,,positive,i,activation,,,,,,0.65,nan,"most studies in ptcs suggest that braf activating mutation is closely associated with extrathyroidal extension, lymph node metastasis, advanced tumor stages, disease recurrence, and even patient mortality [ xref ].",pmc5599027,1,0.1,39,1,39.1
151,erk,other,,,text,erk,,,rps6ka5,protein,,hgnc:10434,hgnc,10434,,,,d,phosphorylation,,,,,,0.86,nan,"in addition, we also examined the erk specific phosphorylation of elk1, msk1 and p90-rsk xref_bibr, xref_bibr.",pmc6006154,1,0.1,39,1,39.1
153,erk,other,,,text,erk,,,ubiquitin,other,,,text,ubiquitin,,,positive,i,activation,,,,,,0.65,nan,"however, erk phosphorylation can also trigger ubiquitin mediated degradation, and as a result of sustained erk activation mitf protein levels are reduced, a situation that is compatible with proliferation.",pmc4846800,1,0.1,39,1,39.1
310,mir-382-5p,other,,,text,mir-382-5p,,,cell migration,biologicalprocess,,,go,go:0016477,,,positive,i,activation,,,,,,0.65,nan,"therefore, mir-382-5p also reduced cancer cell apoptosis and promoted cell migration and invasion.",pmc5410235,1,0.1,39,1,39.1
233,jun_family,other,,,text,jun_family,,,cell differentiation,biologicalprocess,,,go,go:0030154,,,positive,i,activation,,,,,,0.65,nan,"further, according to our results, erk inhibition by pd and consequently jun hampering promotes the path of erythroid differentiation of mncs.",pmc5824365,1,0.1,39,1,39.1
270,mapk,other,,,text,mapk,,,cisplatin,chemical,,,chebi,chebi:27899,,,positive,i,activation,,,,,,0.65,nan,"our group has previously described the significance of sos and mapk activation in cisplatin resistance (kong etal., 2015).",pmc5537703,1,0.1,39,1,39.1
265,map4k4,protein,,hgnc:6866,hgnc,6866,,,jnk,other,,,text,jnk,,,positive,i,activation,,,,,,0.65,nan,"map4k4 activates mapk and jnk through tak1 (a map3k) and mkk4 and mkk7 (map2ks) in hek293t cells (yao etal., 1999).",pmc5467491,1,0.1,39,1,39.1
264,map4k4,protein,,hgnc:6866,hgnc,6866,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.991866,nan,"to further test that map4k4 bypasses mek to activate erk, we tested whether overexpression of map4k4 prevents mek inhibitor mediated inhibition of erk.",pmc5467491,1,0.1,39,1,39.1
263,map4k4,protein,,hgnc:6866,hgnc,6866,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,0.65,nan,"functionally, overexpression of map4k4 in these cell lines could also promote cell proliferation.",pmc5467491,1,0.1,39,1,39.1
262,map4k4,protein,,hgnc:6866,hgnc,6866,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,negative,i,inhibition,,,,,,0.951,nan,the results of mtt assays showed that downregulation of map4k4 significantly inhibited cell proliferation regardless of kras or egfr mutation status.,pmc5467491,1,0.1,39,1,39.1
261,map4k4,protein,,hgnc:6866,hgnc,6866,,,activation,other,,,text,activation,,,negative,i,inhibition,,,,,,0.65,nan,"the current study showed that in t790m‐mutated egfr‐tki‐resistant cell line h1975, downregulation of map4k4 inhibited erk activation in the presence and absence of erlotinib treatment (fig.  xref g), implying that map4k4 bypasses egfr to promote erk activation; that is, map4k4 functioned in parallel with egfr to regulate erk activation, which in turn suggests that suppressing erk reactivation through targeting map4k4 in lung adenocarcinoma could be a novel strategy to overcome egfr‐tki resistance.",pmc5467491,1,0.1,39,1,39.1
260,map2k7,protein,,hgnc:6847,hgnc,6847,,,jnk,other,,,text,jnk,,,,i,phosphorylation,,,,,,0.65,nan,"mkk7 activation induces the dual phosphorylation of jnk, and the cleavage of caspase 8 and bid xref_bibr, xref_bibr.",pmc5636874,1,0.1,39,1,39.1
259,ly294002,chemical,,,chebi,chebi:65329,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.65,nan,"however, the addition of either u0126 or ly294002 together with tgf-beta1 severely induced apoptosis.",pmc4440819,1,0.1,39,1,39.1
258,lipopolysaccharide,chemical,,,chebi,chebi:16412,,,tlr4,protein,,hgnc:11850,hgnc,11850,,,positive,i,increaseamount,,,,,,0.65,nan,"we found that lps increased the expression levels of tlr4, myd88, and traf6, but the levels were inhibited by rgz or enhanced by gw9662.",pmc5190119,1,0.1,39,1,39.1
257,lipopolysaccharide,chemical,,,chebi,chebi:16412,,,tlr4,protein,,hgnc:11850,hgnc,11850,,,positive,i,activation,,,,,,0.923,nan,"the results showed that ppargamma knockdown promoted lps induced tlr4, myd88, and traf6 expression in ec109 cells.",pmc5190119,1,0.1,39,1,39.1
256,lipopolysaccharide,chemical,,,chebi,chebi:16412,,,inflammatory response,biologicalprocess,,,go,go:0006954,,,positive,i,activation,,,,,,0.65,nan,"ppargamma agonist suppressed erk mapk signal activation to inhibit activity of cellular no and reactive oxygen species formation, counteracting lps induced inflammatory response in pulp cells [xref_bibr].",pmc5190119,1,0.1,39,1,39.1
255,letrozole,chemical,,,chebi,chebi:6413,,,slc25a22,protein,,hgnc:19954,hgnc,19954,,,positive,i,activation,,,,,,0.9419,nan,cck-8 assay showed that letrozole could promote the proliferation of gc-1 spg cells and exhibited time and dose effects (xref_fig).,pmc5958651,1,0.1,39,1,39.1
254,letrozole,chemical,,,chebi,chebi:6413,,,ras/erk1/c-myc,other,,,text,ras/erk1/c-myc,,,positive,i,increaseamount,,,,,,0.923,nan,the results of rt-pcr and western blot analysis confirmed letrozole significantly activated the expression of ras/erk1/c-myc in the classical mapk pathway.,pmc5958651,1,0.1,39,1,39.1
253,letrozole,chemical,,,chebi,chebi:6413,,,ras/erk/c-myc,other,,,text,ras/erk/c-myc,,,negative,i,decreaseamount,,,,,,0.86,nan,"further, letrozole + mapk inhibition significantly decreased the mrna levels of ras/erk/c-myc (p < 0.05) (xref_fig).",pmc5958651,1,0.1,39,1,39.1
252,letrozole,chemical,,,chebi,chebi:6413,,,pcna,protein,,hgnc:8729,hgnc,8729,,,positive,i,increaseamount,,,,,,0.65,nan,"letrozole significantly increased the protein levels of ki-67 and pcna (p < 0.05) (xref_fig), in comparison to the control group.",pmc5958651,1,0.1,39,1,39.1
251,letrozole,chemical,,,chebi,chebi:6413,,,mki67,protein,,hgnc:7107,hgnc,7107,,,positive,i,increaseamount,,,,,,0.65,nan,"letrozole significantly increased the protein levels of ki-67 and pcna (p < 0.05) (xref_fig), in comparison to the control group.",pmc5958651,1,0.1,39,1,39.1
250,letrozole,chemical,,,chebi,chebi:6413,,,mapk,other,,,text,mapk,,,positive,i,activation,,,,,,0.65,nan,"in conclusion, letrozole activated the mapk signaling pathway and promoted the proliferation of mouse spermatogonia gc-1 spg cells.",pmc5958651,1,0.1,39,1,39.1
249,letrozole,chemical,,,chebi,chebi:6413,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,0.9419,nan,cck-8 assay showed that letrozole could promote the proliferation of gc-1 spg cells and exhibited time and dose effects (xref_fig).,pmc5958651,1,0.1,39,1,39.1
247,l-dopa,chemical,,,chebi,chebi:15765,,,rasgrf1,protein,,hgnc:9875,hgnc,9875,,,positive,i,activation,,,,,,0.65,nan,nf1 +/- and ras-grf1 oe mice were unilaterally lesioned with 6-ohda and treated with an escalating l-dopa dosing regimen.,pmc6194127,1,0.1,39,1,39.1
246,l-dopa,chemical,,,chebi,chebi:15765,,,oxidopamine,chemical,,,chebi,chebi:78741,,,positive,i,activation,,,,,,0.65,nan,nf1 +/- and ras-grf1 oe mice were unilaterally lesioned with 6-ohda and treated with an escalating l-dopa dosing regimen.,pmc6194127,1,0.1,39,1,39.1
245,l-dopa,chemical,,,chebi,chebi:15765,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,erk1/2 activation by l-dopa takes place through the crosstalk between d1r/ac/pka/darpp-32 pathway and nmda and ras pathway.,pmc6194127,1,0.1,39,1,39.1
244,ksr,other,,,text,ksr,,,ras,other,,,text,ras,,,positive,i,activation,,,,,,0.86,nan,"thus, upon ras activation ksr brings mek to the plasma membrane in close proximity to the raf kinase.",pmc4020307,1,0.1,39,1,39.1
243,ksr,other,,,text,ksr,,,ras,other,,,text,ras,,,negative,i,inhibition,,,,,,0.86,nan,"the scaffold protein ksr (kinase suppressor of ras) helps in raf activation, but also contributes to the sequential phosphorylation steps of the mapk cascade by bringing together mapk components, raf, mek and erk and mapk.",pmc4020307,1,0.1,39,1,39.1
242,ksr,other,,,text,ksr,,,raf,other,,,text,raf,,,positive,i,activation,,,,,,0.65,nan,"the scaffold protein ksr (kinase suppressor of ras) helps in raf activation, but also contributes to the sequential phosphorylation steps of the mapk cascade by bringing together mapk components, raf, mek and erk and mapk.",pmc4020307,1,0.1,39,1,39.1
241,kras,protein,,hgnc:6407,hgnc,6407,,,runx1,other,,,text,runx1,,,positive,i,activation,,,,,,0.65,nan,"here, we first tested whether kras and other genes involved in these pathways, including nras and its downstream effectors (i.e., mapk1), were mir-181a targets in aml.",pmc5312311,1,0.1,39,1,39.1
237,kras,protein,,hgnc:6407,hgnc,6407,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,"clearly, not only did the reduction of ptprs expression modulate the erk activity in cells with a mutant kras driven erk pathway, but an increase in erk activation was also seen in the cells with wild-type kras.",pmc6006154,1,0.1,39,1,39.1
235,kras,protein,,hgnc:6407,hgnc,6407,,,cell death,biologicalprocess,,,go,go:0008219,,,negative,i,inhibition,,,,,,0.65,nan,"finally, kras mutations were significantly depleted (p = 0.003; fisher 's exact test) among the cell lines exhibiting net cell death in response to gsk525762 (supplemental table s1), suggesting that activated ras signaling may be a mechanism by which cancer cells are able to survive bet inhibition.",pmc5908790,1,0.1,39,1,39.1
271,mapk,other,,,text,mapk,,,dusp6,protein,,hgnc:3072,hgnc,3072,,,positive,i,increaseamount,,,,,,0.65,nan,we showed in the pccl3 cell lines that the mapk pathway drives the expression of dusp5 and dusp6.,pmc5599027,1,0.1,39,1,39.1
273,mapk,other,,,text,mapk,,,multiple myeloma,other,,,text,multiple myeloma,,,positive,i,activation,,,,,,0.65,nan,"we evaluated the relationships between the identified variants and the clinical and biological features of the disease, and determined the transcriptional signature associated with mapk pathway activation in mm.",pmc4695180,1,0.1,39,1,39.1
274,mapk,other,,,text,mapk,,,ncoa3,protein,,hgnc:7670,hgnc,7670,,,,d,phosphorylation,,,,,,0.8775000000000001,nan,in vitro phosphorylation of ncoa3 by mapk has also been demonstrated [xref_bibr].,pmc5755028,1,0.1,39,1,39.1
291,mek,other,,,text,mek,,,erk,other,,,text,erk,,,,i,dephosphorylation,,,,,,0.65,nan,"dusp5 and dusp6 induction was blocked by mek inhibition, resulting in a decrease in erk phosphorylation (xref_fig).",pmc5599027,1,0.1,39,1,39.1
309,mir-382-5p,other,,,text,mir-382-5p,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,negative,i,inhibition,,,,,,0.65,nan,"therefore, mir-382-5p also reduced cancer cell apoptosis and promoted cell migration and invasion.",pmc5410235,1,0.1,39,1,39.1
308,mir-320,other,,,text,mir-320,,,cell growth,biologicalprocess,,,go,go:0016049,,,positive,i,activation,,,,,,0.65,nan,"pbx3 (pre-b cell leukemia homeobox 3), a putative target gene of mir-320, has been reported to be upregulated in various tumors and promote tumor cell growth through regulating makp and erk pathway.",pmc5609034,1,0.1,39,1,39.1
307,mir-320,other,,,text,mir-320,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.65,nan,"mir-320 may suppress glioma cells growth and induced apoptosis through the pbx3/raf-1/mapk axis, and mir-320 oligonucleotides may be a potential cancer therapeutic for glioma.",pmc5609034,1,0.1,39,1,39.1
305,mir-181a,other,,,text,mir-181a,,,akt,other,,,text,akt,,,positive,i,activation,,,,,,0.65,nan,"here, we first demonstrated that mir-181a targets the ras-mapk1 and ras-akt pathways, which have been found to be activated and support aml leukemogenesis [xref_bibr - xref_bibr].",pmc5312311,1,0.1,39,1,39.1
304,mir-181,other,,,text,mir-181,,,cell differentiation,biologicalprocess,,,go,go:0030154,,,positive,i,activation,,,,,,0.65,nan,"physiologically, mir-181 may accelerate the megakaryocyte differentiation of cd34 positive hematopoietic cells [xref_bibr].",pmc5312311,1,0.1,39,1,39.1
303,mir-181,other,,,text,mir-181,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.65,nan,"with regard to aml, we previously provided preliminary evidence that mir-181 may target elements of the "" inflammasome "" that ultimately lead to nf-kappab activation and leukemia growth, while li et al. showed that mir-181 promoted apoptosis, reduced viability and delayed leukemogenesis in mll rearranged aml by downregulating the homeobox gene pbx3 [xref_bibr].",pmc5312311,1,0.1,39,1,39.1
302,meki,other,,,text,meki,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,negative,i,inhibition,,,,,,0.65,nan,"as expected for p18t-kras g12d, suppressing egfr and her2 activity upstream of mutant kras using afatinib proved ineffective, while monotherapy of meki or erki inhibited proliferation only to a minor extent (xref_fig, right panel).",pmc5127645,1,0.1,39,1,39.1
300,mek-erk,other,,,text,mek-erk,,,multiple myeloma,other,,,text,multiple myeloma,,,positive,i,activation,,,,,,0.65,nan,"in order to obtain a more complete picture of mek-erk signalling activation in mm, we also investigated the entire dataset for mutations in nras and kras, two gtpases that are known for long time to be involved in myelomagenesis [xref_bibr, xref_bibr, xref_bibr, xref_bibr].",pmc4695180,1,0.1,39,1,39.1
299,mek,other,,,text,mek,,,waaa,other,,,text,waaa,,,positive,i,activation,,,,,,0.65,nan,"gsea across a larger panel of crc and paca cell lines treated with the bet and mek combination revealed significant enrichment of these signatures in all cell lines evaluated (supplemental figure s11e; supplemental table s7), and in a majority of cell lines this enrichment was specific to or enhanced by the combination.",pmc5908790,1,0.1,39,1,39.1
296,mek,other,,,text,mek,,,raf1,protein,,hgnc:9829,hgnc,9829,,,positive,i,activation,,,,,,0.65,nan,"some of these mechanisms involve activating nras mutations or loss of the ras suppressor nf1, braf amplification or alternative splicing leading to braf truncations and overexpression or mutation of the mek activators craf, cot/tpl2/map3k8 or mlks.",pmc4846800,1,0.1,39,1,39.1
295,mek,other,,,text,mek,,,jak,other,,,text,jak,,,negative,i,inhibition,,,,,,0.65,nan,"this is in concordance with data from a recent study showing that mek inhibition triggers autocrine activation of jak and stat3 pathway in oncogene addicted cells as a positive feedback mechanism (lee etal., 2014).",pmc5537703,1,0.1,39,1,39.1
293,mek,other,,,text,mek,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.65,nan,sustained inhibition of mek and erk signaling by the bet and mek combination.,pmc5908790,1,0.1,39,1,39.1
290,mek,other,,,text,mek,,,erk,other,,,text,erk,,,,d,phosphorylation,,,,,,0.65,nan,"raf serine/threonine kinase phosphorylates mek to activate mek, and activated mek then phosphorylates erk, leading to its activation (shaul and seger, 2007; wellbrock etal., 2004).",pmc5467491,1,0.1,39,1,39.1
275,mapk,other,,,text,mapk,,,parp1,protein,,hgnc:270,hgnc,270,,,negative,i,inhibition,,,,,,0.65,nan,"similar to western blot analysis, parp cleavage was primarily observed in cells treated with combined src and mapk pathway inhibitors.",pmc5833015,1,0.1,39,1,39.1
289,mek,other,,,text,mek,,,cxcr4,protein,,hgnc:2561,hgnc,2561,,,positive,i,increaseamount,,,,,,0.65,nan,"so, based on our results, inhibition of mek and erk pathway can down-regulate the cxcr4 expression in ucb cd34 + cells during exvivo expansion, which may also contribute to the reduced engraftment ability of pd expanded cells.",pmc5824365,1,0.1,39,1,39.1
288,mek,other,,,text,mek,,,cell differentiation,biologicalprocess,,,go,go:0030154,,,negative,i,inhibition,,,,,,0.65,nan,inhibition of mek and erk signalling pathway promotes erythroid differentiation and reduces hscs engraftment in exvivo expanded haematopoietic stem cells.,pmc5824365,1,0.1,39,1,39.1
287,mek,other,,,text,mek,,,cd40,protein,,hgnc:11919,hgnc,11919,,,positive,i,increaseamount,,,,,,0.65,nan,"the expression of cd40, cd80, cd83, and mhci was also reduced by direct mek inhibition, whereas it was unaffected by braf inhibition.",pmc3809567,1,0.1,39,1,39.1
285,mapk8ip1,protein,,hgnc:6882,hgnc,6882,,,jnk,other,,,text,jnk,,,positive,i,activation,,,,,,0.65,nan,"jip1 has been previously shown to mediate tnfalpha stimulation of the jnk pathway, such that tnfalpha treatment may be a useful means to stimulate jnk pathway for the screening that exploits jip1-phosphatase tethers xref_bibr, xref_bibr.",pmc5636874,1,0.1,39,1,39.1
284,mapk7,protein,,hgnc:6880,hgnc,6880,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,0.65,nan,"the authors found that in genetically engineered mice with erk1,2 deficiency, proliferation of intestinal tumor cells was rescued by activation of erk5 signaling.",pmc5723691,1,0.1,39,1,39.1
282,mapk1,protein,,hgnc:6871,hgnc,6871,,,mek,other,,,text,mek,,,,i,dephosphorylation,,,,,,0.65,nan,"downregulation of ras and mapk1 resulted in ras-mapk1 inhibition, decreased mek and akt phosphorylation and decreased myc levels.",pmc5312311,1,0.1,39,1,39.1
281,mapk1,protein,,hgnc:6871,hgnc,6871,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,0.65,nan,"the reduced proliferation induced by tf-np-mir-181a treatment was reversed by lentiviral expression of kras, nras and mapk1 in oci-aml3 cells (xref_supplementary; xref_supplementary) attenuating the anti-leukemic activity of tf-np-mir-181a and thereby supporting the relevance of these targets to leukemogenesis.",pmc5312311,1,0.1,39,1,39.1
280,mapk,other,,,text,mapk,,,tumor microenvironment,other,,,text,tumor microenvironment,,,negative,i,inhibition,,,,,,0.65,nan,mapk inhibition may enhance dc function in the tumor microenvironment by several mechanisms.,pmc3809567,1,0.1,39,1,39.1
1,4'-epidoxorubicin,chemical,,,chebi,chebi:47898,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,"to make a further validation, we explored and found erk phosphorylation elevation in mda-mb-231 cells treated with epirubicin, which further implicated erk pathway inhibitors could be used together with epirubicin or in epirubicin resistant cells.",pmc5746140,1,0.1,39,1,39.1
278,mapk,other,,,text,mapk,,,sos,other,,,text,sos,,,positive,i,activation,,,,,,0.65,nan,"as rasip1 is not included in the kegg and go-terms, these results provide an independent line of evidence of altered mapk signaling in sos.",pmc3498325,1,0.1,39,1,39.1
277,mapk,other,,,text,mapk,,,sensitization,biologicalprocess,,,go,go:0046960,,,positive,i,activation,,,,,,0.65,nan,"these results indicated that the
antinociceptive effect of tgn-020 might possibly be related to the suppression of
astrocytic activation.accumulating evidence shows that all three mapk pathways, such as erk, jnk, and
p38mapk pathways, contribute to pain sensitization after tissue and nerve injury
through distinct molecular and cellular mechanisms.",pmc6113736,1,0.1,39,1,39.1
276,mapk,other,,,text,mapk,,,ras/erk/c-myc,other,,,text,ras/erk/c-myc,,,positive,i,increaseamount,,,,,,0.86,nan,"on the other hand, letrozole + mapk inhibition significantly decreased the protein levels of ras/erk/c-myc (p < 0.05) (xref_fig).",pmc5958651,1,0.1,39,1,39.1
234,kitlg,protein,,hgnc:6343,hgnc,6343,,,cell cycle,biologicalprocess,,,go,go:0007049,,,positive,i,activation,,,,,,0.65,nan,"in addition, erk1/2 actively participates in the process of mouse spermatogonial stem cell factor (scf) accelerating the cell cycle progression by inducing the transient activation of mapk cascades.",pmc5958651,1,0.1,39,1,39.1
232,jun_family,other,,,text,jun_family,,,cell differentiation,biologicalprocess,,,go,go:0030154,,,negative,i,inhibition,,,,,,0.65,nan,"conversely, pu1 and jun -- the important repressors of erythroid differentiation programme 24, 25 -- significantly down-regulated in pd expanded cells.",pmc5824365,1,0.1,39,1,39.1
154,erki,other,,,text,erki,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,negative,i,inhibition,,,,,,0.65,nan,"as expected for p18t-kras g12d, suppressing egfr and her2 activity upstream of mutant kras using afatinib proved ineffective, while monotherapy of meki or erki inhibited proliferation only to a minor extent (xref_fig, right panel).",pmc5127645,1,0.1,39,1,39.1
231,jun,protein,,hgnc:6204,hgnc,6204,,,gata1,protein,,hgnc:4170,hgnc,4170,,,negative,i,inhibition,,,,,,0.65,nan,"as gata1 function is required for erythroid differentiation of human haematopoietic stem cells, the c-jun ability to repress gata1 is most likely responsible for inhibition of erythroid differentiation by c-jun observed in hscs 24.",pmc5824365,1,0.1,39,1,39.1
190,gsk525762,other,,,text,gsk525762,,,erk,other,,,text,erk,,,negative,i,inhibition,,,,,,0.65,nan,"strikingly, combination of gsk525762 with trametinib in rko cells attenuated this reactivation of erk1/2.",pmc5908790,1,0.1,39,1,39.1
189,gnaq,protein,,hgnc:4390,hgnc,4390,,,mapk,other,,,text,mapk,,,positive,i,activation,,,,,,0.65,nan,"although uveal melanomas rarely have braf and nras mutations, the mapk pathway is constitutively activated by gnaq or gna11 mutations that occur in approximately 80% of primary uveal melanomas.",pmc4179759,1,0.1,39,1,39.1
188,gna11,protein,,hgnc:4379,hgnc,4379,,,mapk,other,,,text,mapk,,,positive,i,activation,,,,,,0.65,nan,"although uveal melanomas rarely have braf and nras mutations, the mapk pathway is constitutively activated by gnaq or gna11 mutations that occur in approximately 80% of primary uveal melanomas.",pmc4179759,1,0.1,39,1,39.1
186,glucocorticoid,chemical,,,chebi,chebi:24261,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.65,nan,"while gep of preb 697 shcbp cells showed differential expression of genes upstream of the gr (i.e. scg2, oat, dnajc15) and significant impairment of gr target gene expression in response to gc treatment, no impact was seen on gc induced apoptosis.",pmc5395114,1,0.1,39,1,39.1
184,genomic instability,other,,,text,genomic instability,,,cellular senescence,biologicalprocess,,,go,go:0090398,,,positive,i,activation,,,,,,0.65,nan,it may be reasonable to suggest acquisition of tp53 mutation imparts genomic instability that in turn leads to accumulation of other mutations permissive overcoming senescence and other anti-growth signals induced by constitutive ras activation (for example through acquisition of pten loss of function mutations seen here).,pmc4494777,1,0.1,39,1,39.1
183,gef,biologicalprocess,,,go,go:0008433,,,gtp,chemical,,,chebi,chebi:15996,,,positive,i,activation,,,,,,0.65,nan,"ras activation is catalyzed by guanine nucleotide exchange factors (gefs), such as son of sevenless (sos), which displace gdp and allow gtp to preferentially occupy the vacant nucleotide binding site due to its relative abundance in the cytoplasm.",pmc4067595,1,0.1,39,1,39.1
182,gap,biologicalprocess,,,go,go:0005096,,,signaling,other,,,text,signaling,,,negative,i,inhibition,,,,,,0.65,nan,"the nf1 gene encodes neurofibromin (nf1), a gap that inhibits ras signaling by stimulating hydrolysis of active ras–gtp into inactive ras–gdp.",pmc4067595,1,0.1,39,1,39.1
181,gap,biologicalprocess,,,go,go:0005096,,,ras,other,,,text,ras,,,negative,i,inhibition,,,,,,0.65,nan,"the nf1 gene encodes neurofibromin (nf1), a gap that inhibits ras signaling by stimulating hydrolysis of active ras-gtp into inactive ras-gdp.",pmc4067595,1,0.1,39,1,39.1
180,gabpa,protein,,hgnc:4071,hgnc,4071,,,"transcription, dna-templated",biologicalprocess,,,go,go:0006351,,,positive,i,activation,,,,,,0.86,nan,"amongst the several ets1 members that have been shown to bind at the sites created by the mutation at -124 position, gabpa has been shown to drive efficient tert transcription [xref_bibr].",pmc5288173,1,0.1,39,1,39.1
176,foxo3,protein,,hgnc:3821,hgnc,3821,,,slc2a1,protein,,hgnc:11005,hgnc,11005,,,negative,i,decreaseamount,,,,,,0.65,nan,"among these, stable knockdown of foxo3, ncoa3, and tcf7l2 restored growth in low glucose but reduced mek and mapk phosphorylation, reduced anchorage independent growth, and modulated expressions of glut1 and ras pathway related proteins.",pmc5755028,1,0.1,39,1,39.1
175,foxo3,protein,,hgnc:3821,hgnc,3821,,,ras,other,,,text,ras,,,negative,i,decreaseamount,,,,,,0.65,nan,"among these, stable knockdown of foxo3, ncoa3, and tcf7l2 restored growth in low glucose but reduced mek and mapk phosphorylation, reduced anchorage independent growth, and modulated expressions of glut1 and ras pathway related proteins.",pmc5755028,1,0.1,39,1,39.1
174,foxo3,protein,,hgnc:3821,hgnc,3821,,,mek,other,,,text,mek,,,,i,phosphorylation,,,,,,0.86,nan,"hence, stable knockdown of foxo3, ncoa3, and tcf7l2 significantly reduced anchorage independent growth and mek and erk phosphorylation.",pmc5755028,1,0.1,39,1,39.1
173,foxo3,protein,,hgnc:3821,hgnc,3821,,,mapk,other,,,text,mapk,,,,i,phosphorylation,,,,,,0.65,nan,"among these, stable knockdown of foxo3, ncoa3, and tcf7l2 restored growth in low glucose but reduced mek and mapk phosphorylation, reduced anchorage independent growth, and modulated expressions of glut1 and ras pathway related proteins.",pmc5755028,1,0.1,39,1,39.1
172,foxo3,protein,,hgnc:3821,hgnc,3821,,,kras,protein,,hgnc:6407,hgnc,6407,,,negative,i,inhibition,,,,,,0.65,nan,"stable knockdown of foxo3, ncoa3, and tcf7l2 increased growth of dld-1 kras wt/- cells in low glucose without any growth advantage in normal glucose medium.",pmc5755028,1,0.1,39,1,39.1
170,foxo3,protein,,hgnc:3821,hgnc,3821,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,0.65,nan,"hence, stable knockdown of foxo3, ncoa3, and tcf7l2 significantly reduced anchorage independent growth and mek and erk phosphorylation.",pmc5755028,1,0.1,39,1,39.1
169,fos_family,other,,,text,fos_family,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,"these include multiple transcription factors and targets of erk signaling such as fos and ier3 as well as mapk-phosphatases and sprouty genes involved in feedback inhibition of mek and erk signaling (dual specificity phosphatases 6 (dusp6), dusp1, dusp4, dusp5 and spry4)) [xref_bibr].",pmc2911390,1,0.1,39,1,39.1
168,forskolin,chemical,,,chebi,chebi:42471,,,preb,protein,,hgnc:9356,hgnc,9356,,,positive,i,activation,,,,,,0.65,nan,these genes included those previously identified in mouse embryonic fibroblasts (mef) 15 and also those determined by gep of preb 697 cells treated with ibmx and forskolin (online supplementary table s3).,pmc5395114,1,0.1,39,1,39.1
167,flo8,other,,,text,flo8,,,xv-1 loci,other,,,text,xv-1 loci,,,positive,i,activation,,,,,,0.65,nan,"the chromosome xiv locus corresponds to end3 3s, while allele replacements in a backcross segregant that carried the six-way interaction confirmed that flo8 3s, mss11 by, and ira2delta2933 underlie the chromosome v, xiii, and xv-1 loci, respectively (xref_fig and xref_supplementary; methods).",pmc4618523,1,0.1,39,1,39.1
166,flo8,other,,,text,flo8,,,xiii,other,,,text,xiii,,,positive,i,activation,,,,,,0.65,nan,"the chromosome xiv locus corresponds to end3 3s, while allele replacements in a backcross segregant that carried the six-way interaction confirmed that flo8 3s, mss11 by, and ira2delta2933 underlie the chromosome v, xiii, and xv-1 loci, respectively (xref_fig and xref_supplementary; methods).",pmc4618523,1,0.1,39,1,39.1
165,flo11,other,,,text,flo11,,,ras,other,,,text,ras,,,positive,i,activation,,,,,,0.65,nan,"given that ira2delta2933 alleviated repression of flo11 in 3s, we hypothesized that it might do so by indirectly inhibiting sfl1, which is thought to negatively regulate flo11 and other targets of the ras pathway when ras signaling is low by recruiting the ssn6-tup1 corepressor complex [xref_bibr], which in turn recruits the histone deacetylase hda1 [xref_bibr, xref_bibr].",pmc4618523,1,0.1,39,1,39.1
164,fingolimod hydrochloride,chemical,,,chebi,chebi:63112,,,ppp2,other,,,text,ppp2,,,positive,i,activation,,,,,,0.86,nan,"the pp2a activator fty720 was purchased from cayman chemical (ann arbor, mi, usa).",pmc5467491,1,0.1,39,1,39.1
163,fgf2,protein,,hgnc:3676,hgnc,3676,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.923,nan,"in contrast, fgf2 stimulation or overexpression of constitutively active ras, raf, or mek enhances the activity of the tgf-beta1-induced ras -- erk pathway.",pmc4440819,1,0.1,39,1,39.1
162,fas,protein,,hgnc:11920,hgnc,11920,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,"regulation of erk1/2 activation by saturated fas in pancreatic beta-cells has also been shown [xref_bibr, xref_bibr].",pmc4783893,1,0.1,39,1,39.1
161,fas,protein,,hgnc:11920,hgnc,11920,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.86,nan,"our previous studies as well as others have shown that saturated fas induce apoptosis in pancreatic beta-cells [xref_bibr, xref_bibr, xref_bibr, xref_bibr, xref_bibr, xref_bibr].",pmc4783893,1,0.1,39,1,39.1
160,fa,other,,,text,fa,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,"regulation of erk1/2 activation by saturated fas in pancreatic β-cells has also been shown [ xref , xref ].",pmc4783893,1,0.1,39,1,39.1
156,esr2a,other,,,text,esr2a,,,rerg,protein,,hgnc:15980,hgnc,15980,,,positive,i,increaseamount,,,,,,0.65,nan,"rerg gene expression is stimulated by both estrogen receptor (er) alpha [xref_bibr] and erbeta1 [xref_bibr, xref_bibr], and it has been reported as a marker for eralpha positive luminal like breast cancer and is associated with better clinical outcomes [xref_bibr] or a favorable response to adjuvant tamoxifen treatment [xref_bibr].",pmc5410235,1,0.1,39,1,39.1
155,esr1,protein,,hgnc:3467,hgnc,3467,,,rerg,protein,,hgnc:15980,hgnc,15980,,,positive,i,increaseamount,,,,,,0.86,nan,"rerg gene expression is stimulated by both estrogen receptor (er) alpha [xref_bibr] and erbeta1 [xref_bibr, xref_bibr], and it has been reported as a marker for eralpha positive luminal like breast cancer and is associated with better clinical outcomes [xref_bibr] or a favorable response to adjuvant tamoxifen treatment [xref_bibr].",pmc5410235,1,0.1,39,1,39.1
191,gsk525762,other,,,text,gsk525762,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,"taken together, these data suggest that adaptive rtk activation may account for the gsk525762 mediated induction of mek and erk signaling in this model.",pmc5908790,1,0.1,39,1,39.1
192,gsk525762,other,,,text,gsk525762,,,erk,other,,,text,erk,,,positive,i,increaseamount,,,,,,0.65,nan,"gsk525762 treatment up-regulated p-erk1/2 levels in both ras pathway wild-type and mutant cell lines, suggesting that mek and erk pathway activation may also be a mechanism of adaptive bet inhibitor resistance.",pmc5908790,1,0.1,39,1,39.1
193,gsk525762,other,,,text,gsk525762,,,mek,other,,,text,mek,,,positive,i,activation,,,,,,0.65,nan,"taken together, these data suggest that adaptive rtk activation may account for the gsk525762 mediated induction of mek and erk signaling in this model.",pmc5908790,1,0.1,39,1,39.1
216,integrins,biologicalprocess,,,go,go:0034666,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,negative,i,inhibition,,,,,,0.65,nan,"nevertheless, the activation of the alpha4beta1 integrin after engagement by gc1q and the ubiquitination of hrasgtp downregulated cell proliferation under both 2d and 3d conditions.",pmc5432316,1,0.1,39,1,39.1
229,jnk,other,,,text,jnk,,,jnk,other,,,text,jnk,,,positive,i,activation,,,,,,0.86,nan,the utilized anti-dual phospho-jnk antibody can capture phosphorylated jnk only when both the threonine and tyrosine residues of the tpy motif in the activation loop of jnk are phosphorylated to produce a fully activated form of jnk 50.,pmc5636874,1,0.1,39,1,39.1
228,jnk,other,,,text,jnk,,,jnk,other,,,text,jnk,,,negative,i,inhibition,,,,,,0.65,nan,"further analyses revealed that of three pathway member kinases, ptpn1 directly dephosphorylates jnk, the terminal kinase of the pathway, and negatively regulates the jnk mapk pathway.",pmc5636874,1,0.1,39,1,39.1
227,jnk,other,,,text,jnk,,,cell population proliferation,biologicalprocess,,,go,go:0008283,,,positive,i,activation,,,,,,0.86,nan,"this research highlighted that erk, jnk, and p38 mapk activation was regulated by tlr4 pathway, and that inhibition of tlr4, myd88, erk, jnk, and p38 attenuated proliferation and induced apoptosis esophageal cancer cells in vitro.",pmc5190119,1,0.1,39,1,39.1
226,jnk,other,,,text,jnk,,,cell death,biologicalprocess,,,go,go:0008219,,,positive,i,activation,,,,,,0.86,nan,"thus, it is difficult to observe the cell death response caused by jnk pathway in 293t cells that harbor nfkappab pathway.",pmc5636874,1,0.1,39,1,39.1
225,jnk,other,,,text,jnk,,,cell death,biologicalprocess,,,go,go:0008219,,,negative,i,inhibition,,,,,,0.65,nan,"ptpn1 d181a failed to inhibit tnfalpha stimulated jnk phosphorylation, and led to an increased cell death in p65 deficient mef cells.",pmc5636874,1,0.1,39,1,39.1
224,jnk,other,,,text,jnk,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,negative,i,inhibition,,,,,,0.65,nan,"this research highlighted that erk, jnk, and p38 mapk activation was regulated by tlr4 pathway, and that inhibition of tlr4, myd88, erk, jnk, and p38 attenuated proliferation and induced apoptosis esophageal cancer cells in vitro.",pmc5190119,1,0.1,39,1,39.1
223,irinotecan,chemical,,,chebi,chebi:80630,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.86,nan,"however, apoptosis induced by irinotecan was not obvious compared with controls.",pmc5729429,1,0.1,39,1,39.1
222,iradelta2933,other,,,text,iradelta2933,,,sfl1,other,,,text,sfl1,,,negative,i,inhibition,,,,,,0.65,nan,this suggests that iradelta2933 disrupts sfl1 mediated transcriptional repression of ras target genes.,pmc4618523,1,0.1,39,1,39.1
221,ira2delta2933,other,,,text,ira2delta2933,,,xv-1 loci,other,,,text,xv-1 loci,,,positive,i,activation,,,,,,0.65,nan,"the chromosome xiv locus corresponds to end3 3s, while allele replacements in a backcross segregant that carried the six-way interaction confirmed that flo8 3s, mss11 by, and ira2delta2933 underlie the chromosome v, xiii, and xv-1 loci, respectively (xref_fig and xref_supplementary; methods).",pmc4618523,1,0.1,39,1,39.1
220,ira2delta2933,other,,,text,ira2delta2933,,,xiii,other,,,text,xiii,,,positive,i,activation,,,,,,0.65,nan,"the chromosome xiv locus corresponds to end3 3s, while allele replacements in a backcross segregant that carried the six-way interaction confirmed that flo8 3s, mss11 by, and ira2delta2933 underlie the chromosome v, xiii, and xv-1 loci, respectively (xref_fig and xref_supplementary; methods).",pmc4618523,1,0.1,39,1,39.1
219,iqgap,other,,,text,iqgap,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,"the scaffold protein ksr competes with craf for inhibitor induced braf binding and can counteract the "" paradoxical activation "" of erk, but another scaffold protein, iqgap promotes erk activation and the targeted interruption of its interaction with erk1/2 can contribute to mapk-pathway inhibition.",pmc4846800,1,0.1,39,1,39.1
218,interferon,other,,,text,interferon,,,innate immune response,biologicalprocess,,,go,go:0045087,,,positive,i,activation,,,,,,0.65,nan,"overall, we identified a significant overlap of transcriptional activity induced by oncogenic ras/raf/mek/erk inhibition and innate immune response stimulated by type i ifn.",pmc4535867,1,0.1,39,1,39.1
208,ier3,protein,,hgnc:5392,hgnc,5392,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,"these include multiple transcription factors and targets of erk signaling such as fos and ier3 as well as mapk-phosphatases and sprouty genes involved in feedback inhibition of mek and erk signaling (dual specificity phosphatases 6 (dusp6), dusp1, dusp4, dusp5 and spry4)) [xref_bibr].",pmc2911390,1,0.1,39,1,39.1
194,gtp,chemical,,,chebi,chebi:15996,,,pi3k,other,,,text,pi3k,,,positive,i,activation,,,,,,0.65,nan,"upon activation of a growth factor receptor, ras-guanidine exchange factors (e.g. shp2 encoded by ptpn11) activate ras by enabling binding of gtp, which activates the raf and pi3 kinases and ralgds.",pmc5886052,1,0.1,39,1,39.1
206,histone deacetylase inhibitors,other,,,text,histone deacetylase inhibitors,,,mitf,protein,,hgnc:7105,hgnc,7105,,,positive,i,activation,,,,,,0.65,nan,"xref_bibr because mek independent resistance is not sensitive to mek inhibitor monotherapy, the combined inhibition of mek inhibitors and akt inhibitors or mek inhibitors plus histone deacetylase inhibitors suppressing mitf may reverse the resistance.",pmc4179759,1,0.1,39,1,39.1
205,hgf,protein,,hgnc:4893,hgnc,4893,,,erk,other,,,text,erk,,,positive,i,activation,,,,,,0.65,nan,"furthermore, these conclusions are in line with the previous findings that the ras -- erk pathway induced by hepatocyte growth factor (hgf) or fgf1 interferes with tgf-beta1-induced emt in primary cultured aecs and aec cell lines [xref_bibr, xref_bibr].",pmc4440819,1,0.1,39,1,39.1
204,hdac1,protein,,hgnc:4852,hgnc,4852,,,mitosis,biologicalprocess,,,go,go:0007067,,,positive,i,activation,,,,,,0.65,nan,"studies involving the knockdown of hdac1 have shown that loss of hdac1 expression blocked mitosis in tumor cells (senese etal., 2007), while hdac3 silencing reduces the growth of colon cancer cells (wilson etal., 2006).",pmc5537703,1,0.1,39,1,39.1
203,hcpt,other,,,text,hcpt,,,apoptotic process,biologicalprocess,,,go,go:0006915,,,positive,i,activation,,,,,,0.65,nan,"in addition to negative regulation of topi, hcpt has been reported to enhance apoptosis via p53 [xref_bibr], p38 mapk, erk, akt [xref_bibr], and nf-kappab [xref_bibr] pathways.",pmc5729429,1,0.1,39,1,39.1
202,guanosine,other,,,text,guanosine,,,gtpase,other,,,text,gtpase,,,positive,i,activation,,,,,,0.65,nan,"guanosine triphosphatase (gtpase)-activating enzymes (gaps) stimulate low-level intrinsic gtpase activity and convert ras proteins to their inactive gdp bound forms, whereas corresponding exchange enzymes (guanine nucleotide exchange factors [gefs]) catalyze the replacement of gdp with gtp to activate the switch.",pmc5467702,1,0.1,39,1,39.1
201,guanine,chemical,,,chebi,chebi:16235,,,ras,other,,,text,ras,,,positive,i,activation,,,,,,0.65,nan,"ras activation is catalyzed by guanine nucleotide exchange factors (gefs), such as son of sevenless (sos), which displace gdp and allow gtp to preferentially occupy the vacant nucleotide binding site due to its relative abundance in the cytoplasm.",pmc4067595,1,0.1,39,1,39.1
200,guanine,chemical,,,chebi,chebi:16235,,,mapk,other,,,text,mapk,,,positive,i,activation,,,,,,0.65,nan,"son of sevenless is a guanine nucleotide exchange factor that regulates the activation of ras-gtpases and subsequently induces mapk signaling (gureasko etal., 2008; rogge etal., 1991).",pmc5537703,1,0.1,39,1,39.1
199,guanine,chemical,,,chebi,chebi:16235,,,gtp,chemical,,,chebi,chebi:15996,,,positive,i,activation,,,,,,0.65,nan,"ras activation is catalyzed by guanine nucleotide exchange factors (gefs), such as son of sevenless (sos), which displace gdp and allow gtp to preferentially occupy the vacant nucleotide binding site due to its relative abundance in the cytoplasm.",pmc4067595,1,0.1,39,1,39.1
198,gtpase)-activating enzymes,other,,,text,gtpase)-activating enzymes,,,gtpase,other,,,text,gtpase,,,positive,i,activation,,,,,,0.65,nan,"guanosine triphosphatase (gtpase)-activating enzymes (gaps) stimulate low-level intrinsic gtpase activity and convert ras proteins to their inactive gdp bound forms, whereas corresponding exchange enzymes (guanine nucleotide exchange factors [gefs]) catalyze the replacement of gdp with gtp to activate the switch.",pmc5467702,1,0.1,39,1,39.1
197,gtpase activating proteins,other,,,text,gtpase activating proteins,,,ras,other,,,text,ras,,,negative,i,inhibition,,,,,,0.65,nan,"ras proteins exhibit intrinsic low-level hydrolytic activity and are negatively regulated by gtpase activating proteins (gaps) such as neurofibromin (nf1), which stimulate gtp hydrolysis and formation of inactive ras-gdp.",pmc4067595,1,0.1,39,1,39.1
196,gtp,chemical,,,chebi,chebi:15996,,,ralgds,protein,,hgnc:9842,hgnc,9842,,,positive,i,activation,,,,,,0.65,nan,"upon activation of a growth factor receptor, ras-guanidine exchange factors (e.g. shp2 encoded by ptpn11) activate ras by enabling binding of gtp, which activates the raf and pi3 kinases and ralgds.",pmc5886052,1,0.1,39,1,39.1
195,gtp,chemical,,,chebi,chebi:15996,,,raf,other,,,text,raf,,,positive,i,activation,,,,,,0.65,nan,"upon activation of a growth factor receptor, ras-guanidine exchange factors (e.g. shp2 encoded by ptpn11) activate ras by enabling binding of gtp, which activates the raf and pi3 kinases and ralgds.",pmc5886052,1,0.1,39,1,39.1
558,zr-75-1r,other,,,text,zr-75-1r,,,erk,other,,,text,erk,,,,i,phosphorylation,,,,,,0.65,nan,"consistent with a switch from dependence on akt signaling to dependence on signaling through ras and erk, the zr-75-1r line showed decreased phosphorylation of akt and increased phosphorylation of erk.",pmc2911390,1,0.1,39,1,39.1
